data_1hej_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hej _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 562' ' ' VAL . . . . . 0.523 ' CG1' ' SG ' ' C' ' 641' ' ' CYS . 2.7 p . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.311 0.577 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 563' ' ' SER . . . . . 0.48 ' N ' HG23 ' C' ' 562' ' ' VAL . 0.1 OUTLIER -144.86 141.21 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.131 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.09 121.63 42.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 565' ' ' VAL . . . . . 0.535 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 0.6 OUTLIER -122.46 152.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 566' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' C' ' 565' ' ' VAL . 1.9 ptm85 -52.39 143.78 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 567' ' ' GLY . . . . . . . . . . . . . . . -117.58 -145.75 8.07 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.955 -1.593 . . . . 0.0 109.726 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 568' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.04 118.21 29.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 569' ' ' GLU . . . . . 0.403 ' OE1' ' NH2' ' C' ' 566' ' ' ARG . 0.1 OUTLIER -110.24 177.91 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 570' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 22.0 m-90 -132.89 -92.89 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -138.83 -75.86 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 572' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' C' ' 630' ' ' LYS . 0.8 OUTLIER -80.16 -15.76 56.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 573' ' ' ARG . . . . . 0.422 ' HA ' ' HG3' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -133.05 156.11 47.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 109.315 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 574' ' ' PHE . . . . . 0.551 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 36.4 p90 -134.67 151.83 51.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 575' ' ' ASN . . . . . 0.439 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 4.3 t-20 -122.34 125.32 45.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.398 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 576' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 1.1 t -100.56 158.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 64.7 m -116.78 128.26 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.937 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 578' ' ' TYR . . . . . 0.569 ' HB2' ' CE1' ' C' ' 624' ' ' PHE . 29.8 m-85 -115.24 125.19 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 579' ' ' SER . . . . . 0.456 ' O ' HG21 ' C' ' 562' ' ' VAL . 56.6 m -96.38 141.78 29.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 580' ' ' VAL . . . . . 0.661 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 59.6 t -127.16 160.9 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.573 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 581' ' ' SER . . . . . 0.513 ' N ' HG11 ' C' ' 580' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.469 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.378 0.609 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 586' ' ' TRP . . . . . 0.661 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 27.9 m95 -77.08 124.44 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 110.395 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 587' ' ' VAL . . . . . 0.44 ' O ' HG12 ' C' ' 587' ' ' VAL . 10.0 p -160.14 31.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 588' ' ' VAL . . . . . 0.613 ' CG2' ' O ' ' C' ' 640' ' ' THR . 7.1 p -79.02 148.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.524 -0.735 . . . . 0.0 109.428 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 589' ' ' THR . . . . . 0.54 ' N ' HG21 ' C' ' 588' ' ' VAL . 31.2 m -111.09 114.46 27.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 590' ' ' LEU . . . . . 0.508 ' N ' HD21 ' C' ' 590' ' ' LEU . 4.0 mm? -79.44 126.23 30.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -108.04 87.49 0.49 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 592' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.6 -167.84 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.188 -1.183 . . . . 0.0 109.444 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 593' ' ' ASN . . . . . 0.49 ' ND2' ' OE1' ' C' ' 596' ' ' GLN . 0.9 OUTLIER -111.43 41.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 594' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' C' ' 593' ' ' ASN . . . 44.17 68.8 0.8 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 174.38 -47.18 0.14 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 596' ' ' GLN . . . . . 0.49 ' OE1' ' ND2' ' C' ' 593' ' ' ASN . 0.0 OUTLIER -80.34 170.51 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -1.148 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 4.5 m -151.07 148.12 27.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.541 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.43 113.54 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.492 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 599' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' C' ' 629' ' ' TYR . 6.7 tm0? -89.04 -27.97 20.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.06 168.41 10.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 5.9 p -164.46 163.3 22.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.373 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 602' ' ' TRP . . . . . 0.527 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 31.3 p90 -155.66 158.57 38.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 603' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' C' ' 602' ' ' TRP . 0.4 OUTLIER 76.31 18.98 1.78 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 604' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 164.2 158.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 605' ' ' ALA . . . . . 0.465 ' O ' HD11 ' C' ' 606' ' ' LEU . . . -100.99 154.45 18.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 606' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' C' ' 613' ' ' VAL . 2.2 mp -118.91 164.3 15.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.3 m -131.09 94.17 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.38 17.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 609' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' C' ' 610' ' ' SER . 25.0 m -163.16 29.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 610' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.2 OUTLIER 163.98 106.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 115.61 -87.13 0.43 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 612' ' ' THR . . . . . 0.52 ' CG2' HG22 ' C' ' 589' ' ' THR . 18.4 m -127.35 103.99 7.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 613' ' ' VAL . . . . . 0.517 ' CG1' ' HG ' ' C' ' 606' ' ' LEU . 2.1 t -106.38 109.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.172 -0.955 . . . . 0.0 108.763 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 614' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 0.5 OUTLIER -93.01 145.12 24.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 110.028 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 615' ' ' ALA . . . . . 0.624 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -81.09 167.76 19.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.366 -0.834 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -145.95 153.0 49.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.09 135.12 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.619 2.213 . . . . 0.0 110.421 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 618' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' C' ' 605' ' ' ALA . 6.6 m120 -153.47 26.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 160.22 -93.22 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 2.1 m -178.8 55.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -119.43 118.9 4.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 622' ' ' ASN . . . . . 0.47 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 1.8 m120 -87.98 -22.96 23.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -1.141 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 623' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 55.6 m -107.08 121.88 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 624' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' C' ' 578' ' ' TYR . 11.6 p90 -130.31 142.83 50.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -99.5 147.53 18.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 626' ' ' VAL . . . . . 0.525 ' CG2' ' CE2' ' C' ' 624' ' ' PHE . 23.9 t -139.55 133.08 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -1.175 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 86.9 m -87.87 150.58 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 628' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 91.0 m-85 -136.95 124.95 22.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 629' ' ' TYR . . . . . 0.571 ' CE2' ' HG3' ' C' ' 599' ' ' GLN . 11.1 m-85 -73.34 139.48 46.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 630' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' C' ' 572' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 636' ' ' THR . . . . . 0.534 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 3.5 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 637' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 34.7 Cg_endo -76.95 170.07 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.364 2.043 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -141.27 152.88 23.6 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -95.66 134.8 38.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.521 -0.988 . . . . 0.0 109.269 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 640' ' ' THR . . . . . 0.613 ' O ' ' CG2' ' C' ' 588' ' ' VAL . 0.3 OUTLIER -98.41 143.2 29.12 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.048 0.928 . . . . 0.0 111.046 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 641' ' ' CYS . . . . . 0.523 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 1.5 m . . . . . 0 C--N 1.294 -1.832 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 562' ' ' VAL . . . . . 0.556 ' CG1' ' SG ' ' C' ' 641' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 563' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 19.7 m -154.3 137.6 15.75 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -119.73 90.54 3.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.085 . . . . 0.0 110.156 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 565' ' ' VAL . . . . . 0.561 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 2.0 t -79.85 154.2 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 566' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.41 65.04 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.034 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 567' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' C' ' 569' ' ' GLU . . . -53.08 164.07 2.06 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 568' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' C' ' 575' ' ' ASN . 1.4 mt-10 -42.52 152.64 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 109.913 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 569' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' C' ' 567' ' ' GLY . 0.6 OUTLIER -160.08 97.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.003 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 570' ' ' TRP . . . . . 0.55 ' CE3' ' HB3' ' C' ' 573' ' ' ARG . 10.6 m-90 -57.22 167.12 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 109.553 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 571' ' ' ALA . . . . . 0.428 ' C ' ' HE3' ' C' ' 630' ' ' LYS . . . -67.12 -24.73 65.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.03 -7.29 13.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.335 -0.853 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 573' ' ' ARG . . . . . 0.55 ' HB3' ' CE3' ' C' ' 570' ' ' TRP . 0.1 OUTLIER -134.5 164.48 27.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 574' ' ' PHE . . . . . 0.525 ' O ' ' CG2' ' C' ' 627' ' ' THR . 0.2 OUTLIER -128.84 163.54 25.0 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.323 -0.86 . . . . 0.0 110.705 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 575' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' C' ' 568' ' ' GLU . 2.0 t-20 -157.56 67.6 0.51 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 576' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' C' ' 578' ' ' TYR . 2.9 t -79.67 153.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.56 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 577' ' ' THR . . . . . 0.469 ' O ' HG22 ' C' ' 565' ' ' VAL . 99.5 m -112.94 91.56 3.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 578' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' C' ' 576' ' ' VAL . 63.6 m-85 -85.96 150.43 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 579' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' C' ' 623' ' ' SER . 4.2 m -138.08 131.51 30.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.871 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 580' ' ' VAL . . . . . 0.648 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 2.6 t -106.6 155.26 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 586' ' ' TRP . . . . . 0.648 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 19.6 m95 -69.92 130.73 43.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 111.439 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 587' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' C' ' 586' ' ' TRP . 2.0 t -158.84 29.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 588' ' ' VAL . . . . . 0.606 ' CG1' ' N ' ' C' ' 589' ' ' THR . 2.1 t -79.24 165.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.754 0.788 . . . . 0.0 110.0 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 589' ' ' THR . . . . . 0.606 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -110.47 157.31 19.73 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 590' ' ' LEU . . . . . 0.462 HD11 ' O ' ' C' ' 613' ' ' VAL . 1.1 mp -121.74 132.65 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.002 . . . . 0.0 109.628 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -113.12 77.32 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 592' ' ' LEU . . . . . 0.5 ' N ' HD22 ' C' ' 592' ' ' LEU . 5.6 mt -58.14 145.14 37.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.201 -1.176 . . . . 0.0 109.554 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 593' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 85.5 m-20 -107.41 120.79 43.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.46 9.81 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 49.89 45.79 40.74 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 596' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 47.2 mt-30 -75.96 157.48 33.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 0.0 109.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 597' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.9 OUTLIER -116.37 169.29 9.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 109.436 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 598' ' ' VAL . . . . . 0.469 HG12 ' CD1' ' C' ' 606' ' ' LEU . 59.4 t -97.59 121.85 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 599' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 1.9 tt0 -85.11 -50.95 6.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 1.9 m -165.93 155.39 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 39.4 p -147.93 155.59 41.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 602' ' ' TRP . . . . . 0.501 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 30.5 p90 -137.41 154.32 49.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 603' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.52 30.21 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 604' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 163.9 146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 605' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' C' ' 616' ' ' ARG . . . -86.1 166.28 15.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 606' ' ' LEU . . . . . 0.469 ' CD1' HG12 ' C' ' 598' ' ' VAL . 22.9 mt -120.73 154.19 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 607' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' C' ' 616' ' ' ARG . 90.6 m -133.8 74.39 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 136.26 -160.77 24.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 609' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' C' ' 610' ' ' SER . 22.8 p -177.78 35.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.417 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 610' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.5 OUTLIER 166.11 145.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 68.42 -139.62 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 612' ' ' THR . . . . . 0.473 ' CG2' HG23 ' C' ' 589' ' ' THR . 3.3 m -79.94 107.1 12.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 613' ' ' VAL . . . . . 0.462 ' O ' HD11 ' C' ' 590' ' ' LEU . 2.1 t -103.38 157.17 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.237 -0.914 . . . . 0.0 108.887 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 614' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 1.3 m -121.47 139.03 54.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 109.645 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 615' ' ' ALA . . . . . 0.647 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -89.39 159.25 17.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 616' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' C' ' 607' ' ' THR . 3.0 mtt180 -132.35 153.31 81.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 617' ' ' PRO . . . . . 0.472 ' N ' ' HB2' ' C' ' 586' ' ' TRP . 35.5 Cg_endo -77.86 127.81 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -117.55 14.32 14.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 60.04 71.67 0.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 70.1 m -154.92 -41.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.19 -167.73 39.49 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 622' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 580' ' ' VAL . 28.4 m120 -107.42 -21.28 12.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 623' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' C' ' 579' ' ' SER . 96.4 p -81.62 121.75 26.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 624' ' ' PHE . . . . . 0.628 ' CE1' ' CH2' ' C' ' 586' ' ' TRP . 2.8 p90 -137.84 142.75 40.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -105.66 139.91 14.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 626' ' ' VAL . . . . . 0.566 HG13 ' CZ ' ' C' ' 628' ' ' PHE . 53.8 t -134.31 133.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.14 . . . . 0.0 109.634 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 627' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' C' ' 574' ' ' PHE . 45.8 m -95.41 145.24 25.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 628' ' ' PHE . . . . . 0.566 ' CZ ' HG13 ' C' ' 626' ' ' VAL . 91.8 m-85 -126.9 144.56 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 629' ' ' TYR . . . . . 0.531 ' CE1' ' HG2' ' C' ' 573' ' ' ARG . 11.0 m-85 -97.47 136.1 38.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 630' ' ' LYS . . . . . 0.525 ' HD3' ' CE1' ' C' ' 574' ' ' PHE . 27.5 pttt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 636' ' ' THR . . . . . 0.455 HG22 ' HD2' ' C' ' 637' ' ' PRO . 28.9 m . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 637' ' ' PRO . . . . . 0.514 ' CD ' ' CE2' ' C' ' 574' ' ' PHE . 35.9 Cg_endo -79.78 170.82 16.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.375 2.05 . . . . 0.0 109.927 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 638' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' C' ' 578' ' ' TYR . . . -163.44 156.94 28.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.365 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -81.02 179.03 8.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.467 -1.019 . . . . 0.0 109.014 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 640' ' ' THR . . . . . 0.571 ' O ' HG11 ' C' ' 588' ' ' VAL . 0.2 OUTLIER -130.4 140.75 50.57 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.141 0.972 . . . . 0.0 111.122 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 641' ' ' CYS . . . . . 0.556 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.493 1.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.448 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 562' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' C' ' 641' ' ' CYS . 2.3 t . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 167.23 13.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 109.646 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -132.33 92.89 3.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 565' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 1.9 t -79.77 162.02 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.933 . . . . 0.0 109.191 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 566' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.1 OUTLIER -83.13 62.01 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 567' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' C' ' 566' ' ' ARG . . . -37.3 157.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 568' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 27.5 mt-10 -39.98 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -1.039 . . . . 0.0 110.2 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 569' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' C' ' 568' ' ' GLU . 2.9 mp0 -147.14 -163.92 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 570' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -141.5 -96.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -139.4 -72.89 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.035 -1.041 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.73 -37.11 36.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 108.863 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 573' ' ' ARG . . . . . 0.559 ' HB3' ' CE1' ' C' ' 629' ' ' TYR . 33.0 ptt180 -110.17 149.96 29.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 0.0 109.012 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 574' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 11.5 p90 -130.05 154.17 47.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 575' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' C' ' 568' ' ' GLU . 11.7 t-20 -108.09 172.48 6.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.182 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 576' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 2.3 t -150.12 157.71 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 32.7 m -128.7 94.66 3.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 578' ' ' TYR . . . . . 0.64 ' CD2' ' CE1' ' C' ' 624' ' ' PHE . 92.8 m-85 -79.82 137.55 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 3.4 m -120.07 121.31 38.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 580' ' ' VAL . . . . . 0.629 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 2.8 t -108.79 142.61 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 586' ' ' TRP . . . . . 0.629 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 24.3 m95 -69.57 120.85 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 587' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.88 31.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 588' ' ' VAL . . . . . 0.609 ' CG2' ' O ' ' C' ' 640' ' ' THR . 2.9 p -79.26 149.98 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 589' ' ' THR . . . . . 0.559 ' CG2' ' CG2' ' C' ' 612' ' ' THR . 0.2 OUTLIER -112.63 115.87 29.28 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 590' ' ' LEU . . . . . 0.456 HD11 ' O ' ' C' ' 613' ' ' VAL . 6.4 mp -81.74 128.77 34.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -101.81 88.89 0.73 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 592' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' C' ' 596' ' ' GLN . 9.6 mp -75.17 122.12 23.14 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 593' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 26.0 m-80 -111.5 138.69 47.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 96.63 31.04 7.28 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 58.38 19.86 42.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 596' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 1.8 mm100 -51.75 156.42 1.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -1.143 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 597' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.5 OUTLIER -141.56 153.83 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.45 140.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 599' ' ' GLN . . . . . 0.462 ' OE1' ' OH ' ' C' ' 629' ' ' TYR . 6.4 tt0 -109.54 -42.56 4.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.08 160.3 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 601' ' ' SER . . . . . 0.468 ' OG ' HG11 ' C' ' 626' ' ' VAL . 0.7 OUTLIER -159.75 164.12 34.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 602' ' ' TRP . . . . . 0.57 ' CH2' ' HA2' ' C' ' 625' ' ' GLY . 14.2 p90 -153.24 170.48 20.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 603' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' C' ' 602' ' ' TRP . 3.9 t-20 76.4 12.78 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.486 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 604' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 165.28 173.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -121.67 139.94 52.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 606' ' ' LEU . . . . . 0.511 HD22 ' CG1' ' C' ' 613' ' ' VAL . 6.7 mp -114.23 163.0 15.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 63.2 m -120.24 106.67 12.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 130.49 147.04 6.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 609' ' ' SER . . . . . . . . . . . . . 4.7 p -116.34 -6.06 11.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 32.9 t -173.38 124.09 0.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.01 -124.37 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 612' ' ' THR . . . . . 0.559 ' CG2' ' CG2' ' C' ' 589' ' ' THR . 92.8 m -90.15 106.78 18.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -1.19 . . . . 0.0 109.389 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 613' ' ' VAL . . . . . 0.511 ' CG1' HD22 ' C' ' 606' ' ' LEU . 2.1 t -103.21 117.99 49.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.004 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 614' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 6.9 m -90.22 137.63 32.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 615' ' ' ALA . . . . . 0.608 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -79.29 145.91 33.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 109.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 616' ' ' ARG . . . . . 0.456 ' HG2' ' HD2' ' C' ' 617' ' ' PRO . 0.0 OUTLIER -131.46 143.83 50.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.441 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 617' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' C' ' 616' ' ' ARG . 36.0 Cg_endo -78.39 155.17 28.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 110.314 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -145.51 32.78 1.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.86 . . . . 0.0 109.316 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 110.24 57.26 0.51 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.53 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.235 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.6 99.01 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 622' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' C' ' 580' ' ' VAL . 16.9 m120 -97.83 -0.36 45.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.629 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 623' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 3.3 m -117.04 126.79 53.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.075 -1.015 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 624' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' C' ' 578' ' ' TYR . 23.4 p90 -142.87 141.65 31.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 625' ' ' GLY . . . . . 0.57 ' HA2' ' CH2' ' C' ' 602' ' ' TRP . . . -109.49 142.09 16.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 626' ' ' VAL . . . . . 0.468 HG11 ' OG ' ' C' ' 601' ' ' SER . 3.2 t -140.51 156.37 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 627' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' C' ' 599' ' ' GLN . 68.6 m -121.52 140.99 51.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 628' ' ' PHE . . . . . 0.568 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 18.6 m-85 -132.05 140.98 49.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 629' ' ' TYR . . . . . 0.559 ' CE1' ' HB3' ' C' ' 573' ' ' ARG . 60.5 m-85 -86.37 124.13 32.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.937 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 630' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.505 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 636' ' ' THR . . . . . 0.536 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 2.6 m . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 637' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 35.6 Cg_endo -77.36 97.33 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.421 2.08 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -71.74 152.29 48.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -101.48 133.3 46.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -1.108 . . . . 0.0 109.548 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 640' ' ' THR . . . . . 0.609 ' O ' ' CG2' ' C' ' 588' ' ' VAL . 0.3 OUTLIER -99.66 145.91 27.07 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.9 0.857 . . . . 0.0 111.2 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 641' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' C' ' 562' ' ' VAL . 1.6 m . . . . . 0 C--N 1.296 -1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 109.262 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 562' ' ' VAL . . . . . 0.541 ' CG2' ' SG ' ' C' ' 641' ' ' CYS . 1.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.426 0.631 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 71.7 m -127.83 138.02 52.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -95.53 130.26 42.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.755 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 565' ' ' VAL . . . . . 0.551 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 1.9 t -117.81 163.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.104 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 566' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' C' ' 567' ' ' GLY . 1.0 OUTLIER -83.09 62.62 6.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 567' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -41.34 165.95 0.01 OUTLIER Glycine 0 N--CA 1.485 1.919 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 568' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 6.6 mt-10 -41.43 165.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.445 -1.033 . . . . 0.0 110.184 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.29 -162.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 570' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 27.4 m-90 -151.94 -100.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.63 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -142.03 -68.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.08 . . . . 0.0 109.481 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 572' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' C' ' 630' ' ' LYS . 0.9 OUTLIER -79.88 -17.78 52.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 0.0 109.331 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 573' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 144.36 47.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 109.185 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 574' ' ' PHE . . . . . 0.635 ' CE1' ' CG2' ' C' ' 636' ' ' THR . 36.6 p90 -122.29 151.57 40.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.371 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 575' ' ' ASN . . . . . 0.514 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.5 t-20 -113.61 152.14 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 576' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 2.5 t -128.36 156.83 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 577' ' ' THR . . . . . 0.458 ' O ' HG22 ' C' ' 565' ' ' VAL . 18.8 m -127.61 104.54 7.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 578' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' C' ' 623' ' ' SER . 67.8 m-85 -91.47 146.42 23.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 579' ' ' SER . . . . . 0.475 ' O ' HG11 ' C' ' 562' ' ' VAL . 1.1 m -125.5 115.07 19.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 580' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' C' ' 562' ' ' VAL . 11.6 t -85.09 161.26 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 581' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' C' ' 580' ' ' VAL . 14.8 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.027 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 586' ' ' TRP . . . . . 0.633 ' CZ3' ' CB ' ' C' ' 615' ' ' ALA . 60.3 p-90 -87.8 112.73 22.75 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.883 . . . . 0.0 109.7 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 587' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -107.39 96.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 588' ' ' VAL . . . . . 0.6 ' CG1' ' N ' ' C' ' 589' ' ' THR . 11.5 t -79.53 161.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.192 0.996 . . . . 0.0 110.729 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 589' ' ' THR . . . . . 0.6 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -120.48 104.1 9.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 590' ' ' LEU . . . . . 0.52 HD11 ' CG1' ' C' ' 613' ' ' VAL . 0.2 OUTLIER -78.78 137.01 37.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.044 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -125.58 78.02 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 592' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' C' ' 592' ' ' LEU . 2.5 mt -61.86 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.311 -1.111 . . . . 0.0 109.537 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 593' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -100.25 29.96 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.96 55.26 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . -134.22 -65.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.38 164.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -1.17 . . . . 0.0 109.466 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 11.9 p -148.33 154.6 40.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 63.8 t -85.05 137.28 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 599' ' ' GLN . . . . . 0.561 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 16.9 tm0? -106.95 -41.19 5.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 600' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' C' ' 599' ' ' GLN . 34.9 p -165.84 151.22 8.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 601' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' C' ' 626' ' ' VAL . 38.2 m -145.37 150.79 37.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 602' ' ' TRP . . . . . 0.522 ' CZ2' ' HA2' ' C' ' 625' ' ' GLY . 45.6 p90 -129.62 157.42 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 603' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' C' ' 602' ' ' TRP . 0.1 OUTLIER 76.22 20.04 1.66 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 604' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 156.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.443 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 605' ' ' ALA . . . . . 0.422 ' C ' HD23 ' C' ' 606' ' ' LEU . . . -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 606' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' C' ' 606' ' ' LEU . 3.6 mm? -102.16 170.71 7.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.9 m -123.61 121.51 35.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 608' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' C' ' 609' ' ' SER . . . 99.84 -56.0 0.87 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 609' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' C' ' 608' ' ' GLY . 2.8 m 69.28 24.21 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 6.8 p -171.82 150.49 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 53.41 -119.35 10.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 612' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' C' ' 590' ' ' LEU . 57.3 m -86.19 108.14 18.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 613' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' C' ' 590' ' ' LEU . 2.1 t -102.28 164.56 3.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.247 -0.908 . . . . 0.0 108.89 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 614' ' ' THR . . . . . 0.498 ' N ' ' CG1' ' C' ' 613' ' ' VAL . 8.9 m -130.36 146.82 51.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 615' ' ' ALA . . . . . 0.633 ' CB ' ' CZ3' ' C' ' 586' ' ' TRP . . . -79.68 157.71 27.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.115 -0.991 . . . . 0.0 109.467 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 83.34 2.22 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 142.86 20.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.694 2.263 . . . . 0.0 110.465 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -111.56 -15.99 13.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . -147.74 48.73 0.63 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.21 42.18 7.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -81.94 114.83 3.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 622' ' ' ASN . . . . . 0.482 ' CB ' ' HB ' ' C' ' 580' ' ' VAL . 57.4 m-20 -106.77 -42.49 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 623' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 15.0 m -92.17 118.27 30.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 624' ' ' PHE . . . . . 0.477 ' CB ' ' HB1' ' C' ' 604' ' ' ALA . 28.9 p90 -143.14 152.41 41.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.551 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 625' ' ' GLY . . . . . 0.522 ' HA2' ' CZ2' ' C' ' 602' ' ' TRP . . . -108.85 134.94 12.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 626' ' ' VAL . . . . . 0.435 ' HA ' ' OG ' ' C' ' 601' ' ' SER . 25.8 t -126.58 134.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 53.9 m -79.9 159.77 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 628' ' ' PHE . . . . . 0.578 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 78.7 m-85 -150.62 116.76 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 629' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 46.7 m-85 -69.87 138.42 52.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 630' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' C' ' 572' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 O-C-N 121.201 -0.937 . . . . 0.0 108.985 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 636' ' ' THR . . . . . 0.635 ' CG2' ' CE1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 637' ' ' PRO . . . . . 0.546 ' HG3' ' CG ' ' C' ' 628' ' ' PHE . 35.2 Cg_endo -77.94 172.19 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.636 2.224 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -148.26 133.78 4.76 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.137 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -90.88 131.54 36.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.959 . . . . 0.0 108.858 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 640' ' ' THR . . . . . 0.579 ' O ' HG11 ' C' ' 588' ' ' VAL . 2.7 m -93.85 150.35 20.46 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.355 1.074 . . . . 0.0 111.973 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 641' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' C' ' 588' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.476 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 562' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' C' ' 641' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.685 0.755 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 563' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 3.3 m -160.23 158.48 30.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -140.08 84.85 1.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 565' ' ' VAL . . . . . 0.547 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 1.9 t -79.79 166.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 109.036 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 566' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.0 OUTLIER -83.64 61.63 6.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 567' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' C' ' 568' ' ' GLU . . . -38.95 154.97 0.02 OUTLIER Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 568' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 32.5 mt-10 -44.48 170.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 109.904 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 569' ' ' GLU . . . . . 0.416 ' HB3' ' HA ' ' C' ' 574' ' ' PHE . 20.1 mt-10 -141.15 -164.07 1.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 570' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 15.0 m-90 -140.7 -100.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.603 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -143.54 -71.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.525 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.96 -11.2 59.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 573' ' ' ARG . . . . . 0.561 ' HD3' ' CE1' ' C' ' 629' ' ' TYR . 0.0 OUTLIER -144.1 145.3 32.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.913 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 574' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' C' ' 628' ' ' PHE . 52.7 p90 -110.97 159.17 17.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 575' ' ' ASN . . . . . 0.576 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 11.0 t-20 -116.27 170.5 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 576' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 2.5 t -150.51 157.16 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.828 . . . . 0.0 109.308 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 20.7 m -122.01 102.99 8.51 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 578' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' C' ' 563' ' ' SER . 96.7 m-85 -88.9 133.64 34.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 579' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 3.5 m -114.48 146.82 40.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 580' ' ' VAL . . . . . 0.658 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 41.7 t -128.9 156.2 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.591 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 581' ' ' SER . . . . . 0.513 ' N ' HG11 ' C' ' 580' ' ' VAL . 13.2 m . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.055 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 586' ' ' TRP . . . . . 0.658 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 28.0 m95 -69.75 124.14 23.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 110.572 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 587' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' C' ' 586' ' ' TRP . 21.2 t -159.87 31.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 588' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' C' ' 640' ' ' THR . 6.0 p -79.28 148.29 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 589' ' ' THR . . . . . 0.541 ' N ' HG21 ' C' ' 588' ' ' VAL . 40.3 m -111.24 115.76 29.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 590' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.75 127.4 32.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.243 -0.91 . . . . 0.0 109.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -107.58 79.04 0.25 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 592' ' ' LEU . . . . . 0.513 ' N ' HD22 ' C' ' 592' ' ' LEU . 1.0 OUTLIER -65.62 -173.36 0.15 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.179 -1.189 . . . . 0.0 109.384 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 593' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' C' ' 593' ' ' ASN . 2.8 m-20 -91.27 -163.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . -90.96 69.12 2.19 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 150.64 -28.82 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -61.95 134.15 56.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.47 162.49 27.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.81 126.13 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 599' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' C' ' 600' ' ' SER . 14.2 tm0? -91.0 -43.75 9.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 600' ' ' SER . . . . . 0.508 ' HB3' ' NE2' ' C' ' 599' ' ' GLN . 36.7 p -163.82 170.13 17.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 601' ' ' SER . . . . . 0.459 ' HB3' HG21 ' C' ' 626' ' ' VAL . 1.8 p -161.33 165.56 28.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.264 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 602' ' ' TRP . . . . . 0.569 ' CH2' ' HA2' ' C' ' 625' ' ' GLY . 26.2 p90 -158.48 159.39 35.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 603' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.04 21.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 604' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 169.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -110.62 172.86 6.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 606' ' ' LEU . . . . . 0.447 HD22 ' OG ' ' C' ' 601' ' ' SER . 3.4 pp -151.71 155.06 37.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 607' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' C' ' 613' ' ' VAL . 4.4 m -120.11 109.24 15.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 116.83 178.99 17.88 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 609' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' C' ' 610' ' ' SER . 1.1 m -154.63 20.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -1.16 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 610' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' C' ' 609' ' ' SER . 3.1 p 164.11 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.501 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.98 -98.94 0.93 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 612' ' ' THR . . . . . 0.526 ' CG2' HG22 ' C' ' 589' ' ' THR . 83.8 m -122.15 101.95 7.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 109.426 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 613' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' C' ' 614' ' ' THR . 2.1 t -106.14 165.41 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.188 -0.945 . . . . 0.0 108.964 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 614' ' ' THR . . . . . 0.503 ' N ' ' CG1' ' C' ' 613' ' ' VAL . 11.7 m -139.18 137.24 35.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.978 . . . . 0.0 109.571 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 615' ' ' ALA . . . . . 0.628 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -79.55 137.24 37.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 616' ' ' ARG . . . . . 0.534 ' CG ' ' HD2' ' C' ' 617' ' ' PRO . 42.3 ttp180 -113.21 140.94 24.91 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.335 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 617' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' C' ' 616' ' ' ARG . 35.9 Cg_endo -77.88 138.46 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.418 2.079 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -115.35 -11.3 11.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 619' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 130.5 -2.48 5.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 620' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 166.73 126.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -1.209 . . . . 0.0 109.469 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 148.28 113.71 0.73 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 622' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' C' ' 580' ' ' VAL . 25.1 m120 -115.65 -18.48 10.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.492 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 623' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 50.4 m -116.61 111.39 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.182 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 624' ' ' PHE . . . . . 0.561 ' CE2' HG22 ' C' ' 626' ' ' VAL . 33.1 p90 -123.07 142.74 50.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 625' ' ' GLY . . . . . 0.569 ' HA2' ' CH2' ' C' ' 602' ' ' TRP . . . -102.47 153.91 18.44 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 626' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' C' ' 624' ' ' PHE . 59.1 t -149.67 141.49 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 627' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' C' ' 628' ' ' PHE . 21.6 m -102.19 166.15 10.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.352 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 628' ' ' PHE . . . . . 0.572 ' HB2' ' CZ ' ' C' ' 574' ' ' PHE . 97.0 m-85 -143.57 125.29 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.575 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 629' ' ' TYR . . . . . 0.561 ' CE1' ' HD3' ' C' ' 573' ' ' ARG . 10.3 m-85 -81.15 127.55 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 630' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' C' ' 629' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.535 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 636' ' ' THR . . . . . 0.57 HG21 ' CE2' ' C' ' 574' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 637' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' C' ' 628' ' ' PHE . 35.9 Cg_endo -78.61 171.13 17.2 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.539 2.159 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -147.73 139.45 7.79 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -93.39 132.05 38.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -1.074 . . . . 0.0 109.168 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 640' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' C' ' 588' ' ' VAL . 0.4 OUTLIER -98.46 143.63 28.69 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.994 0.902 . . . . 0.0 111.12 -179.252 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 641' ' ' CYS . . . . . 0.53 ' HB2' ' CG2' ' C' ' 562' ' ' VAL . 1.5 m . . . . . 0 C--N 1.294 -1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.533 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.247 0.546 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . -164.6 53.73 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 559' ' ' SER . . . . . 0.467 ' HB3' HG21 ' C' ' 643' ' ' THR . 57.0 p -84.98 170.64 12.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -1.139 . . . . 0.0 109.377 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 560' ' ' CYS . . . . . 0.451 ' SG ' HG13 ' C' ' 562' ' ' VAL . 0.0 OUTLIER -88.24 161.19 17.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 561' ' ' SER . . . . . . . . . . . . . 4.4 p -108.01 116.57 32.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 108.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 562' ' ' VAL . . . . . 0.523 ' CG1' ' SG ' ' C' ' 641' ' ' CYS . 2.7 p -160.86 161.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.005 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 563' ' ' SER . . . . . 0.48 ' N ' HG23 ' C' ' 562' ' ' VAL . 0.1 OUTLIER -144.86 141.21 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.131 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.09 121.63 42.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 565' ' ' VAL . . . . . 0.535 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 0.6 OUTLIER -122.46 152.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 566' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' C' ' 565' ' ' VAL . 1.9 ptm85 -52.39 143.78 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 567' ' ' GLY . . . . . . . . . . . . . . . -117.58 -145.75 8.07 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.955 -1.593 . . . . 0.0 109.726 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 568' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.04 118.21 29.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 569' ' ' GLU . . . . . 0.403 ' OE1' ' NH2' ' C' ' 566' ' ' ARG . 0.1 OUTLIER -110.24 177.91 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 570' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 22.0 m-90 -132.89 -92.89 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -138.83 -75.86 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 572' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' C' ' 630' ' ' LYS . 0.8 OUTLIER -80.16 -15.76 56.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 573' ' ' ARG . . . . . 0.422 ' HA ' ' HG3' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -133.05 156.11 47.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 109.315 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 574' ' ' PHE . . . . . 0.551 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 36.4 p90 -134.67 151.83 51.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 575' ' ' ASN . . . . . 0.439 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 4.3 t-20 -122.34 125.32 45.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.398 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 576' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 1.1 t -100.56 158.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 64.7 m -116.78 128.26 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.937 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 578' ' ' TYR . . . . . 0.569 ' HB2' ' CE1' ' C' ' 624' ' ' PHE . 29.8 m-85 -115.24 125.19 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 579' ' ' SER . . . . . 0.456 ' O ' HG21 ' C' ' 562' ' ' VAL . 56.6 m -96.38 141.78 29.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 580' ' ' VAL . . . . . 0.661 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 59.6 t -127.16 160.9 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.573 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 581' ' ' SER . . . . . 0.513 ' N ' HG11 ' C' ' 580' ' ' VAL . 0.1 OUTLIER -110.41 -26.89 9.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.469 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 582' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' C' ' 583' ' ' SER . . . -96.49 -70.39 1.04 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 583' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' C' ' 582' ' ' GLY . 0.2 OUTLIER 81.33 -66.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.893 . . . . 0.0 109.435 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 584' ' ' SER . . . . . 0.427 ' C ' ' O ' ' C' ' 583' ' ' SER . 1.5 m -43.34 -29.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 0.0 109.448 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 30.5 t -110.98 66.08 0.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 586' ' ' TRP . . . . . 0.661 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 27.9 m95 -77.08 124.44 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 110.395 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 587' ' ' VAL . . . . . 0.44 ' O ' HG12 ' C' ' 587' ' ' VAL . 10.0 p -160.14 31.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 588' ' ' VAL . . . . . 0.613 ' CG2' ' O ' ' C' ' 640' ' ' THR . 7.1 p -79.02 148.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.524 -0.735 . . . . 0.0 109.428 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 589' ' ' THR . . . . . 0.54 ' N ' HG21 ' C' ' 588' ' ' VAL . 31.2 m -111.09 114.46 27.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 590' ' ' LEU . . . . . 0.508 ' N ' HD21 ' C' ' 590' ' ' LEU . 4.0 mm? -79.44 126.23 30.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -108.04 87.49 0.49 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 592' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.6 -167.84 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.188 -1.183 . . . . 0.0 109.444 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 593' ' ' ASN . . . . . 0.506 ' ND2' ' HB1' ' C' ' 635' ' ' ALA . 0.9 OUTLIER -111.43 41.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 594' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' C' ' 593' ' ' ASN . . . 44.17 68.8 0.8 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 174.38 -47.18 0.14 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 596' ' ' GLN . . . . . 0.49 ' OE1' ' ND2' ' C' ' 593' ' ' ASN . 0.0 OUTLIER -80.34 170.51 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -1.148 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 4.5 m -151.07 148.12 27.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.541 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 85.1 t -69.43 113.54 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.492 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 599' ' ' GLN . . . . . 0.571 ' HG3' ' CE2' ' C' ' 629' ' ' TYR . 6.7 tm0? -89.04 -27.97 20.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.06 168.41 10.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 5.9 p -164.46 163.3 22.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.373 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 602' ' ' TRP . . . . . 0.527 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 31.3 p90 -155.66 158.57 38.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 603' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' C' ' 602' ' ' TRP . 0.4 OUTLIER 76.31 18.98 1.78 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 604' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 164.2 158.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 605' ' ' ALA . . . . . 0.465 ' O ' HD11 ' C' ' 606' ' ' LEU . . . -100.99 154.45 18.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 606' ' ' LEU . . . . . 0.517 ' HG ' ' CG1' ' C' ' 613' ' ' VAL . 2.2 mp -118.91 164.3 15.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.3 m -131.09 94.17 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.38 17.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 609' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' C' ' 610' ' ' SER . 25.0 m -163.16 29.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 610' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.2 OUTLIER 163.98 106.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 115.61 -87.13 0.43 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 612' ' ' THR . . . . . 0.52 ' CG2' HG22 ' C' ' 589' ' ' THR . 18.4 m -127.35 103.99 7.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 613' ' ' VAL . . . . . 0.517 ' CG1' ' HG ' ' C' ' 606' ' ' LEU . 2.1 t -106.38 109.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.172 -0.955 . . . . 0.0 108.763 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 614' ' ' THR . . . . . 0.536 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 0.5 OUTLIER -93.01 145.12 24.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 110.028 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 615' ' ' ALA . . . . . 0.624 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -81.09 167.76 19.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.366 -0.834 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -145.95 153.0 49.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.09 135.12 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.619 2.213 . . . . 0.0 110.421 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 618' ' ' ASN . . . . . 0.442 ' OD1' ' HB2' ' C' ' 605' ' ' ALA . 6.6 m120 -153.47 26.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 160.22 -93.22 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 2.1 m -178.8 55.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 621' ' ' GLY . . . . . 0.449 ' O ' ' OG ' ' C' ' 583' ' ' SER . . . -119.43 118.9 4.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 622' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' C' ' 583' ' ' SER . 1.8 m120 -87.98 -22.96 23.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -1.141 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 623' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 55.6 m -107.08 121.88 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 624' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' C' ' 578' ' ' TYR . 11.6 p90 -130.31 142.83 50.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -99.5 147.53 18.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 626' ' ' VAL . . . . . 0.525 ' CG2' ' CE2' ' C' ' 624' ' ' PHE . 23.9 t -139.55 133.08 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -1.175 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 86.9 m -87.87 150.58 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 628' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 91.0 m-85 -136.95 124.95 22.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 629' ' ' TYR . . . . . 0.571 ' CE2' ' HG3' ' C' ' 599' ' ' GLN . 11.1 m-85 -73.34 139.48 46.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 630' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' C' ' 572' ' ' ASP . 0.2 OUTLIER -94.29 -67.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 631' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' C' ' 630' ' ' LYS . 6.5 m-20 43.94 32.26 0.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 116.77 9.78 10.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 633' ' ' SER . . . . . . . . . . . . . 1.2 m -110.68 115.97 30.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 19.1 m -111.25 -1.91 15.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.639 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 635' ' ' ALA . . . . . 0.506 ' HB1' ' ND2' ' C' ' 593' ' ' ASN . . . -89.44 138.96 30.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.664 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 636' ' ' THR . . . . . 0.534 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 3.5 m -89.42 141.54 28.95 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.263 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 637' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 34.7 Cg_endo -76.95 170.07 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.364 2.043 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -141.27 152.88 23.6 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -95.66 134.8 38.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.521 -0.988 . . . . 0.0 109.269 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 640' ' ' THR . . . . . 0.613 ' O ' ' CG2' ' C' ' 588' ' ' VAL . 0.3 OUTLIER -98.41 143.2 29.12 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.048 0.928 . . . . 0.0 111.046 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 641' ' ' CYS . . . . . 0.523 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 1.5 m -160.05 68.68 0.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 642' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' C' ' 559' ' ' SER . . . -146.03 165.06 30.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.41 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 643' ' ' THR . . . . . 0.467 HG21 ' HB3' ' C' ' 559' ' ' SER . 72.0 p -109.58 104.89 14.0 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.326 -0.859 . . . . 0.0 109.358 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.514 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 557' ' ' THR . . . . . 0.468 HG21 ' N ' ' C' ' 558' ' ' GLY . 89.4 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 558' ' ' GLY . . . . . 0.468 ' N ' HG21 ' C' ' 557' ' ' THR . . . 51.51 71.46 0.65 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 171.6 4.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -1.135 . . . . 0.0 109.513 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 560' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 0.0 OUTLIER -59.91 169.34 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 108.91 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 561' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' C' ' 560' ' ' CYS . 68.2 m -114.84 125.7 53.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 109.303 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 562' ' ' VAL . . . . . 0.556 ' CG1' ' SG ' ' C' ' 641' ' ' CYS . 3.7 m -143.98 176.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 563' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 19.7 m -154.3 137.6 15.75 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -119.73 90.54 3.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.085 . . . . 0.0 110.156 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 565' ' ' VAL . . . . . 0.561 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 2.0 t -79.85 154.2 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 566' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.41 65.04 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.034 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 567' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' C' ' 569' ' ' GLU . . . -53.08 164.07 2.06 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 568' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' C' ' 575' ' ' ASN . 1.4 mt-10 -42.52 152.64 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 109.913 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 569' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' C' ' 567' ' ' GLY . 0.6 OUTLIER -160.08 97.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.003 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 570' ' ' TRP . . . . . 0.55 ' CE3' ' HB3' ' C' ' 573' ' ' ARG . 10.6 m-90 -57.22 167.12 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 109.553 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 571' ' ' ALA . . . . . 0.428 ' C ' ' HE3' ' C' ' 630' ' ' LYS . . . -67.12 -24.73 65.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.03 -7.29 13.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.335 -0.853 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 573' ' ' ARG . . . . . 0.55 ' HB3' ' CE3' ' C' ' 570' ' ' TRP . 0.1 OUTLIER -134.5 164.48 27.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 574' ' ' PHE . . . . . 0.525 ' O ' ' CG2' ' C' ' 627' ' ' THR . 0.2 OUTLIER -128.84 163.54 25.0 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.323 -0.86 . . . . 0.0 110.705 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 575' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' C' ' 568' ' ' GLU . 2.0 t-20 -157.56 67.6 0.51 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 576' ' ' VAL . . . . . 0.577 HG13 ' CE1' ' C' ' 578' ' ' TYR . 2.9 t -79.67 153.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.56 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 577' ' ' THR . . . . . 0.469 ' O ' HG22 ' C' ' 565' ' ' VAL . 99.5 m -112.94 91.56 3.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 578' ' ' TYR . . . . . 0.577 ' CE1' HG13 ' C' ' 576' ' ' VAL . 63.6 m-85 -85.96 150.43 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 579' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' C' ' 623' ' ' SER . 4.2 m -138.08 131.51 30.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.871 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 580' ' ' VAL . . . . . 0.648 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 2.6 t -106.6 155.26 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.94 64.3 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . 159.88 -25.41 0.31 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 583' ' ' SER . . . . . 0.401 ' O ' ' C ' ' C' ' 584' ' ' SER . 1.0 OUTLIER -88.29 83.51 6.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -1.16 . . . . 0.0 109.544 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 584' ' ' SER . . . . . 0.401 ' C ' ' O ' ' C' ' 583' ' ' SER . 0.1 OUTLIER -44.31 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 109.2 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 12.3 t -79.92 130.9 35.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 108.952 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 586' ' ' TRP . . . . . 0.648 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 19.6 m95 -69.92 130.73 43.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 111.439 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 587' ' ' VAL . . . . . 0.481 ' CG2' ' C ' ' C' ' 586' ' ' TRP . 2.0 t -158.84 29.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 588' ' ' VAL . . . . . 0.606 ' CG1' ' N ' ' C' ' 589' ' ' THR . 2.1 t -79.24 165.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.754 0.788 . . . . 0.0 110.0 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 589' ' ' THR . . . . . 0.606 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -110.47 157.31 19.73 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 590' ' ' LEU . . . . . 0.462 HD11 ' O ' ' C' ' 613' ' ' VAL . 1.1 mp -121.74 132.65 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.002 . . . . 0.0 109.628 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -113.12 77.32 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 592' ' ' LEU . . . . . 0.5 ' N ' HD22 ' C' ' 592' ' ' LEU . 5.6 mt -58.14 145.14 37.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.201 -1.176 . . . . 0.0 109.554 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 593' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 85.5 m-20 -107.41 120.79 43.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.46 9.81 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 49.89 45.79 40.74 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 596' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 47.2 mt-30 -75.96 157.48 33.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 0.0 109.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 597' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.9 OUTLIER -116.37 169.29 9.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 109.436 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 598' ' ' VAL . . . . . 0.469 HG12 ' CD1' ' C' ' 606' ' ' LEU . 59.4 t -97.59 121.85 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 599' ' ' GLN . . . . . 0.515 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 1.9 tt0 -85.11 -50.95 6.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 1.9 m -165.93 155.39 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 39.4 p -147.93 155.59 41.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 602' ' ' TRP . . . . . 0.501 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 30.5 p90 -137.41 154.32 49.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 603' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.52 30.21 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 604' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 163.9 146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 605' ' ' ALA . . . . . 0.429 ' CB ' ' HB2' ' C' ' 616' ' ' ARG . . . -86.1 166.28 15.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 606' ' ' LEU . . . . . 0.469 ' CD1' HG12 ' C' ' 598' ' ' VAL . 22.9 mt -120.73 154.19 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 607' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' C' ' 616' ' ' ARG . 90.6 m -133.8 74.39 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 136.26 -160.77 24.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 609' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' C' ' 610' ' ' SER . 22.8 p -177.78 35.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.417 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 610' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.5 OUTLIER 166.11 145.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 68.42 -139.62 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 612' ' ' THR . . . . . 0.473 ' CG2' HG23 ' C' ' 589' ' ' THR . 3.3 m -79.94 107.1 12.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 613' ' ' VAL . . . . . 0.462 ' O ' HD11 ' C' ' 590' ' ' LEU . 2.1 t -103.38 157.17 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.237 -0.914 . . . . 0.0 108.887 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 614' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 1.3 m -121.47 139.03 54.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 109.645 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 615' ' ' ALA . . . . . 0.647 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -89.39 159.25 17.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 616' ' ' ARG . . . . . 0.52 ' CD ' ' OG1' ' C' ' 607' ' ' THR . 3.0 mtt180 -132.35 153.31 81.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 617' ' ' PRO . . . . . 0.472 ' N ' ' HB2' ' C' ' 586' ' ' TRP . 35.5 Cg_endo -77.86 127.81 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -117.55 14.32 14.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 60.04 71.67 0.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 70.1 m -154.92 -41.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.19 -167.73 39.49 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 622' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 580' ' ' VAL . 28.4 m120 -107.42 -21.28 12.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 623' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' C' ' 579' ' ' SER . 96.4 p -81.62 121.75 26.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 624' ' ' PHE . . . . . 0.628 ' CE1' ' CH2' ' C' ' 586' ' ' TRP . 2.8 p90 -137.84 142.75 40.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -105.66 139.91 14.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 626' ' ' VAL . . . . . 0.566 HG13 ' CZ ' ' C' ' 628' ' ' PHE . 53.8 t -134.31 133.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.14 . . . . 0.0 109.634 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 627' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' C' ' 574' ' ' PHE . 45.8 m -95.41 145.24 25.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 628' ' ' PHE . . . . . 0.566 ' CZ ' HG13 ' C' ' 626' ' ' VAL . 91.8 m-85 -126.9 144.56 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 629' ' ' TYR . . . . . 0.531 ' CE1' ' HG2' ' C' ' 573' ' ' ARG . 11.0 m-85 -97.47 136.1 38.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 630' ' ' LYS . . . . . 0.525 ' HD3' ' CE1' ' C' ' 574' ' ' PHE . 27.5 pttt -139.76 -40.99 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 631' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' C' ' 630' ' ' LYS . 7.9 m-20 73.68 1.79 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 149.7 77.98 0.02 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 633' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' C' ' 630' ' ' LYS . 74.5 m -138.41 147.71 43.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.141 . . . . 0.0 109.487 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.26 -7.36 14.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -88.62 134.31 33.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 636' ' ' THR . . . . . 0.455 HG22 ' HD2' ' C' ' 637' ' ' PRO . 28.9 m -90.14 140.49 27.36 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 637' ' ' PRO . . . . . 0.514 ' CD ' ' CE2' ' C' ' 574' ' ' PHE . 35.9 Cg_endo -79.78 170.82 16.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.375 2.05 . . . . 0.0 109.927 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 638' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' C' ' 578' ' ' TYR . . . -163.44 156.94 28.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.365 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -81.02 179.03 8.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.467 -1.019 . . . . 0.0 109.014 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 640' ' ' THR . . . . . 0.571 ' O ' HG11 ' C' ' 588' ' ' VAL . 0.2 OUTLIER -130.4 140.75 50.57 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.141 0.972 . . . . 0.0 111.122 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 641' ' ' CYS . . . . . 0.556 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 1.3 m -160.57 70.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.448 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -137.65 168.73 19.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 43.7 p -116.28 105.42 12.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 CA-C-O 118.043 -1.421 . . . . 0.0 109.585 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 133.87 115.1 1.55 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 70.6 m -148.52 160.71 42.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -1.12 . . . . 0.0 109.415 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 560' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' C' ' 562' ' ' VAL . 19.7 p -115.41 161.47 18.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 561' ' ' SER . . . . . 0.454 ' O ' ' HA ' ' C' ' 580' ' ' VAL . 1.7 m -99.01 31.96 2.83 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 122.601 1.191 . . . . 0.0 108.624 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 562' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' C' ' 641' ' ' CYS . 2.3 t -96.25 118.91 43.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.133 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 167.23 13.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 109.646 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -132.33 92.89 3.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 565' ' ' VAL . . . . . 0.537 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 1.9 t -79.77 162.02 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.933 . . . . 0.0 109.191 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 566' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.1 OUTLIER -83.13 62.01 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 567' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' C' ' 566' ' ' ARG . . . -37.3 157.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 568' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 27.5 mt-10 -39.98 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -1.039 . . . . 0.0 110.2 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 569' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' C' ' 568' ' ' GLU . 2.9 mp0 -147.14 -163.92 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 570' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -141.5 -96.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -139.4 -72.89 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.035 -1.041 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.73 -37.11 36.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 108.863 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 573' ' ' ARG . . . . . 0.559 ' HB3' ' CE1' ' C' ' 629' ' ' TYR . 33.0 ptt180 -110.17 149.96 29.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 0.0 109.012 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 574' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 11.5 p90 -130.05 154.17 47.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 575' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' C' ' 568' ' ' GLU . 11.7 t-20 -108.09 172.48 6.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.182 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 576' ' ' VAL . . . . . 0.537 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 2.3 t -150.12 157.71 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 32.7 m -128.7 94.66 3.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 578' ' ' TYR . . . . . 0.64 ' CD2' ' CE1' ' C' ' 624' ' ' PHE . 92.8 m-85 -79.82 137.55 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 3.4 m -120.07 121.31 38.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 580' ' ' VAL . . . . . 0.629 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 2.8 t -108.79 142.61 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 581' ' ' SER . . . . . 0.44 ' C ' ' CB ' ' C' ' 561' ' ' SER . 0.7 OUTLIER -157.34 55.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . 163.84 -28.96 0.23 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 583' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' C' ' 584' ' ' SER . 5.5 m -56.53 -47.09 80.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -1.125 . . . . 0.0 109.486 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 584' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' C' ' 583' ' ' SER . 0.3 OUTLIER 74.57 -81.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.39 -0.819 . . . . 0.0 109.298 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.98 116.69 20.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.267 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 586' ' ' TRP . . . . . 0.629 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 24.3 m95 -69.57 120.85 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 587' ' ' VAL . . . . . . . . . . . . . 14.4 p -160.88 31.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 588' ' ' VAL . . . . . 0.609 ' CG2' ' O ' ' C' ' 640' ' ' THR . 2.9 p -79.26 149.98 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 589' ' ' THR . . . . . 0.559 ' CG2' ' CG2' ' C' ' 612' ' ' THR . 0.2 OUTLIER -112.63 115.87 29.28 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 590' ' ' LEU . . . . . 0.456 HD11 ' O ' ' C' ' 613' ' ' VAL . 6.4 mp -81.74 128.77 34.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -101.81 88.89 0.73 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 592' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' C' ' 596' ' ' GLN . 9.6 mp -75.17 122.12 23.14 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 593' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 26.0 m-80 -111.5 138.69 47.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 96.63 31.04 7.28 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 58.38 19.86 42.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 596' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 1.8 mm100 -51.75 156.42 1.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -1.143 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 597' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.5 OUTLIER -141.56 153.83 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.45 140.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 599' ' ' GLN . . . . . 0.462 ' OE1' ' OH ' ' C' ' 629' ' ' TYR . 6.4 tt0 -109.54 -42.56 4.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.08 160.3 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 601' ' ' SER . . . . . 0.468 ' OG ' HG11 ' C' ' 626' ' ' VAL . 0.7 OUTLIER -159.75 164.12 34.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 602' ' ' TRP . . . . . 0.57 ' CH2' ' HA2' ' C' ' 625' ' ' GLY . 14.2 p90 -153.24 170.48 20.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 603' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' C' ' 602' ' ' TRP . 3.9 t-20 76.4 12.78 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.486 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 604' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 165.28 173.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -121.67 139.94 52.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 606' ' ' LEU . . . . . 0.511 HD22 ' CG1' ' C' ' 613' ' ' VAL . 6.7 mp -114.23 163.0 15.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 63.2 m -120.24 106.67 12.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 130.49 147.04 6.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 609' ' ' SER . . . . . . . . . . . . . 4.7 p -116.34 -6.06 11.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 32.9 t -173.38 124.09 0.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.01 -124.37 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 612' ' ' THR . . . . . 0.559 ' CG2' ' CG2' ' C' ' 589' ' ' THR . 92.8 m -90.15 106.78 18.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -1.19 . . . . 0.0 109.389 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 613' ' ' VAL . . . . . 0.511 ' CG1' HD22 ' C' ' 606' ' ' LEU . 2.1 t -103.21 117.99 49.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.004 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 614' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 6.9 m -90.22 137.63 32.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 615' ' ' ALA . . . . . 0.608 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -79.29 145.91 33.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 109.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 616' ' ' ARG . . . . . 0.456 ' HG2' ' HD2' ' C' ' 617' ' ' PRO . 0.0 OUTLIER -131.46 143.83 50.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.441 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 617' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' C' ' 616' ' ' ARG . 36.0 Cg_endo -78.39 155.17 28.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 110.314 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -145.51 32.78 1.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.86 . . . . 0.0 109.316 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 110.24 57.26 0.51 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 68.53 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.235 . . . . 0.0 109.443 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.6 99.01 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 622' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' C' ' 580' ' ' VAL . 16.9 m120 -97.83 -0.36 45.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.629 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 623' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 3.3 m -117.04 126.79 53.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.075 -1.015 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 624' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' C' ' 578' ' ' TYR . 23.4 p90 -142.87 141.65 31.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 625' ' ' GLY . . . . . 0.57 ' HA2' ' CH2' ' C' ' 602' ' ' TRP . . . -109.49 142.09 16.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 626' ' ' VAL . . . . . 0.468 HG11 ' OG ' ' C' ' 601' ' ' SER . 3.2 t -140.51 156.37 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 627' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' C' ' 599' ' ' GLN . 68.6 m -121.52 140.99 51.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 628' ' ' PHE . . . . . 0.568 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 18.6 m-85 -132.05 140.98 49.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 629' ' ' TYR . . . . . 0.559 ' CE1' ' HB3' ' C' ' 573' ' ' ARG . 60.5 m-85 -86.37 124.13 32.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.937 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 630' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER -125.86 -34.46 2.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.505 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 631' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' C' ' 630' ' ' LYS . 15.4 m-20 66.01 23.39 11.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 68.68 33.94 77.17 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 633' ' ' SER . . . . . . . . . . . . . 1.8 m -148.2 39.5 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.191 . . . . 0.0 109.58 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 59.9 m -156.88 161.1 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -90.16 166.3 13.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 636' ' ' THR . . . . . 0.536 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 2.6 m -75.97 141.7 71.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.191 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 637' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 35.6 Cg_endo -77.36 97.33 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.421 2.08 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -71.74 152.29 48.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -101.48 133.3 46.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -1.108 . . . . 0.0 109.548 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 640' ' ' THR . . . . . 0.609 ' O ' ' CG2' ' C' ' 588' ' ' VAL . 0.3 OUTLIER -99.66 145.91 27.07 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.9 0.857 . . . . 0.0 111.2 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 641' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' C' ' 562' ' ' VAL . 1.6 m -118.87 92.49 3.82 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 109.262 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -107.76 157.88 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 47.5 p -114.7 105.9 13.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.3 0.571 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . -166.39 -151.03 6.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 52.5 p -112.78 161.13 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -1.194 . . . . 0.0 109.442 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 560' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' C' ' 561' ' ' SER . 0.0 OUTLIER -108.51 166.1 11.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 561' ' ' SER . . . . . 0.529 ' N ' ' SG ' ' C' ' 560' ' ' CYS . 0.3 OUTLIER -132.06 130.63 41.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 562' ' ' VAL . . . . . 0.541 ' CG2' ' SG ' ' C' ' 641' ' ' CYS . 1.7 t -154.27 158.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.233 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 71.7 m -127.83 138.02 52.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -95.53 130.26 42.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.755 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 565' ' ' VAL . . . . . 0.551 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 1.9 t -117.81 163.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.104 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 566' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' C' ' 567' ' ' GLY . 1.0 OUTLIER -83.09 62.62 6.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 567' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -41.34 165.95 0.01 OUTLIER Glycine 0 N--CA 1.485 1.919 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 568' ' ' GLU . . . . . 0.466 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 6.6 mt-10 -41.43 165.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.445 -1.033 . . . . 0.0 110.184 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.29 -162.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 570' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 27.4 m-90 -151.94 -100.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.63 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -142.03 -68.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.08 . . . . 0.0 109.481 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 572' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' C' ' 630' ' ' LYS . 0.9 OUTLIER -79.88 -17.78 52.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 0.0 109.331 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 573' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 144.36 47.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 109.185 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 574' ' ' PHE . . . . . 0.635 ' CE1' ' CG2' ' C' ' 636' ' ' THR . 36.6 p90 -122.29 151.57 40.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.371 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 575' ' ' ASN . . . . . 0.514 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.5 t-20 -113.61 152.14 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 576' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 2.5 t -128.36 156.83 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 577' ' ' THR . . . . . 0.458 ' O ' HG22 ' C' ' 565' ' ' VAL . 18.8 m -127.61 104.54 7.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.299 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 578' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' C' ' 623' ' ' SER . 67.8 m-85 -91.47 146.42 23.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 579' ' ' SER . . . . . 0.475 ' O ' HG11 ' C' ' 562' ' ' VAL . 1.1 m -125.5 115.07 19.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.699 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 580' ' ' VAL . . . . . 0.487 ' HA ' HG11 ' C' ' 562' ' ' VAL . 11.6 t -85.09 161.26 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 581' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' C' ' 580' ' ' VAL . 14.8 p -129.05 62.95 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 582' ' ' GLY . . . . . 0.48 ' O ' ' OG ' ' C' ' 583' ' ' SER . . . 173.89 -30.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 583' ' ' SER . . . . . 0.527 ' O ' ' N ' ' C' ' 585' ' ' SER . 2.7 p 50.57 -105.49 0.19 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -1.084 . . . . 0.0 109.448 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 584' ' ' SER . . . . . 0.448 ' C ' ' O ' ' C' ' 583' ' ' SER . 31.2 m 40.24 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.235 -0.916 . . . . 0.0 109.736 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 585' ' ' SER . . . . . 0.527 ' N ' ' O ' ' C' ' 583' ' ' SER . 45.2 m -142.15 65.8 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.04 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 586' ' ' TRP . . . . . 0.633 ' CZ3' ' CB ' ' C' ' 615' ' ' ALA . 60.3 p-90 -87.8 112.73 22.75 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.883 . . . . 0.0 109.7 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 587' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -107.39 96.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 588' ' ' VAL . . . . . 0.6 ' CG1' ' N ' ' C' ' 589' ' ' THR . 11.5 t -79.53 161.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.192 0.996 . . . . 0.0 110.729 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 589' ' ' THR . . . . . 0.6 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -120.48 104.1 9.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 590' ' ' LEU . . . . . 0.52 HD11 ' CG1' ' C' ' 613' ' ' VAL . 0.2 OUTLIER -78.78 137.01 37.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.044 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -125.58 78.02 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 592' ' ' LEU . . . . . 0.448 ' CD2' ' N ' ' C' ' 592' ' ' LEU . 2.5 mt -61.86 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.311 -1.111 . . . . 0.0 109.537 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 593' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -100.25 29.96 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.96 55.26 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . -134.22 -65.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 596' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' C' ' 633' ' ' SER . 0.8 OUTLIER -54.38 164.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -1.17 . . . . 0.0 109.466 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 11.9 p -148.33 154.6 40.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 63.8 t -85.05 137.28 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 599' ' ' GLN . . . . . 0.561 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 16.9 tm0? -106.95 -41.19 5.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 600' ' ' SER . . . . . 0.438 ' OG ' ' OE1' ' C' ' 599' ' ' GLN . 34.9 p -165.84 151.22 8.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.406 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 601' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' C' ' 626' ' ' VAL . 38.2 m -145.37 150.79 37.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 602' ' ' TRP . . . . . 0.522 ' CZ2' ' HA2' ' C' ' 625' ' ' GLY . 45.6 p90 -129.62 157.42 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 603' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' C' ' 602' ' ' TRP . 0.1 OUTLIER 76.22 20.04 1.66 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 604' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 156.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.443 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 605' ' ' ALA . . . . . 0.422 ' C ' HD23 ' C' ' 606' ' ' LEU . . . -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 606' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' C' ' 606' ' ' LEU . 3.6 mm? -102.16 170.71 7.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.9 m -123.61 121.51 35.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 608' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' C' ' 609' ' ' SER . . . 99.84 -56.0 0.87 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 609' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' C' ' 608' ' ' GLY . 2.8 m 69.28 24.21 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 6.8 p -171.82 150.49 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 53.41 -119.35 10.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 612' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' C' ' 590' ' ' LEU . 57.3 m -86.19 108.14 18.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 613' ' ' VAL . . . . . 0.52 ' CG1' HD11 ' C' ' 590' ' ' LEU . 2.1 t -102.28 164.56 3.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.247 -0.908 . . . . 0.0 108.89 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 614' ' ' THR . . . . . 0.498 ' N ' ' CG1' ' C' ' 613' ' ' VAL . 8.9 m -130.36 146.82 51.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 615' ' ' ALA . . . . . 0.633 ' CB ' ' CZ3' ' C' ' 586' ' ' TRP . . . -79.68 157.71 27.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.115 -0.991 . . . . 0.0 109.467 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 83.34 2.22 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 142.86 20.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.694 2.263 . . . . 0.0 110.465 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -111.56 -15.99 13.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . -147.74 48.73 0.63 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.21 42.18 7.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -81.94 114.83 3.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 622' ' ' ASN . . . . . 0.482 ' CB ' ' HB ' ' C' ' 580' ' ' VAL . 57.4 m-20 -106.77 -42.49 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 623' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 15.0 m -92.17 118.27 30.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 624' ' ' PHE . . . . . 0.477 ' CB ' ' HB1' ' C' ' 604' ' ' ALA . 28.9 p90 -143.14 152.41 41.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.551 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 625' ' ' GLY . . . . . 0.522 ' HA2' ' CZ2' ' C' ' 602' ' ' TRP . . . -108.85 134.94 12.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 626' ' ' VAL . . . . . 0.435 ' HA ' ' OG ' ' C' ' 601' ' ' SER . 25.8 t -126.58 134.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 53.9 m -79.9 159.77 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 628' ' ' PHE . . . . . 0.578 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 78.7 m-85 -150.62 116.76 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 629' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 46.7 m-85 -69.87 138.42 52.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 630' ' ' LYS . . . . . 0.504 ' CG ' ' N ' ' C' ' 631' ' ' ASN . 0.0 OUTLIER -97.57 -63.86 1.09 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.201 -0.937 . . . . 0.0 108.985 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 631' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' C' ' 630' ' ' LYS . 2.5 m-80 41.86 53.37 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 109.55 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 68.27 41.01 87.21 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 633' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' C' ' 630' ' ' LYS . 90.2 p -80.06 -150.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -1.121 . . . . 0.0 109.593 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.3 -149.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.489 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 635' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 636' ' ' THR . . . -49.6 138.17 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 636' ' ' THR . . . . . 0.635 ' CG2' ' CE1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER -47.15 174.98 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.324 -0.86 . . . . 0.0 109.638 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 637' ' ' PRO . . . . . 0.546 ' HG3' ' CG ' ' C' ' 628' ' ' PHE . 35.2 Cg_endo -77.94 172.19 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.636 2.224 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -148.26 133.78 4.76 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.137 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -90.88 131.54 36.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.959 . . . . 0.0 108.858 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 640' ' ' THR . . . . . 0.579 ' O ' HG11 ' C' ' 588' ' ' VAL . 2.7 m -93.85 150.35 20.46 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.355 1.074 . . . . 0.0 111.973 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 641' ' ' CYS . . . . . 0.559 ' SG ' ' CG2' ' C' ' 588' ' ' VAL . 1.3 m -160.98 69.96 0.37 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.476 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -156.29 164.32 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 47.9 p -114.49 105.38 13.03 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.515 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 557' ' ' THR . . . . . 0.404 ' C ' HG22 ' C' ' 643' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 558' ' ' GLY . . . . . 0.497 ' N ' HG22 ' C' ' 643' ' ' THR . . . -111.37 108.22 2.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.92 169.16 11.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.436 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 560' ' ' CYS . . . . . 0.473 ' O ' ' HB3' ' C' ' 641' ' ' CYS . 0.5 OUTLIER -120.18 137.14 54.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 109.522 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 561' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' C' ' 581' ' ' SER . 46.3 m -76.06 120.37 21.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.069 -1.02 . . . . 0.0 108.399 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 562' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' C' ' 641' ' ' CYS . 0.0 OUTLIER -139.78 175.84 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.111 -0.993 . . . . 0.0 110.292 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 563' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 3.3 m -160.23 158.48 30.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -140.08 84.85 1.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 565' ' ' VAL . . . . . 0.547 ' O ' ' CG1' ' C' ' 576' ' ' VAL . 1.9 t -79.79 166.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 109.036 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 566' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.0 OUTLIER -83.64 61.63 6.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 567' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' C' ' 568' ' ' GLU . . . -38.95 154.97 0.02 OUTLIER Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 568' ' ' GLU . . . . . 0.467 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 32.5 mt-10 -44.48 170.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 109.904 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 569' ' ' GLU . . . . . 0.416 ' HB3' ' HA ' ' C' ' 574' ' ' PHE . 20.1 mt-10 -141.15 -164.07 1.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 570' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 15.0 m-90 -140.7 -100.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.603 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -143.54 -71.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.525 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 572' ' ' ASP . . . . . 0.465 ' CA ' ' OD1' ' C' ' 631' ' ' ASN . 3.0 m-20 -79.96 -11.2 59.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 573' ' ' ARG . . . . . 0.561 ' HD3' ' CE1' ' C' ' 629' ' ' TYR . 0.0 OUTLIER -144.1 145.3 32.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.913 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 574' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' C' ' 628' ' ' PHE . 52.7 p90 -110.97 159.17 17.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 575' ' ' ASN . . . . . 0.576 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 11.0 t-20 -116.27 170.5 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 576' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' C' ' 565' ' ' VAL . 2.5 t -150.51 157.16 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.828 . . . . 0.0 109.308 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 20.7 m -122.01 102.99 8.51 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 578' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' C' ' 563' ' ' SER . 96.7 m-85 -88.9 133.64 34.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 579' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 3.5 m -114.48 146.82 40.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 580' ' ' VAL . . . . . 0.658 ' CG2' ' CH2' ' C' ' 586' ' ' TRP . 41.7 t -128.9 156.2 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.591 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 581' ' ' SER . . . . . 0.527 ' HB2' ' CB ' ' C' ' 561' ' ' SER . 13.2 m -102.85 47.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 582' ' ' GLY . . . . . 0.446 ' HA3' ' ND2' ' C' ' 622' ' ' ASN . . . 60.01 44.97 96.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 583' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' C' ' 584' ' ' SER . 0.5 OUTLIER -43.72 -28.14 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.113 . . . . 0.0 109.6 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 584' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' C' ' 583' ' ' SER . 2.1 t 76.92 -2.62 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 109.545 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 24.7 m -160.26 96.65 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.161 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 586' ' ' TRP . . . . . 0.658 ' CH2' ' CG2' ' C' ' 580' ' ' VAL . 28.0 m95 -69.75 124.14 23.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 110.572 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 587' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' C' ' 586' ' ' TRP . 21.2 t -159.87 31.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 588' ' ' VAL . . . . . 0.587 ' CG2' ' O ' ' C' ' 640' ' ' THR . 6.0 p -79.28 148.29 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 589' ' ' THR . . . . . 0.541 ' N ' HG21 ' C' ' 588' ' ' VAL . 40.3 m -111.24 115.76 29.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 590' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.75 127.4 32.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.243 -0.91 . . . . 0.0 109.469 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -107.58 79.04 0.25 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 592' ' ' LEU . . . . . 0.513 ' N ' HD22 ' C' ' 592' ' ' LEU . 1.0 OUTLIER -65.62 -173.36 0.15 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.179 -1.189 . . . . 0.0 109.384 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 593' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' C' ' 593' ' ' ASN . 2.8 m-20 -91.27 -163.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . -90.96 69.12 2.19 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 150.64 -28.82 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -61.95 134.15 56.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.47 162.49 27.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.81 126.13 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 599' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' C' ' 600' ' ' SER . 14.2 tm0? -91.0 -43.75 9.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 600' ' ' SER . . . . . 0.508 ' HB3' ' NE2' ' C' ' 599' ' ' GLN . 36.7 p -163.82 170.13 17.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 601' ' ' SER . . . . . 0.459 ' HB3' HG21 ' C' ' 626' ' ' VAL . 1.8 p -161.33 165.56 28.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.264 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 602' ' ' TRP . . . . . 0.569 ' CH2' ' HA2' ' C' ' 625' ' ' GLY . 26.2 p90 -158.48 159.39 35.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 603' ' ' ASN . . . . . 0.515 ' O ' ' CB ' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.04 21.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 604' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 169.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -110.62 172.86 6.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 606' ' ' LEU . . . . . 0.447 HD22 ' OG ' ' C' ' 601' ' ' SER . 3.4 pp -151.71 155.06 37.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 607' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' C' ' 613' ' ' VAL . 4.4 m -120.11 109.24 15.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 116.83 178.99 17.88 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 609' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' C' ' 610' ' ' SER . 1.1 m -154.63 20.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -1.16 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 610' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' C' ' 609' ' ' SER . 3.1 p 164.11 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.501 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.98 -98.94 0.93 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 612' ' ' THR . . . . . 0.526 ' CG2' HG22 ' C' ' 589' ' ' THR . 83.8 m -122.15 101.95 7.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 109.426 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 613' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' C' ' 614' ' ' THR . 2.1 t -106.14 165.41 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.188 -0.945 . . . . 0.0 108.964 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 614' ' ' THR . . . . . 0.503 ' N ' ' CG1' ' C' ' 613' ' ' VAL . 11.7 m -139.18 137.24 35.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.978 . . . . 0.0 109.571 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 615' ' ' ALA . . . . . 0.628 ' CB ' ' CE3' ' C' ' 586' ' ' TRP . . . -79.55 137.24 37.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 616' ' ' ARG . . . . . 0.534 ' CG ' ' HD2' ' C' ' 617' ' ' PRO . 42.3 ttp180 -113.21 140.94 24.91 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.335 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 617' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' C' ' 616' ' ' ARG . 35.9 Cg_endo -77.88 138.46 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.418 2.079 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -115.35 -11.3 11.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 619' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 130.5 -2.48 5.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 620' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 166.73 126.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -1.209 . . . . 0.0 109.469 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 148.28 113.71 0.73 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 622' ' ' ASN . . . . . 0.466 ' O ' ' HB ' ' C' ' 580' ' ' VAL . 25.1 m120 -115.65 -18.48 10.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.492 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 623' ' ' SER . . . . . 0.452 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 50.4 m -116.61 111.39 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.182 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 624' ' ' PHE . . . . . 0.561 ' CE2' HG22 ' C' ' 626' ' ' VAL . 33.1 p90 -123.07 142.74 50.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 625' ' ' GLY . . . . . 0.569 ' HA2' ' CH2' ' C' ' 602' ' ' TRP . . . -102.47 153.91 18.44 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 626' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' C' ' 624' ' ' PHE . 59.1 t -149.67 141.49 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 627' ' ' THR . . . . . 0.516 ' CG2' ' N ' ' C' ' 628' ' ' PHE . 21.6 m -102.19 166.15 10.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.352 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 628' ' ' PHE . . . . . 0.572 ' HB2' ' CZ ' ' C' ' 574' ' ' PHE . 97.0 m-85 -143.57 125.29 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.575 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 629' ' ' TYR . . . . . 0.561 ' CE1' ' HD3' ' C' ' 573' ' ' ARG . 10.3 m-85 -81.15 127.55 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 630' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' C' ' 631' ' ' ASN . 0.0 OUTLIER 174.94 -29.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.535 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 631' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' C' ' 630' ' ' LYS . 11.1 m-20 83.41 39.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.545 -0.722 . . . . 0.0 110.211 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 632' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' C' ' 631' ' ' ASN . . . 41.13 96.37 0.01 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 633' ' ' SER . . . . . 0.54 ' N ' ' HD2' ' C' ' 630' ' ' LYS . 21.7 m -156.64 43.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 634' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' C' ' 633' ' ' SER . 0.1 OUTLIER 170.82 -153.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.378 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -90.06 131.1 36.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 636' ' ' THR . . . . . 0.57 HG21 ' CE2' ' C' ' 574' ' ' PHE . 0.0 OUTLIER -53.1 176.98 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 637' ' ' PRO . . . . . 0.57 ' HG3' ' CE2' ' C' ' 628' ' ' PHE . 35.9 Cg_endo -78.61 171.13 17.2 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.539 2.159 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -147.73 139.45 7.79 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -93.39 132.05 38.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -1.074 . . . . 0.0 109.168 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 640' ' ' THR . . . . . 0.587 ' O ' ' CG2' ' C' ' 588' ' ' VAL . 0.4 OUTLIER -98.46 143.63 28.69 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.994 0.902 . . . . 0.0 111.12 -179.252 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 641' ' ' CYS . . . . . 0.53 ' HB2' ' CG2' ' C' ' 562' ' ' VAL . 1.5 m -160.54 85.81 0.72 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.533 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -159.41 155.43 26.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 643' ' ' THR . . . . . 0.497 HG22 ' N ' ' C' ' 558' ' ' GLY . 46.1 p -115.08 105.91 13.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.316 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.572 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 562' ' ' VAL . . . . . 0.706 ' HB ' HG22 ' C' ' 580' ' ' VAL . 2.7 p . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.311 0.577 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 563' ' ' SER . . . . . 0.509 ' N ' HG22 ' C' ' 562' ' ' VAL . 0.1 OUTLIER -144.86 141.21 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.131 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.09 121.63 42.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 565' ' ' VAL . . . . . 0.822 ' O ' HG12 ' C' ' 576' ' ' VAL . 0.6 OUTLIER -122.46 152.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 566' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' C' ' 565' ' ' VAL . 1.9 ptm85 -52.39 143.78 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 567' ' ' GLY . . . . . . . . . . . . . . . -117.58 -145.75 8.07 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.955 -1.593 . . . . 0.0 109.726 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 568' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.04 118.21 29.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 569' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' C' ' 574' ' ' PHE . 0.1 OUTLIER -110.24 177.91 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 570' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 22.0 m-90 -132.89 -92.89 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -138.83 -75.86 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 572' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' C' ' 630' ' ' LYS . 0.8 OUTLIER -80.16 -15.76 56.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 573' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -133.05 156.11 47.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 109.315 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 574' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 36.4 p90 -134.67 151.83 51.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 575' ' ' ASN . . . . . 0.449 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 4.3 t-20 -122.34 125.32 45.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.398 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 576' ' ' VAL . . . . . 0.822 HG12 ' O ' ' C' ' 565' ' ' VAL . 1.1 t -100.56 158.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 64.7 m -116.78 128.26 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.937 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 578' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' C' ' 624' ' ' PHE . 29.8 m-85 -115.24 125.19 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 579' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 56.6 m -96.38 141.78 29.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 580' ' ' VAL . . . . . 1.003 HG21 ' CH2' ' C' ' 586' ' ' TRP . 59.6 t -127.16 160.9 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.573 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 581' ' ' SER . . . . . 0.483 ' N ' HG12 ' C' ' 580' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.469 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.378 0.609 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 586' ' ' TRP . . . . . 1.003 ' CH2' HG21 ' C' ' 580' ' ' VAL . 27.9 m95 -77.08 124.44 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 110.395 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 587' ' ' VAL . . . . . 0.471 HG13 ' O ' ' C' ' 587' ' ' VAL . 10.0 p -160.14 31.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 588' ' ' VAL . . . . . 1.092 HG23 ' O ' ' C' ' 640' ' ' THR . 7.1 p -79.02 148.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.524 -0.735 . . . . 0.0 109.428 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 589' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 612' ' ' THR . 31.2 m -111.09 114.46 27.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 590' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' C' ' 590' ' ' LEU . 4.0 mm? -79.44 126.23 30.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -108.04 87.49 0.49 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 592' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.6 -167.84 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.188 -1.183 . . . . 0.0 109.444 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 593' ' ' ASN . . . . . 0.449 ' HB2' ' OE1' ' C' ' 596' ' ' GLN . 0.8 OUTLIER -111.43 41.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 594' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' C' ' 593' ' ' ASN . . . 44.17 68.8 0.8 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 174.38 -47.18 0.14 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 596' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' C' ' 593' ' ' ASN . 0.0 OUTLIER -80.34 170.51 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -1.148 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 4.5 m -151.07 148.12 27.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.541 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 598' ' ' VAL . . . . . 0.421 HG13 HG13 ' C' ' 626' ' ' VAL . 85.1 t -69.43 113.54 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.492 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 599' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' C' ' 629' ' ' TYR . 6.7 tm0? -89.04 -27.97 20.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.06 168.41 10.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 5.9 p -164.46 163.3 22.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.373 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 602' ' ' TRP . . . . . 0.527 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 31.3 p90 -155.66 158.57 38.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 603' ' ' ASN . . . . . 0.688 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.4 OUTLIER 76.31 18.98 1.78 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 604' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 164.2 158.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 605' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 606' ' ' LEU . . . -100.99 154.45 18.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 606' ' ' LEU . . . . . 0.558 HD23 HG11 ' C' ' 613' ' ' VAL . 2.2 mp -118.91 164.3 15.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.3 m -131.09 94.17 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.38 17.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 609' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' C' ' 610' ' ' SER . 25.0 m -163.16 29.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 610' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.2 OUTLIER 163.98 106.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 115.61 -87.13 0.43 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 612' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 589' ' ' THR . 18.4 m -127.35 103.99 7.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 613' ' ' VAL . . . . . 0.558 HG11 HD23 ' C' ' 606' ' ' LEU . 2.1 t -106.38 109.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.172 -0.955 . . . . 0.0 108.763 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 614' ' ' THR . . . . . 0.755 HG23 ' O ' ' C' ' 588' ' ' VAL . 0.5 OUTLIER -93.01 145.12 24.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 110.028 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 615' ' ' ALA . . . . . 0.817 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -81.09 167.76 19.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.366 -0.834 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -145.95 153.0 49.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.09 135.12 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.619 2.213 . . . . 0.0 110.421 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -153.47 26.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 160.22 -93.22 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 2.1 m -178.8 55.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -119.43 118.9 4.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 622' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' C' ' 580' ' ' VAL . 1.8 m120 -87.98 -22.96 23.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -1.141 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 623' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 55.6 m -107.08 121.88 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 624' ' ' PHE . . . . . 0.587 ' HE2' HG21 ' C' ' 626' ' ' VAL . 11.6 p90 -130.31 142.83 50.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -99.5 147.53 18.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 626' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' C' ' 624' ' ' PHE . 23.9 t -139.55 133.08 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -1.175 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 86.9 m -87.87 150.58 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 628' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 91.0 m-85 -136.95 124.95 22.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 629' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' C' ' 599' ' ' GLN . 11.1 m-85 -73.34 139.48 46.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 630' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' C' ' 572' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 636' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 3.5 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 637' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 34.7 Cg_endo -76.95 170.07 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.364 2.043 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -141.27 152.88 23.6 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 639' ' ' ALA . . . . . 0.855 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -95.66 134.8 38.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.521 -0.988 . . . . 0.0 109.269 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 640' ' ' THR . . . . . 1.092 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -98.41 143.2 29.12 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.048 0.928 . . . . 0.0 111.046 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 641' ' ' CYS . . . . . 0.54 ' SG ' HG11 ' C' ' 562' ' ' VAL . 1.5 m . . . . . 0 C--N 1.294 -1.832 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 562' ' ' VAL . . . . . 0.595 HG11 ' SG ' ' C' ' 641' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 563' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 19.7 m -154.3 137.6 15.75 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -119.73 90.54 3.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.085 . . . . 0.0 110.156 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 565' ' ' VAL . . . . . 0.64 ' O ' HG13 ' C' ' 576' ' ' VAL . 2.0 t -79.85 154.2 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 566' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.41 65.04 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.034 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 567' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' C' ' 569' ' ' GLU . . . -53.08 164.07 2.06 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 568' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' C' ' 575' ' ' ASN . 1.4 mt-10 -42.52 152.64 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 109.913 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 569' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' C' ' 567' ' ' GLY . 0.6 OUTLIER -160.08 97.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.003 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 570' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' C' ' 573' ' ' ARG . 10.6 m-90 -57.22 167.12 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 109.553 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 571' ' ' ALA . . . . . 0.436 ' C ' ' HE3' ' C' ' 630' ' ' LYS . . . -67.12 -24.73 65.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.03 -7.29 13.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.335 -0.853 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 573' ' ' ARG . . . . . 0.578 ' HB3' ' CE3' ' C' ' 570' ' ' TRP . 0.1 OUTLIER -134.5 164.48 27.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 574' ' ' PHE . . . . . 0.943 ' O ' HG23 ' C' ' 627' ' ' THR . 0.2 OUTLIER -128.84 163.54 25.0 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.323 -0.86 . . . . 0.0 110.705 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 575' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' C' ' 568' ' ' GLU . 17.2 t30 -157.56 67.6 0.51 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 576' ' ' VAL . . . . . 0.64 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.9 t -79.67 153.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.56 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 99.5 m -112.94 91.56 3.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 578' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' C' ' 576' ' ' VAL . 63.6 m-85 -85.96 150.43 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 579' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 623' ' ' SER . 4.2 m -138.08 131.51 30.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.871 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 580' ' ' VAL . . . . . 0.725 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 2.6 t -106.6 155.26 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 586' ' ' TRP . . . . . 1.006 ' CE3' ' HB3' ' C' ' 615' ' ' ALA . 19.6 m95 -69.92 130.73 43.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 111.439 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 587' ' ' VAL . . . . . 0.506 HG22 ' O ' ' C' ' 586' ' ' TRP . 2.0 t -158.84 29.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 588' ' ' VAL . . . . . 0.684 HG22 ' SG ' ' C' ' 641' ' ' CYS . 2.1 t -79.24 165.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.754 0.788 . . . . 0.0 110.0 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 589' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 612' ' ' THR . 0.0 OUTLIER -110.47 157.31 19.73 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 590' ' ' LEU . . . . . 0.92 HD13 HG12 ' C' ' 613' ' ' VAL . 1.1 mp -121.74 132.65 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.002 . . . . 0.0 109.628 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -113.12 77.32 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 592' ' ' LEU . . . . . 0.536 HD23 ' N ' ' C' ' 592' ' ' LEU . 5.6 mt -58.14 145.14 37.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.201 -1.176 . . . . 0.0 109.554 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 593' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 85.5 m-20 -107.41 120.79 43.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.46 9.81 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 49.89 45.79 40.74 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 596' ' ' GLN . . . . . 0.469 ' O ' HD12 ' C' ' 592' ' ' LEU . 47.2 mt-30 -75.96 157.48 33.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 0.0 109.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 597' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.9 OUTLIER -116.37 169.29 9.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 109.436 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 598' ' ' VAL . . . . . 0.873 HG11 HD13 ' C' ' 606' ' ' LEU . 59.4 t -97.59 121.85 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 599' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 1.9 tt0 -85.11 -50.95 6.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 1.9 m -165.93 155.39 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 601' ' ' SER . . . . . 0.487 ' HB3' HD11 ' C' ' 606' ' ' LEU . 39.4 p -147.93 155.59 41.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 602' ' ' TRP . . . . . 0.501 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 30.5 p90 -137.41 154.32 49.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 603' ' ' ASN . . . . . 0.709 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 2.2 t-20 76.52 30.21 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 604' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.9 146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 605' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' C' ' 616' ' ' ARG . . . -86.1 166.28 15.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 606' ' ' LEU . . . . . 0.873 HD13 HG11 ' C' ' 598' ' ' VAL . 22.9 mt -120.73 154.19 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 607' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' C' ' 616' ' ' ARG . 90.6 m -133.8 74.39 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 136.26 -160.77 24.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 609' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' C' ' 610' ' ' SER . 22.8 p -177.78 35.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.417 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 610' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.5 OUTLIER 166.11 145.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 68.42 -139.62 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 612' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 589' ' ' THR . 3.3 m -79.94 107.1 12.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 613' ' ' VAL . . . . . 0.92 HG12 HD13 ' C' ' 590' ' ' LEU . 2.1 t -103.38 157.17 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.237 -0.914 . . . . 0.0 108.887 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 614' ' ' THR . . . . . 0.529 HG23 ' O ' ' C' ' 588' ' ' VAL . 1.3 m -121.47 139.03 54.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 109.645 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 615' ' ' ALA . . . . . 1.006 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -89.39 159.25 17.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 616' ' ' ARG . . . . . 0.901 ' HB2' ' HB3' ' C' ' 605' ' ' ALA . 3.0 mtt180 -132.35 153.31 81.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 617' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' C' ' 586' ' ' TRP . 35.5 Cg_endo -77.86 127.81 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -117.55 14.32 14.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 60.04 71.67 0.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 70.1 m -154.92 -41.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.19 -167.73 39.49 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 622' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 580' ' ' VAL . 28.4 m120 -107.42 -21.28 12.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 623' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 579' ' ' SER . 96.4 p -81.62 121.75 26.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 624' ' ' PHE . . . . . 0.628 ' CE1' ' CH2' ' C' ' 586' ' ' TRP . 2.8 p90 -137.84 142.75 40.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -105.66 139.91 14.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 626' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.31 133.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.14 . . . . 0.0 109.634 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 627' ' ' THR . . . . . 0.943 HG23 ' O ' ' C' ' 574' ' ' PHE . 45.8 m -95.41 145.24 25.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 628' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' C' ' 574' ' ' PHE . 91.8 m-85 -126.9 144.56 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 629' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' C' ' 573' ' ' ARG . 11.0 m-85 -97.47 136.1 38.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 630' ' ' LYS . . . . . 0.531 ' HD3' ' CE1' ' C' ' 574' ' ' PHE . 27.5 pttt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 636' ' ' THR . . . . . 0.639 HG23 ' HD2' ' C' ' 637' ' ' PRO . 28.9 m . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 637' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' C' ' 636' ' ' THR . 35.9 Cg_endo -79.78 170.82 16.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.375 2.05 . . . . 0.0 109.927 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 638' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' C' ' 578' ' ' TYR . . . -163.44 156.94 28.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.365 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -81.02 179.03 8.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.467 -1.019 . . . . 0.0 109.014 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 640' ' ' THR . . . . . 0.6 ' O ' HG13 ' C' ' 588' ' ' VAL . 0.2 OUTLIER -130.4 140.75 50.57 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.141 0.972 . . . . 0.0 111.122 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 641' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.493 1.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.448 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 562' ' ' VAL . . . . . 0.554 HG22 HG22 ' C' ' 580' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 167.23 13.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 109.646 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -132.33 92.89 3.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 565' ' ' VAL . . . . . 0.567 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.77 162.02 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.933 . . . . 0.0 109.191 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 566' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.1 OUTLIER -83.13 62.01 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 567' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' C' ' 566' ' ' ARG . . . -37.3 157.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 568' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 27.5 mt-10 -39.98 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -1.039 . . . . 0.0 110.2 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 569' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 568' ' ' GLU . 2.9 mp0 -147.14 -163.92 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 570' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -141.5 -96.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -139.4 -72.89 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.035 -1.041 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.73 -37.11 36.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 108.863 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 573' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' C' ' 629' ' ' TYR . 33.0 ptt180 -110.17 149.96 29.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 0.0 109.012 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 574' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 11.5 p90 -130.05 154.17 47.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 575' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' C' ' 568' ' ' GLU . 11.7 t-20 -108.09 172.48 6.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.182 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 576' ' ' VAL . . . . . 0.567 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.3 t -150.12 157.71 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 32.7 m -128.7 94.66 3.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 578' ' ' TYR . . . . . 0.64 ' CD2' ' CE1' ' C' ' 624' ' ' PHE . 92.8 m-85 -79.82 137.55 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 3.4 m -120.07 121.31 38.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 580' ' ' VAL . . . . . 0.83 HG21 ' CH2' ' C' ' 586' ' ' TRP . 2.8 t -108.79 142.61 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 586' ' ' TRP . . . . . 0.83 ' CH2' HG21 ' C' ' 580' ' ' VAL . 24.3 m95 -69.57 120.85 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 587' ' ' VAL . . . . . 0.618 ' O ' HG22 ' C' ' 587' ' ' VAL . 14.4 p -160.88 31.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 588' ' ' VAL . . . . . 0.974 HG23 ' O ' ' C' ' 640' ' ' THR . 2.9 p -79.26 149.98 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 589' ' ' THR . . . . . 0.855 HG22 ' CG2' ' C' ' 612' ' ' THR . 0.2 OUTLIER -112.63 115.87 29.28 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 590' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.74 128.77 34.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -101.81 88.89 0.73 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 592' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 596' ' ' GLN . 9.6 mp -75.17 122.12 23.14 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 593' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 26.0 m-80 -111.5 138.69 47.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 96.63 31.04 7.28 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 58.38 19.86 42.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 596' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 1.8 mm100 -51.75 156.42 1.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -1.143 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 597' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.5 OUTLIER -141.56 153.83 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.45 140.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 599' ' ' GLN . . . . . 0.439 ' HG3' ' OH ' ' C' ' 629' ' ' TYR . 6.4 tt0 -109.54 -42.56 4.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.08 160.3 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 601' ' ' SER . . . . . 0.503 ' OG ' HG13 ' C' ' 626' ' ' VAL . 0.7 OUTLIER -159.75 164.12 34.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 602' ' ' TRP . . . . . 0.572 ' CH2' ' HA3' ' C' ' 625' ' ' GLY . 14.2 p90 -153.24 170.48 20.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 603' ' ' ASN . . . . . 0.664 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 3.9 t-20 76.4 12.78 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.486 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 604' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 165.28 173.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -121.67 139.94 52.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 606' ' ' LEU . . . . . 0.758 HD23 ' CG1' ' C' ' 613' ' ' VAL . 6.7 mp -114.23 163.0 15.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 63.2 m -120.24 106.67 12.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 130.49 147.04 6.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 609' ' ' SER . . . . . . . . . . . . . 4.7 p -116.34 -6.06 11.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 32.9 t -173.38 124.09 0.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.01 -124.37 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 612' ' ' THR . . . . . 0.855 ' CG2' HG22 ' C' ' 589' ' ' THR . 92.8 m -90.15 106.78 18.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -1.19 . . . . 0.0 109.389 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 613' ' ' VAL . . . . . 0.758 ' CG1' HD23 ' C' ' 606' ' ' LEU . 2.1 t -103.21 117.99 49.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.004 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 614' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 6.9 m -90.22 137.63 32.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 615' ' ' ALA . . . . . 0.727 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.29 145.91 33.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 109.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 616' ' ' ARG . . . . . 0.474 ' HG2' ' HD2' ' C' ' 617' ' ' PRO . 0.0 OUTLIER -131.46 143.83 50.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.441 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 617' ' ' PRO . . . . . 0.474 ' HD2' ' HG2' ' C' ' 616' ' ' ARG . 36.0 Cg_endo -78.39 155.17 28.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 110.314 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -145.51 32.78 1.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.86 . . . . 0.0 109.316 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 619' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' C' ' 620' ' ' SER . . . 110.24 57.26 0.51 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 620' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 68.53 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.235 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.6 99.01 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 622' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 16.9 m120 -97.83 -0.36 45.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.629 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 623' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 3.3 m -117.04 126.79 53.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.075 -1.015 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 624' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' C' ' 578' ' ' TYR . 23.4 p90 -142.87 141.65 31.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 625' ' ' GLY . . . . . 0.572 ' HA3' ' CH2' ' C' ' 602' ' ' TRP . . . -109.49 142.09 16.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 626' ' ' VAL . . . . . 0.503 HG13 ' OG ' ' C' ' 601' ' ' SER . 3.2 t -140.51 156.37 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 627' ' ' THR . . . . . 0.446 HG23 ' O ' ' C' ' 574' ' ' PHE . 68.6 m -121.52 140.99 51.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 628' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 18.6 m-85 -132.05 140.98 49.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 629' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' C' ' 573' ' ' ARG . 60.5 m-85 -86.37 124.13 32.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.937 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 630' ' ' LYS . . . . . 0.544 ' HG2' ' CD1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.505 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 636' ' ' THR . . . . . 0.605 HG22 ' HD2' ' C' ' 637' ' ' PRO . 2.6 m . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 637' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' C' ' 636' ' ' THR . 35.6 Cg_endo -77.36 97.33 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.421 2.08 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -71.74 152.29 48.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 639' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -101.48 133.3 46.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -1.108 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 640' ' ' THR . . . . . 0.974 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -99.66 145.91 27.07 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.9 0.857 . . . . 0.0 111.2 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 641' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.296 -1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 109.262 178.847 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 562' ' ' VAL . . . . . 0.541 ' CG2' ' SG ' ' C' ' 641' ' ' CYS . 1.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.426 0.631 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 71.7 m -127.83 138.02 52.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -95.53 130.26 42.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.755 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 565' ' ' VAL . . . . . 0.678 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -117.81 163.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.104 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 566' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' C' ' 567' ' ' GLY . 1.0 OUTLIER -83.09 62.62 6.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 567' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -41.34 165.95 0.01 OUTLIER Glycine 0 N--CA 1.485 1.919 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 568' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 6.6 mt-10 -41.43 165.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.445 -1.033 . . . . 0.0 110.184 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.29 -162.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 570' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 27.4 m-90 -151.94 -100.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.63 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -142.03 -68.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.08 . . . . 0.0 109.481 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 572' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' C' ' 630' ' ' LYS . 0.9 OUTLIER -79.88 -17.78 52.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 0.0 109.331 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 573' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 144.36 47.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 109.185 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 574' ' ' PHE . . . . . 1.038 ' CE1' HG22 ' C' ' 636' ' ' THR . 36.6 p90 -122.29 151.57 40.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.371 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 575' ' ' ASN . . . . . 0.519 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.1 t30 -113.61 152.14 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 576' ' ' VAL . . . . . 0.678 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -128.36 156.83 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 18.8 m -127.61 104.54 7.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.299 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 578' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' C' ' 623' ' ' SER . 67.8 m-85 -91.47 146.42 23.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 1.1 m -125.5 115.07 19.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 580' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' C' ' 586' ' ' TRP . 11.6 t -85.09 161.26 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 581' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' C' ' 580' ' ' VAL . 14.8 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.027 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 586' ' ' TRP . . . . . 0.679 ' HE3' HG23 ' C' ' 588' ' ' VAL . 60.3 p-90 -87.8 112.73 22.75 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.883 . . . . 0.0 109.7 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 587' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' C' ' 614' ' ' THR . 1.0 OUTLIER -107.39 96.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 588' ' ' VAL . . . . . 0.813 HG22 ' SG ' ' C' ' 641' ' ' CYS . 11.5 t -79.53 161.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.192 0.996 . . . . 0.0 110.729 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 589' ' ' THR . . . . . 0.6 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -120.48 104.1 9.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 590' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' C' ' 613' ' ' VAL . 0.2 OUTLIER -78.78 137.01 37.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.044 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -125.58 78.02 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 592' ' ' LEU . . . . . 0.674 HD23 ' N ' ' C' ' 592' ' ' LEU . 2.5 mt -61.86 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.311 -1.111 . . . . 0.0 109.537 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 593' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -100.25 29.96 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.96 55.26 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . -134.22 -65.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -54.38 164.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -1.17 . . . . 0.0 109.466 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 11.9 p -148.33 154.6 40.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 63.8 t -85.05 137.28 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 599' ' ' GLN . . . . . 0.564 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 16.9 tm0? -106.95 -41.19 5.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 34.9 p -165.84 151.22 8.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.406 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 601' ' ' SER . . . . . 0.636 ' OG ' HG13 ' C' ' 626' ' ' VAL . 38.2 m -145.37 150.79 37.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 602' ' ' TRP . . . . . 0.527 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 45.6 p90 -129.62 157.42 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 603' ' ' ASN . . . . . 0.684 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.22 20.04 1.66 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 604' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 156.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.443 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 605' ' ' ALA . . . . . 0.618 ' C ' HD22 ' C' ' 606' ' ' LEU . . . -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 606' ' ' LEU . . . . . 0.693 HD22 ' N ' ' C' ' 606' ' ' LEU . 3.6 mm? -102.16 170.71 7.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.9 m -123.61 121.51 35.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 608' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' C' ' 609' ' ' SER . . . 99.84 -56.0 0.87 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 609' ' ' SER . . . . . 0.809 ' H ' HG22 ' C' ' 613' ' ' VAL . 2.8 m 69.28 24.21 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 6.8 p -171.82 150.49 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 53.41 -119.35 10.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 612' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 590' ' ' LEU . 57.3 m -86.19 108.14 18.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 613' ' ' VAL . . . . . 0.809 HG22 ' H ' ' C' ' 609' ' ' SER . 2.1 t -102.28 164.56 3.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.247 -0.908 . . . . 0.0 108.89 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 614' ' ' THR . . . . . 0.523 ' CG2' HG23 ' C' ' 587' ' ' VAL . 8.9 m -130.36 146.82 51.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 615' ' ' ALA . . . . . 0.633 ' CB ' ' CZ3' ' C' ' 586' ' ' TRP . . . -79.68 157.71 27.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.115 -0.991 . . . . 0.0 109.467 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 83.34 2.22 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 142.86 20.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.694 2.263 . . . . 0.0 110.465 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -111.56 -15.99 13.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . -147.74 48.73 0.63 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.21 42.18 7.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -81.94 114.83 3.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 622' ' ' ASN . . . . . 0.496 ' CB ' ' HB ' ' C' ' 580' ' ' VAL . 57.4 m-20 -106.77 -42.49 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 623' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 15.0 m -92.17 118.27 30.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 624' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -143.14 152.41 41.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 625' ' ' GLY . . . . . 0.527 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -108.85 134.94 12.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 626' ' ' VAL . . . . . 0.636 HG13 ' OG ' ' C' ' 601' ' ' SER . 25.8 t -126.58 134.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 627' ' ' THR . . . . . 0.483 HG22 ' N ' ' C' ' 628' ' ' PHE . 53.9 m -79.9 159.77 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 628' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 78.7 m-85 -150.62 116.76 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 629' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 46.7 m-85 -69.87 138.42 52.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 630' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' C' ' 572' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 O-C-N 121.201 -0.937 . . . . 0.0 108.985 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 636' ' ' THR . . . . . 1.038 HG22 ' CE1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 637' ' ' PRO . . . . . 0.606 ' HB3' HD22 ' C' ' 592' ' ' LEU . 35.2 Cg_endo -77.94 172.19 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.636 2.224 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -148.26 133.78 4.76 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.137 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 639' ' ' ALA . . . . . 0.698 ' HB1' HG11 ' C' ' 588' ' ' VAL . . . -90.88 131.54 36.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.959 . . . . 0.0 108.858 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 640' ' ' THR . . . . . 0.622 ' O ' HG13 ' C' ' 588' ' ' VAL . 2.7 m -93.85 150.35 20.46 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.355 1.074 . . . . 0.0 111.973 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 641' ' ' CYS . . . . . 0.813 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.476 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 562' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' C' ' 641' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.685 0.755 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 563' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 3.3 m -160.23 158.48 30.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -140.08 84.85 1.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 565' ' ' VAL . . . . . 0.6 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.79 166.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 109.036 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 566' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.0 OUTLIER -83.64 61.63 6.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 567' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' C' ' 568' ' ' GLU . . . -38.95 154.97 0.02 OUTLIER Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 568' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 32.5 mt-10 -44.48 170.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 109.904 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 569' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' C' ' 574' ' ' PHE . 20.1 mt-10 -141.15 -164.07 1.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 570' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 15.0 m-90 -140.7 -100.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.603 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -143.54 -71.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.525 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.96 -11.2 59.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 573' ' ' ARG . . . . . 0.577 ' HD3' ' CE1' ' C' ' 629' ' ' TYR . 0.0 OUTLIER -144.1 145.3 32.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.913 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 574' ' ' PHE . . . . . 0.602 ' CE2' HG22 ' C' ' 636' ' ' THR . 52.7 p90 -110.97 159.17 17.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 575' ' ' ASN . . . . . 0.568 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 11.0 t-20 -116.27 170.5 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 576' ' ' VAL . . . . . 0.6 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -150.51 157.16 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.828 . . . . 0.0 109.308 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 20.7 m -122.01 102.99 8.51 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 578' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' C' ' 563' ' ' SER . 96.7 m-85 -88.9 133.64 34.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 579' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 3.5 m -114.48 146.82 40.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 580' ' ' VAL . . . . . 1.066 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 41.7 t -128.9 156.2 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.591 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.055 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 586' ' ' TRP . . . . . 1.066 ' CZ2' HG21 ' C' ' 580' ' ' VAL . 28.0 m95 -69.75 124.14 23.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 110.572 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 587' ' ' VAL . . . . . 0.55 HG12 ' O ' ' C' ' 587' ' ' VAL . 21.2 t -159.87 31.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 588' ' ' VAL . . . . . 1.071 HG23 ' O ' ' C' ' 640' ' ' THR . 6.0 p -79.28 148.29 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 589' ' ' THR . . . . . 0.968 ' CG2' HG23 ' C' ' 612' ' ' THR . 40.3 m -111.24 115.76 29.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 590' ' ' LEU . . . . . 0.544 ' HB3' HD21 ' C' ' 592' ' ' LEU . 0.4 OUTLIER -79.75 127.4 32.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.243 -0.91 . . . . 0.0 109.469 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -107.58 79.04 0.25 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 592' ' ' LEU . . . . . 0.756 HD23 ' N ' ' C' ' 592' ' ' LEU . 1.0 OUTLIER -65.62 -173.36 0.15 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.179 -1.189 . . . . 0.0 109.384 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 593' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' C' ' 593' ' ' ASN . 2.8 m-20 -91.27 -163.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . -90.96 69.12 2.19 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 150.64 -28.82 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -61.95 134.15 56.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.47 162.49 27.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.81 126.13 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 599' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' C' ' 600' ' ' SER . 14.2 tm0? -91.0 -43.75 9.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 600' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' C' ' 599' ' ' GLN . 36.7 p -163.82 170.13 17.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 601' ' ' SER . . . . . 0.663 ' HB3' HG22 ' C' ' 626' ' ' VAL . 1.8 p -161.33 165.56 28.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.264 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 602' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 26.2 p90 -158.48 159.39 35.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 603' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.04 21.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 604' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 169.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 605' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' C' ' 616' ' ' ARG . . . -110.62 172.86 6.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 606' ' ' LEU . . . . . 0.422 ' C ' HD12 ' C' ' 606' ' ' LEU . 3.4 pp -151.71 155.06 37.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 607' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' C' ' 613' ' ' VAL . 4.4 m -120.11 109.24 15.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 608' ' ' GLY . . . . . 0.486 ' CA ' HG22 ' C' ' 613' ' ' VAL . . . 116.83 178.99 17.88 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 609' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' C' ' 610' ' ' SER . 1.1 m -154.63 20.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -1.16 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 610' ' ' SER . . . . . 0.571 ' HA ' HD12 ' C' ' 592' ' ' LEU . 3.1 p 164.11 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.501 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.98 -98.94 0.93 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 612' ' ' THR . . . . . 0.968 HG23 ' CG2' ' C' ' 589' ' ' THR . 83.8 m -122.15 101.95 7.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 109.426 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 613' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' C' ' 614' ' ' THR . 2.1 t -106.14 165.41 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.188 -0.945 . . . . 0.0 108.964 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 614' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 11.7 m -139.18 137.24 35.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.978 . . . . 0.0 109.571 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 615' ' ' ALA . . . . . 0.78 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.55 137.24 37.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 616' ' ' ARG . . . . . 0.621 ' HB3' ' HB3' ' C' ' 605' ' ' ALA . 42.3 ttp180 -113.21 140.94 24.91 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.335 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 617' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' C' ' 616' ' ' ARG . 35.9 Cg_endo -77.88 138.46 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.418 2.079 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -115.35 -11.3 11.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 619' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 130.5 -2.48 5.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 620' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 166.73 126.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -1.209 . . . . 0.0 109.469 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 148.28 113.71 0.73 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 25.1 m120 -115.65 -18.48 10.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.492 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 623' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 50.4 m -116.61 111.39 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.182 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 624' ' ' PHE . . . . . 0.547 ' HE2' HG21 ' C' ' 626' ' ' VAL . 33.1 p90 -123.07 142.74 50.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 625' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -102.47 153.91 18.44 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 626' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' C' ' 601' ' ' SER . 59.1 t -149.67 141.49 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 627' ' ' THR . . . . . 0.602 HG22 ' N ' ' C' ' 628' ' ' PHE . 21.6 m -102.19 166.15 10.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.352 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 628' ' ' PHE . . . . . 0.603 ' CE2' ' HG3' ' C' ' 637' ' ' PRO . 97.0 m-85 -143.57 125.29 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.575 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 629' ' ' TYR . . . . . 0.577 ' CE1' ' HD3' ' C' ' 573' ' ' ARG . 10.3 m-85 -81.15 127.55 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 630' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' C' ' 629' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.535 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 636' ' ' THR . . . . . 0.63 HG22 ' CD ' ' C' ' 637' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 637' ' ' PRO . . . . . 0.63 ' CD ' HG22 ' C' ' 636' ' ' THR . 35.9 Cg_endo -78.61 171.13 17.2 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.539 2.159 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -147.73 139.45 7.79 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 639' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -93.39 132.05 38.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -1.074 . . . . 0.0 109.168 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 640' ' ' THR . . . . . 1.071 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.4 OUTLIER -98.46 143.63 28.69 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.994 0.902 . . . . 0.0 111.12 -179.252 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 641' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' C' ' 562' ' ' VAL . 1.5 m . . . . . 0 C--N 1.294 -1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.533 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.247 0.546 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . -164.6 53.73 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 559' ' ' SER . . . . . 0.573 ' HB3' HG23 ' C' ' 643' ' ' THR . 57.0 p -84.98 170.64 12.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -1.139 . . . . 0.0 109.377 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 560' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' C' ' 641' ' ' CYS . 0.0 OUTLIER -88.24 161.19 17.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 561' ' ' SER . . . . . . . . . . . . . 4.4 p -108.01 116.57 32.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 108.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 562' ' ' VAL . . . . . 0.706 ' HB ' HG22 ' C' ' 580' ' ' VAL . 2.7 p -160.86 161.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.005 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 563' ' ' SER . . . . . 0.509 ' N ' HG22 ' C' ' 562' ' ' VAL . 0.1 OUTLIER -144.86 141.21 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.131 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.09 121.63 42.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 565' ' ' VAL . . . . . 0.822 ' O ' HG12 ' C' ' 576' ' ' VAL . 0.6 OUTLIER -122.46 152.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 566' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' C' ' 565' ' ' VAL . 1.9 ptm85 -52.39 143.78 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 567' ' ' GLY . . . . . . . . . . . . . . . -117.58 -145.75 8.07 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.955 -1.593 . . . . 0.0 109.726 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 568' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.04 118.21 29.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 569' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' C' ' 574' ' ' PHE . 0.1 OUTLIER -110.24 177.91 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 570' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 22.0 m-90 -132.89 -92.89 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -138.83 -75.86 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 572' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' C' ' 630' ' ' LYS . 0.8 OUTLIER -80.16 -15.76 56.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 573' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -133.05 156.11 47.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 109.315 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 574' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 36.4 p90 -134.67 151.83 51.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 575' ' ' ASN . . . . . 0.449 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 4.3 t-20 -122.34 125.32 45.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.398 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 576' ' ' VAL . . . . . 0.822 HG12 ' O ' ' C' ' 565' ' ' VAL . 1.1 t -100.56 158.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 64.7 m -116.78 128.26 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.937 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 578' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' C' ' 624' ' ' PHE . 29.8 m-85 -115.24 125.19 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 579' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 56.6 m -96.38 141.78 29.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 580' ' ' VAL . . . . . 1.003 HG21 ' CH2' ' C' ' 586' ' ' TRP . 59.6 t -127.16 160.9 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.573 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 581' ' ' SER . . . . . 0.483 ' N ' HG12 ' C' ' 580' ' ' VAL . 0.1 OUTLIER -110.41 -26.89 9.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.469 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 582' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' C' ' 583' ' ' SER . . . -96.49 -70.39 1.04 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 583' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' C' ' 582' ' ' GLY . 0.2 OUTLIER 81.33 -66.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.893 . . . . 0.0 109.435 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 584' ' ' SER . . . . . 0.427 ' C ' ' O ' ' C' ' 583' ' ' SER . 1.5 m -43.34 -29.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 0.0 109.448 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 30.5 t -110.98 66.08 0.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 586' ' ' TRP . . . . . 1.003 ' CH2' HG21 ' C' ' 580' ' ' VAL . 27.9 m95 -77.08 124.44 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 110.395 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 587' ' ' VAL . . . . . 0.471 HG13 ' O ' ' C' ' 587' ' ' VAL . 10.0 p -160.14 31.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 588' ' ' VAL . . . . . 1.092 HG23 ' O ' ' C' ' 640' ' ' THR . 7.1 p -79.02 148.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.524 -0.735 . . . . 0.0 109.428 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 589' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 612' ' ' THR . 31.2 m -111.09 114.46 27.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 590' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' C' ' 590' ' ' LEU . 4.0 mm? -79.44 126.23 30.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -108.04 87.49 0.49 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 592' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.6 -167.84 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.188 -1.183 . . . . 0.0 109.444 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 593' ' ' ASN . . . . . 0.449 ' HB2' ' OE1' ' C' ' 596' ' ' GLN . 0.8 OUTLIER -111.43 41.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 594' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' C' ' 593' ' ' ASN . . . 44.17 68.8 0.8 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 174.38 -47.18 0.14 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 596' ' ' GLN . . . . . 0.449 ' OE1' ' HB2' ' C' ' 593' ' ' ASN . 0.0 OUTLIER -80.34 170.51 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -1.148 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 4.5 m -151.07 148.12 27.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.541 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 598' ' ' VAL . . . . . 0.421 HG13 HG13 ' C' ' 626' ' ' VAL . 85.1 t -69.43 113.54 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.492 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 599' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' C' ' 629' ' ' TYR . 6.7 tm0? -89.04 -27.97 20.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.06 168.41 10.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 5.9 p -164.46 163.3 22.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.373 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 602' ' ' TRP . . . . . 0.527 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 31.3 p90 -155.66 158.57 38.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 603' ' ' ASN . . . . . 0.688 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.4 OUTLIER 76.31 18.98 1.78 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 604' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 164.2 158.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 605' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 606' ' ' LEU . . . -100.99 154.45 18.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 606' ' ' LEU . . . . . 0.558 HD23 HG11 ' C' ' 613' ' ' VAL . 2.2 mp -118.91 164.3 15.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.3 m -131.09 94.17 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.38 17.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 609' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' C' ' 610' ' ' SER . 25.0 m -163.16 29.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 610' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.2 OUTLIER 163.98 106.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 115.61 -87.13 0.43 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 612' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 589' ' ' THR . 18.4 m -127.35 103.99 7.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 613' ' ' VAL . . . . . 0.558 HG11 HD23 ' C' ' 606' ' ' LEU . 2.1 t -106.38 109.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.172 -0.955 . . . . 0.0 108.763 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 614' ' ' THR . . . . . 0.755 HG23 ' O ' ' C' ' 588' ' ' VAL . 0.5 OUTLIER -93.01 145.12 24.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 110.028 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 615' ' ' ALA . . . . . 0.817 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -81.09 167.76 19.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.366 -0.834 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -145.95 153.0 49.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.09 135.12 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.619 2.213 . . . . 0.0 110.421 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -153.47 26.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 160.22 -93.22 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 2.1 m -178.8 55.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 621' ' ' GLY . . . . . 0.449 ' O ' ' OG ' ' C' ' 583' ' ' SER . . . -119.43 118.9 4.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 622' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' C' ' 583' ' ' SER . 1.8 m120 -87.98 -22.96 23.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -1.141 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 623' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 55.6 m -107.08 121.88 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 624' ' ' PHE . . . . . 0.587 ' HE2' HG21 ' C' ' 626' ' ' VAL . 11.6 p90 -130.31 142.83 50.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -99.5 147.53 18.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 626' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' C' ' 624' ' ' PHE . 23.9 t -139.55 133.08 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -1.175 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 86.9 m -87.87 150.58 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 628' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 91.0 m-85 -136.95 124.95 22.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 629' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' C' ' 599' ' ' GLN . 11.1 m-85 -73.34 139.48 46.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 630' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' C' ' 572' ' ' ASP . 0.2 OUTLIER -94.29 -67.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 631' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' C' ' 630' ' ' LYS . 6.5 m-20 43.94 32.26 0.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 116.77 9.78 10.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 633' ' ' SER . . . . . . . . . . . . . 1.2 m -110.68 115.97 30.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 19.1 m -111.25 -1.91 15.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.639 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -89.44 138.96 30.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.664 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 636' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 3.5 m -89.42 141.54 28.95 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.263 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 637' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 34.7 Cg_endo -76.95 170.07 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.364 2.043 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -141.27 152.88 23.6 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 639' ' ' ALA . . . . . 0.855 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -95.66 134.8 38.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.521 -0.988 . . . . 0.0 109.269 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 640' ' ' THR . . . . . 1.092 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -98.41 143.2 29.12 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.048 0.928 . . . . 0.0 111.046 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 641' ' ' CYS . . . . . 0.54 ' SG ' HG11 ' C' ' 562' ' ' VAL . 1.5 m -160.05 68.68 0.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 642' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' C' ' 559' ' ' SER . . . -146.03 165.06 30.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.41 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 643' ' ' THR . . . . . 0.573 HG23 ' HB3' ' C' ' 559' ' ' SER . 72.0 p -109.58 104.89 14.0 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.326 -0.859 . . . . 0.0 109.358 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.514 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 51.51 71.46 0.65 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 171.6 4.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -1.135 . . . . 0.0 109.513 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 560' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 0.0 OUTLIER -59.91 169.34 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 108.91 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 561' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' C' ' 560' ' ' CYS . 68.2 m -114.84 125.7 53.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 109.303 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 562' ' ' VAL . . . . . 0.595 HG11 ' SG ' ' C' ' 641' ' ' CYS . 3.7 m -143.98 176.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 563' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 19.7 m -154.3 137.6 15.75 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -119.73 90.54 3.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.085 . . . . 0.0 110.156 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 565' ' ' VAL . . . . . 0.64 ' O ' HG13 ' C' ' 576' ' ' VAL . 2.0 t -79.85 154.2 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 566' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.41 65.04 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.034 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 567' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' C' ' 569' ' ' GLU . . . -53.08 164.07 2.06 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 568' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' C' ' 575' ' ' ASN . 1.4 mt-10 -42.52 152.64 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 109.913 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 569' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' C' ' 567' ' ' GLY . 0.6 OUTLIER -160.08 97.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.003 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 570' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' C' ' 573' ' ' ARG . 10.6 m-90 -57.22 167.12 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 109.553 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 571' ' ' ALA . . . . . 0.436 ' C ' ' HE3' ' C' ' 630' ' ' LYS . . . -67.12 -24.73 65.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.03 -7.29 13.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.335 -0.853 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 573' ' ' ARG . . . . . 0.578 ' HB3' ' CE3' ' C' ' 570' ' ' TRP . 0.1 OUTLIER -134.5 164.48 27.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 574' ' ' PHE . . . . . 0.943 ' O ' HG23 ' C' ' 627' ' ' THR . 0.2 OUTLIER -128.84 163.54 25.0 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.323 -0.86 . . . . 0.0 110.705 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 575' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' C' ' 568' ' ' GLU . 17.2 t30 -157.56 67.6 0.51 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 576' ' ' VAL . . . . . 0.64 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.9 t -79.67 153.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.56 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 99.5 m -112.94 91.56 3.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 578' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' C' ' 576' ' ' VAL . 63.6 m-85 -85.96 150.43 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 579' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 623' ' ' SER . 4.2 m -138.08 131.51 30.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.871 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 580' ' ' VAL . . . . . 0.725 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 2.6 t -106.6 155.26 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.94 64.3 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . 159.88 -25.41 0.31 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 583' ' ' SER . . . . . 0.401 ' O ' ' C ' ' C' ' 584' ' ' SER . 1.0 OUTLIER -88.29 83.51 6.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -1.16 . . . . 0.0 109.544 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 584' ' ' SER . . . . . 0.401 ' C ' ' O ' ' C' ' 583' ' ' SER . 0.1 OUTLIER -44.31 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 109.2 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 12.3 t -79.92 130.9 35.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 108.952 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 586' ' ' TRP . . . . . 1.006 ' CE3' ' HB3' ' C' ' 615' ' ' ALA . 19.6 m95 -69.92 130.73 43.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 111.439 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 587' ' ' VAL . . . . . 0.506 HG22 ' O ' ' C' ' 586' ' ' TRP . 2.0 t -158.84 29.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 588' ' ' VAL . . . . . 0.684 HG22 ' SG ' ' C' ' 641' ' ' CYS . 2.1 t -79.24 165.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.754 0.788 . . . . 0.0 110.0 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 589' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 612' ' ' THR . 0.0 OUTLIER -110.47 157.31 19.73 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 590' ' ' LEU . . . . . 0.92 HD13 HG12 ' C' ' 613' ' ' VAL . 1.1 mp -121.74 132.65 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.002 . . . . 0.0 109.628 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -113.12 77.32 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 592' ' ' LEU . . . . . 0.536 HD23 ' N ' ' C' ' 592' ' ' LEU . 5.6 mt -58.14 145.14 37.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.201 -1.176 . . . . 0.0 109.554 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 593' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 85.5 m-20 -107.41 120.79 43.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.46 9.81 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 49.89 45.79 40.74 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 596' ' ' GLN . . . . . 0.469 ' O ' HD12 ' C' ' 592' ' ' LEU . 47.2 mt-30 -75.96 157.48 33.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 0.0 109.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 597' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.9 OUTLIER -116.37 169.29 9.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 109.436 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 598' ' ' VAL . . . . . 0.873 HG11 HD13 ' C' ' 606' ' ' LEU . 59.4 t -97.59 121.85 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 599' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 1.9 tt0 -85.11 -50.95 6.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 1.9 m -165.93 155.39 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 601' ' ' SER . . . . . 0.487 ' HB3' HD11 ' C' ' 606' ' ' LEU . 39.4 p -147.93 155.59 41.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 602' ' ' TRP . . . . . 0.501 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 30.5 p90 -137.41 154.32 49.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 603' ' ' ASN . . . . . 0.709 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 2.2 t-20 76.52 30.21 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 604' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.9 146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 605' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' C' ' 616' ' ' ARG . . . -86.1 166.28 15.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 606' ' ' LEU . . . . . 0.873 HD13 HG11 ' C' ' 598' ' ' VAL . 22.9 mt -120.73 154.19 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 607' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' C' ' 616' ' ' ARG . 90.6 m -133.8 74.39 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 136.26 -160.77 24.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 609' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' C' ' 610' ' ' SER . 22.8 p -177.78 35.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.417 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 610' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.5 OUTLIER 166.11 145.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 68.42 -139.62 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 612' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 589' ' ' THR . 3.3 m -79.94 107.1 12.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 613' ' ' VAL . . . . . 0.92 HG12 HD13 ' C' ' 590' ' ' LEU . 2.1 t -103.38 157.17 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.237 -0.914 . . . . 0.0 108.887 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 614' ' ' THR . . . . . 0.529 HG23 ' O ' ' C' ' 588' ' ' VAL . 1.3 m -121.47 139.03 54.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 109.645 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 615' ' ' ALA . . . . . 1.006 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -89.39 159.25 17.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 616' ' ' ARG . . . . . 0.901 ' HB2' ' HB3' ' C' ' 605' ' ' ALA . 3.0 mtt180 -132.35 153.31 81.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 617' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' C' ' 586' ' ' TRP . 35.5 Cg_endo -77.86 127.81 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -117.55 14.32 14.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 60.04 71.67 0.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 70.1 m -154.92 -41.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.19 -167.73 39.49 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 622' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 580' ' ' VAL . 28.4 m120 -107.42 -21.28 12.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 623' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 579' ' ' SER . 96.4 p -81.62 121.75 26.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 624' ' ' PHE . . . . . 0.628 ' CE1' ' CH2' ' C' ' 586' ' ' TRP . 2.8 p90 -137.84 142.75 40.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -105.66 139.91 14.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 626' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.31 133.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.14 . . . . 0.0 109.634 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 627' ' ' THR . . . . . 0.943 HG23 ' O ' ' C' ' 574' ' ' PHE . 45.8 m -95.41 145.24 25.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 628' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' C' ' 574' ' ' PHE . 91.8 m-85 -126.9 144.56 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 629' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' C' ' 573' ' ' ARG . 11.0 m-85 -97.47 136.1 38.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 630' ' ' LYS . . . . . 0.531 ' HD3' ' CE1' ' C' ' 574' ' ' PHE . 27.5 pttt -139.76 -40.99 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 631' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' C' ' 630' ' ' LYS . 7.9 m-20 73.68 1.79 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 149.7 77.98 0.02 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 633' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' C' ' 630' ' ' LYS . 74.5 m -138.41 147.71 43.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.141 . . . . 0.0 109.487 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.26 -7.36 14.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -88.62 134.31 33.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 636' ' ' THR . . . . . 0.639 HG23 ' HD2' ' C' ' 637' ' ' PRO . 28.9 m -90.14 140.49 27.36 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 637' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' C' ' 636' ' ' THR . 35.9 Cg_endo -79.78 170.82 16.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.375 2.05 . . . . 0.0 109.927 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 638' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' C' ' 578' ' ' TYR . . . -163.44 156.94 28.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.365 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -81.02 179.03 8.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.467 -1.019 . . . . 0.0 109.014 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 640' ' ' THR . . . . . 0.6 ' O ' HG13 ' C' ' 588' ' ' VAL . 0.2 OUTLIER -130.4 140.75 50.57 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.141 0.972 . . . . 0.0 111.122 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 641' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m -160.57 70.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.448 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -137.65 168.73 19.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 43.7 p -116.28 105.42 12.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 CA-C-O 118.043 -1.421 . . . . 0.0 109.585 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 133.87 115.1 1.55 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 70.6 m -148.52 160.71 42.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -1.12 . . . . 0.0 109.415 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 560' ' ' CYS . . . . . 0.42 ' HB2' HG23 ' C' ' 562' ' ' VAL . 19.7 p -115.41 161.47 18.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 561' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' C' ' 580' ' ' VAL . 1.7 m -99.01 31.96 2.83 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 122.601 1.191 . . . . 0.0 108.624 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 562' ' ' VAL . . . . . 0.554 HG22 HG22 ' C' ' 580' ' ' VAL . 2.3 t -96.25 118.91 43.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.133 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 167.23 13.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 109.646 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -132.33 92.89 3.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 565' ' ' VAL . . . . . 0.567 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.77 162.02 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.933 . . . . 0.0 109.191 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 566' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.1 OUTLIER -83.13 62.01 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 567' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' C' ' 566' ' ' ARG . . . -37.3 157.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 568' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 27.5 mt-10 -39.98 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -1.039 . . . . 0.0 110.2 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 569' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 568' ' ' GLU . 2.9 mp0 -147.14 -163.92 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 570' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -141.5 -96.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -139.4 -72.89 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.035 -1.041 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.73 -37.11 36.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 108.863 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 573' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' C' ' 629' ' ' TYR . 33.0 ptt180 -110.17 149.96 29.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 0.0 109.012 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 574' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 11.5 p90 -130.05 154.17 47.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 575' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' C' ' 568' ' ' GLU . 11.7 t-20 -108.09 172.48 6.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.182 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 576' ' ' VAL . . . . . 0.567 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.3 t -150.12 157.71 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 32.7 m -128.7 94.66 3.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 578' ' ' TYR . . . . . 0.64 ' CD2' ' CE1' ' C' ' 624' ' ' PHE . 92.8 m-85 -79.82 137.55 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 3.4 m -120.07 121.31 38.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 580' ' ' VAL . . . . . 0.83 HG21 ' CH2' ' C' ' 586' ' ' TRP . 2.8 t -108.79 142.61 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 581' ' ' SER . . . . . 0.44 ' C ' ' CB ' ' C' ' 561' ' ' SER . 0.7 OUTLIER -157.34 55.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . 163.84 -28.96 0.23 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 583' ' ' SER . . . . . 0.527 ' OG ' HG22 ' C' ' 562' ' ' VAL . 5.5 m -56.53 -47.09 80.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -1.125 . . . . 0.0 109.486 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 584' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' C' ' 583' ' ' SER . 0.3 OUTLIER 74.57 -81.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.39 -0.819 . . . . 0.0 109.298 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.98 116.69 20.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.267 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 586' ' ' TRP . . . . . 0.83 ' CH2' HG21 ' C' ' 580' ' ' VAL . 24.3 m95 -69.57 120.85 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 587' ' ' VAL . . . . . 0.618 ' O ' HG22 ' C' ' 587' ' ' VAL . 14.4 p -160.88 31.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 588' ' ' VAL . . . . . 0.974 HG23 ' O ' ' C' ' 640' ' ' THR . 2.9 p -79.26 149.98 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 589' ' ' THR . . . . . 0.855 HG22 ' CG2' ' C' ' 612' ' ' THR . 0.2 OUTLIER -112.63 115.87 29.28 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 590' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.74 128.77 34.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -101.81 88.89 0.73 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 592' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 596' ' ' GLN . 9.6 mp -75.17 122.12 23.14 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 593' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 26.0 m-80 -111.5 138.69 47.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 96.63 31.04 7.28 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 58.38 19.86 42.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 596' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 1.8 mm100 -51.75 156.42 1.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -1.143 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 597' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.5 OUTLIER -141.56 153.83 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.45 140.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 599' ' ' GLN . . . . . 0.439 ' HG3' ' OH ' ' C' ' 629' ' ' TYR . 6.4 tt0 -109.54 -42.56 4.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.08 160.3 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 601' ' ' SER . . . . . 0.503 ' OG ' HG13 ' C' ' 626' ' ' VAL . 0.7 OUTLIER -159.75 164.12 34.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 602' ' ' TRP . . . . . 0.572 ' CH2' ' HA3' ' C' ' 625' ' ' GLY . 14.2 p90 -153.24 170.48 20.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 603' ' ' ASN . . . . . 0.664 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 3.9 t-20 76.4 12.78 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.486 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 604' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 165.28 173.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -121.67 139.94 52.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 606' ' ' LEU . . . . . 0.758 HD23 ' CG1' ' C' ' 613' ' ' VAL . 6.7 mp -114.23 163.0 15.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 63.2 m -120.24 106.67 12.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 130.49 147.04 6.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 609' ' ' SER . . . . . . . . . . . . . 4.7 p -116.34 -6.06 11.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 32.9 t -173.38 124.09 0.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.01 -124.37 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 612' ' ' THR . . . . . 0.855 ' CG2' HG22 ' C' ' 589' ' ' THR . 92.8 m -90.15 106.78 18.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -1.19 . . . . 0.0 109.389 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 613' ' ' VAL . . . . . 0.758 ' CG1' HD23 ' C' ' 606' ' ' LEU . 2.1 t -103.21 117.99 49.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.004 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 614' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 6.9 m -90.22 137.63 32.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 615' ' ' ALA . . . . . 0.727 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.29 145.91 33.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 109.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 616' ' ' ARG . . . . . 0.474 ' HG2' ' HD2' ' C' ' 617' ' ' PRO . 0.0 OUTLIER -131.46 143.83 50.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.441 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 617' ' ' PRO . . . . . 0.474 ' HD2' ' HG2' ' C' ' 616' ' ' ARG . 36.0 Cg_endo -78.39 155.17 28.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 110.314 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -145.51 32.78 1.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.86 . . . . 0.0 109.316 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 619' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' C' ' 620' ' ' SER . . . 110.24 57.26 0.51 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 620' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 68.53 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.235 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.6 99.01 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 622' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 16.9 m120 -97.83 -0.36 45.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.629 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 623' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 3.3 m -117.04 126.79 53.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.075 -1.015 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 624' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' C' ' 578' ' ' TYR . 23.4 p90 -142.87 141.65 31.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 625' ' ' GLY . . . . . 0.572 ' HA3' ' CH2' ' C' ' 602' ' ' TRP . . . -109.49 142.09 16.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 626' ' ' VAL . . . . . 0.503 HG13 ' OG ' ' C' ' 601' ' ' SER . 3.2 t -140.51 156.37 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 627' ' ' THR . . . . . 0.446 HG23 ' O ' ' C' ' 574' ' ' PHE . 68.6 m -121.52 140.99 51.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 628' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 18.6 m-85 -132.05 140.98 49.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 629' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' C' ' 573' ' ' ARG . 60.5 m-85 -86.37 124.13 32.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.937 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 630' ' ' LYS . . . . . 0.544 ' HG2' ' CD1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER -125.86 -34.46 2.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.505 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 631' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' C' ' 630' ' ' LYS . 15.4 m-20 66.01 23.39 11.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 68.68 33.94 77.17 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 633' ' ' SER . . . . . . . . . . . . . 1.8 m -148.2 39.5 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.191 . . . . 0.0 109.58 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 59.9 m -156.88 161.1 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -90.16 166.3 13.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 636' ' ' THR . . . . . 0.605 HG22 ' HD2' ' C' ' 637' ' ' PRO . 2.6 m -75.97 141.7 71.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.191 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 637' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' C' ' 636' ' ' THR . 35.6 Cg_endo -77.36 97.33 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.421 2.08 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -71.74 152.29 48.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 639' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -101.48 133.3 46.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -1.108 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 640' ' ' THR . . . . . 0.974 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -99.66 145.91 27.07 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.9 0.857 . . . . 0.0 111.2 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 641' ' ' CYS . . . . . . . . . . . . . 1.6 m -118.87 92.49 3.82 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 109.262 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -107.76 157.88 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 47.5 p -114.7 105.9 13.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.3 0.571 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . -166.39 -151.03 6.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 52.5 p -112.78 161.13 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -1.194 . . . . 0.0 109.442 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 560' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' C' ' 561' ' ' SER . 0.0 OUTLIER -108.51 166.1 11.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 561' ' ' SER . . . . . 0.529 ' N ' ' SG ' ' C' ' 560' ' ' CYS . 0.3 OUTLIER -132.06 130.63 41.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 562' ' ' VAL . . . . . 0.541 ' CG2' ' SG ' ' C' ' 641' ' ' CYS . 1.7 t -154.27 158.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.233 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 71.7 m -127.83 138.02 52.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -95.53 130.26 42.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.755 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 565' ' ' VAL . . . . . 0.678 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -117.81 163.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.104 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 566' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' C' ' 567' ' ' GLY . 1.0 OUTLIER -83.09 62.62 6.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 567' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -41.34 165.95 0.01 OUTLIER Glycine 0 N--CA 1.485 1.919 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 568' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 6.6 mt-10 -41.43 165.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.445 -1.033 . . . . 0.0 110.184 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.29 -162.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 570' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 27.4 m-90 -151.94 -100.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.63 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -142.03 -68.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.08 . . . . 0.0 109.481 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 572' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' C' ' 630' ' ' LYS . 0.9 OUTLIER -79.88 -17.78 52.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 0.0 109.331 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 573' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 144.36 47.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 109.185 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 574' ' ' PHE . . . . . 1.038 ' CE1' HG22 ' C' ' 636' ' ' THR . 36.6 p90 -122.29 151.57 40.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.371 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 575' ' ' ASN . . . . . 0.519 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.1 t30 -113.61 152.14 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 576' ' ' VAL . . . . . 0.678 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -128.36 156.83 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 18.8 m -127.61 104.54 7.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.299 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 578' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' C' ' 623' ' ' SER . 67.8 m-85 -91.47 146.42 23.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 1.1 m -125.5 115.07 19.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 580' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' C' ' 586' ' ' TRP . 11.6 t -85.09 161.26 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 581' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' C' ' 580' ' ' VAL . 14.8 p -129.05 62.95 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 582' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' C' ' 583' ' ' SER . . . 173.89 -30.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 583' ' ' SER . . . . . 0.527 ' O ' ' N ' ' C' ' 585' ' ' SER . 2.7 p 50.57 -105.49 0.19 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -1.084 . . . . 0.0 109.448 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 584' ' ' SER . . . . . 0.448 ' C ' ' O ' ' C' ' 583' ' ' SER . 31.2 m 40.24 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.235 -0.916 . . . . 0.0 109.736 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 585' ' ' SER . . . . . 0.527 ' N ' ' O ' ' C' ' 583' ' ' SER . 45.2 m -142.15 65.8 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.04 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 586' ' ' TRP . . . . . 0.679 ' HE3' HG23 ' C' ' 588' ' ' VAL . 60.3 p-90 -87.8 112.73 22.75 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.883 . . . . 0.0 109.7 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 587' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' C' ' 614' ' ' THR . 1.0 OUTLIER -107.39 96.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 588' ' ' VAL . . . . . 0.813 HG22 ' SG ' ' C' ' 641' ' ' CYS . 11.5 t -79.53 161.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.192 0.996 . . . . 0.0 110.729 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 589' ' ' THR . . . . . 0.6 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -120.48 104.1 9.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 590' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' C' ' 613' ' ' VAL . 0.2 OUTLIER -78.78 137.01 37.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.044 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -125.58 78.02 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 592' ' ' LEU . . . . . 0.674 HD23 ' N ' ' C' ' 592' ' ' LEU . 2.5 mt -61.86 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.311 -1.111 . . . . 0.0 109.537 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 593' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -100.25 29.96 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.96 55.26 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . -134.22 -65.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 596' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' C' ' 633' ' ' SER . 3.6 mt-30 -54.38 164.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -1.17 . . . . 0.0 109.466 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 11.9 p -148.33 154.6 40.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 63.8 t -85.05 137.28 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 599' ' ' GLN . . . . . 0.564 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 16.9 tm0? -106.95 -41.19 5.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 34.9 p -165.84 151.22 8.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.406 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 601' ' ' SER . . . . . 0.636 ' OG ' HG13 ' C' ' 626' ' ' VAL . 38.2 m -145.37 150.79 37.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 602' ' ' TRP . . . . . 0.527 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 45.6 p90 -129.62 157.42 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 603' ' ' ASN . . . . . 0.684 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.22 20.04 1.66 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 604' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 156.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.443 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 605' ' ' ALA . . . . . 0.618 ' C ' HD22 ' C' ' 606' ' ' LEU . . . -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 606' ' ' LEU . . . . . 0.693 HD22 ' N ' ' C' ' 606' ' ' LEU . 3.6 mm? -102.16 170.71 7.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.9 m -123.61 121.51 35.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 608' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' C' ' 609' ' ' SER . . . 99.84 -56.0 0.87 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 609' ' ' SER . . . . . 0.809 ' H ' HG22 ' C' ' 613' ' ' VAL . 2.8 m 69.28 24.21 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 6.8 p -171.82 150.49 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 53.41 -119.35 10.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 612' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 590' ' ' LEU . 57.3 m -86.19 108.14 18.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 613' ' ' VAL . . . . . 0.809 HG22 ' H ' ' C' ' 609' ' ' SER . 2.1 t -102.28 164.56 3.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.247 -0.908 . . . . 0.0 108.89 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 614' ' ' THR . . . . . 0.523 ' CG2' HG23 ' C' ' 587' ' ' VAL . 8.9 m -130.36 146.82 51.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 615' ' ' ALA . . . . . 0.633 ' CB ' ' CZ3' ' C' ' 586' ' ' TRP . . . -79.68 157.71 27.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.115 -0.991 . . . . 0.0 109.467 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 83.34 2.22 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 142.86 20.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.694 2.263 . . . . 0.0 110.465 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -111.56 -15.99 13.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . -147.74 48.73 0.63 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.21 42.18 7.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -81.94 114.83 3.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 622' ' ' ASN . . . . . 0.496 ' CB ' ' HB ' ' C' ' 580' ' ' VAL . 57.4 m-20 -106.77 -42.49 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 623' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 15.0 m -92.17 118.27 30.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 624' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -143.14 152.41 41.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 625' ' ' GLY . . . . . 0.527 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -108.85 134.94 12.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 626' ' ' VAL . . . . . 0.636 HG13 ' OG ' ' C' ' 601' ' ' SER . 25.8 t -126.58 134.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 627' ' ' THR . . . . . 0.483 HG22 ' N ' ' C' ' 628' ' ' PHE . 53.9 m -79.9 159.77 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 628' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 78.7 m-85 -150.62 116.76 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 629' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 46.7 m-85 -69.87 138.42 52.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 630' ' ' LYS . . . . . 0.504 ' CG ' ' N ' ' C' ' 631' ' ' ASN . 0.0 OUTLIER -97.57 -63.86 1.09 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.201 -0.937 . . . . 0.0 108.985 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 631' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' C' ' 630' ' ' LYS . 5.7 m120 41.86 53.37 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 109.55 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 68.27 41.01 87.21 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 633' ' ' SER . . . . . 0.503 ' HB2' ' HG3' ' C' ' 596' ' ' GLN . 90.2 p -80.06 -150.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -1.121 . . . . 0.0 109.593 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.3 -149.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.489 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 635' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 636' ' ' THR . . . -49.6 138.17 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 636' ' ' THR . . . . . 1.038 HG22 ' CE1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER -47.15 174.98 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.324 -0.86 . . . . 0.0 109.638 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 637' ' ' PRO . . . . . 0.606 ' HB3' HD22 ' C' ' 592' ' ' LEU . 35.2 Cg_endo -77.94 172.19 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.636 2.224 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -148.26 133.78 4.76 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.137 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 639' ' ' ALA . . . . . 0.698 ' HB1' HG11 ' C' ' 588' ' ' VAL . . . -90.88 131.54 36.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.959 . . . . 0.0 108.858 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 640' ' ' THR . . . . . 0.622 ' O ' HG13 ' C' ' 588' ' ' VAL . 2.7 m -93.85 150.35 20.46 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.355 1.074 . . . . 0.0 111.973 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 641' ' ' CYS . . . . . 0.813 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m -160.98 69.96 0.37 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.476 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -156.29 164.32 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 47.9 p -114.49 105.38 13.03 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.515 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 557' ' ' THR . . . . . 0.42 ' C ' HG21 ' C' ' 643' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 558' ' ' GLY . . . . . 0.561 ' N ' HG21 ' C' ' 643' ' ' THR . . . -111.37 108.22 2.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.92 169.16 11.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.436 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 560' ' ' CYS . . . . . 0.483 ' O ' ' HB3' ' C' ' 641' ' ' CYS . 0.5 OUTLIER -120.18 137.14 54.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 109.522 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 561' ' ' SER . . . . . 0.517 ' O ' HG13 ' C' ' 580' ' ' VAL . 46.3 m -76.06 120.37 21.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.069 -1.02 . . . . 0.0 108.399 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 562' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' C' ' 641' ' ' CYS . 0.0 OUTLIER -139.78 175.84 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.111 -0.993 . . . . 0.0 110.292 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 563' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 3.3 m -160.23 158.48 30.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -140.08 84.85 1.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 565' ' ' VAL . . . . . 0.6 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.79 166.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 109.036 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 566' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.0 OUTLIER -83.64 61.63 6.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 567' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' C' ' 568' ' ' GLU . . . -38.95 154.97 0.02 OUTLIER Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 568' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 32.5 mt-10 -44.48 170.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 109.904 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 569' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' C' ' 574' ' ' PHE . 20.1 mt-10 -141.15 -164.07 1.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 570' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 15.0 m-90 -140.7 -100.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.603 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -143.54 -71.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.525 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 572' ' ' ASP . . . . . 0.465 ' CA ' ' OD1' ' C' ' 631' ' ' ASN . 3.0 m-20 -79.96 -11.2 59.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 573' ' ' ARG . . . . . 0.577 ' HD3' ' CE1' ' C' ' 629' ' ' TYR . 0.0 OUTLIER -144.1 145.3 32.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.913 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 574' ' ' PHE . . . . . 0.602 ' CE2' HG22 ' C' ' 636' ' ' THR . 52.7 p90 -110.97 159.17 17.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 575' ' ' ASN . . . . . 0.568 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 11.0 t-20 -116.27 170.5 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 576' ' ' VAL . . . . . 0.6 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -150.51 157.16 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.828 . . . . 0.0 109.308 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 20.7 m -122.01 102.99 8.51 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 578' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' C' ' 563' ' ' SER . 96.7 m-85 -88.9 133.64 34.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 579' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 3.5 m -114.48 146.82 40.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 580' ' ' VAL . . . . . 1.066 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 41.7 t -128.9 156.2 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.591 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 581' ' ' SER . . . . . 0.513 ' HB2' ' CB ' ' C' ' 561' ' ' SER . 13.2 m -102.85 47.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 582' ' ' GLY . . . . . 0.423 ' N ' HG12 ' C' ' 580' ' ' VAL . . . 60.01 44.97 96.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 583' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' C' ' 584' ' ' SER . 0.5 OUTLIER -43.72 -28.14 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.113 . . . . 0.0 109.6 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 584' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' C' ' 583' ' ' SER . 2.1 t 76.92 -2.62 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 109.545 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 24.7 m -160.26 96.65 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.161 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 586' ' ' TRP . . . . . 1.066 ' CZ2' HG21 ' C' ' 580' ' ' VAL . 28.0 m95 -69.75 124.14 23.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 110.572 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 587' ' ' VAL . . . . . 0.55 HG12 ' O ' ' C' ' 587' ' ' VAL . 21.2 t -159.87 31.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 588' ' ' VAL . . . . . 1.071 HG23 ' O ' ' C' ' 640' ' ' THR . 6.0 p -79.28 148.29 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 589' ' ' THR . . . . . 0.968 ' CG2' HG23 ' C' ' 612' ' ' THR . 40.3 m -111.24 115.76 29.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 590' ' ' LEU . . . . . 0.544 ' HB3' HD21 ' C' ' 592' ' ' LEU . 0.4 OUTLIER -79.75 127.4 32.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.243 -0.91 . . . . 0.0 109.469 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -107.58 79.04 0.25 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 592' ' ' LEU . . . . . 0.756 HD23 ' N ' ' C' ' 592' ' ' LEU . 1.0 OUTLIER -65.62 -173.36 0.15 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.179 -1.189 . . . . 0.0 109.384 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 593' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' C' ' 593' ' ' ASN . 2.8 m-20 -91.27 -163.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . -90.96 69.12 2.19 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 150.64 -28.82 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -61.95 134.15 56.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.47 162.49 27.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.81 126.13 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 599' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' C' ' 600' ' ' SER . 14.2 tm0? -91.0 -43.75 9.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 600' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' C' ' 599' ' ' GLN . 36.7 p -163.82 170.13 17.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 601' ' ' SER . . . . . 0.663 ' HB3' HG22 ' C' ' 626' ' ' VAL . 1.8 p -161.33 165.56 28.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.264 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 602' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 26.2 p90 -158.48 159.39 35.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 603' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.04 21.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 604' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 169.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 605' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' C' ' 616' ' ' ARG . . . -110.62 172.86 6.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 606' ' ' LEU . . . . . 0.422 ' C ' HD12 ' C' ' 606' ' ' LEU . 3.4 pp -151.71 155.06 37.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 607' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' C' ' 613' ' ' VAL . 4.4 m -120.11 109.24 15.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 608' ' ' GLY . . . . . 0.486 ' CA ' HG22 ' C' ' 613' ' ' VAL . . . 116.83 178.99 17.88 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 609' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' C' ' 610' ' ' SER . 1.1 m -154.63 20.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -1.16 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 610' ' ' SER . . . . . 0.571 ' HA ' HD12 ' C' ' 592' ' ' LEU . 3.1 p 164.11 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.501 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.98 -98.94 0.93 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 612' ' ' THR . . . . . 0.968 HG23 ' CG2' ' C' ' 589' ' ' THR . 83.8 m -122.15 101.95 7.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 109.426 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 613' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' C' ' 614' ' ' THR . 2.1 t -106.14 165.41 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.188 -0.945 . . . . 0.0 108.964 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 614' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 11.7 m -139.18 137.24 35.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.978 . . . . 0.0 109.571 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 615' ' ' ALA . . . . . 0.78 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.55 137.24 37.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 616' ' ' ARG . . . . . 0.621 ' HB3' ' HB3' ' C' ' 605' ' ' ALA . 42.3 ttp180 -113.21 140.94 24.91 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.335 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 617' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' C' ' 616' ' ' ARG . 35.9 Cg_endo -77.88 138.46 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.418 2.079 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -115.35 -11.3 11.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 619' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 130.5 -2.48 5.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 620' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 166.73 126.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -1.209 . . . . 0.0 109.469 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 148.28 113.71 0.73 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 85.3 m-20 -115.65 -18.48 10.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.492 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 623' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 50.4 m -116.61 111.39 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.182 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 624' ' ' PHE . . . . . 0.547 ' HE2' HG21 ' C' ' 626' ' ' VAL . 33.1 p90 -123.07 142.74 50.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 625' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -102.47 153.91 18.44 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 626' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' C' ' 601' ' ' SER . 59.1 t -149.67 141.49 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 627' ' ' THR . . . . . 0.602 HG22 ' N ' ' C' ' 628' ' ' PHE . 21.6 m -102.19 166.15 10.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.352 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 628' ' ' PHE . . . . . 0.603 ' CE2' ' HG3' ' C' ' 637' ' ' PRO . 97.0 m-85 -143.57 125.29 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.575 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 629' ' ' TYR . . . . . 0.577 ' CE1' ' HD3' ' C' ' 573' ' ' ARG . 10.3 m-85 -81.15 127.55 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 630' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' C' ' 631' ' ' ASN . 0.0 OUTLIER 174.94 -29.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.535 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 631' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' C' ' 630' ' ' LYS . 11.1 m-20 83.41 39.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.545 -0.722 . . . . 0.0 110.211 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 632' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' C' ' 631' ' ' ASN . . . 41.13 96.37 0.01 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 633' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' C' ' 630' ' ' LYS . 21.7 m -156.64 43.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 634' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' C' ' 633' ' ' SER . 0.1 OUTLIER 170.82 -153.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.378 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -90.06 131.1 36.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 636' ' ' THR . . . . . 0.63 HG22 ' CD ' ' C' ' 637' ' ' PRO . 0.0 OUTLIER -53.1 176.98 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 637' ' ' PRO . . . . . 0.63 ' CD ' HG22 ' C' ' 636' ' ' THR . 35.9 Cg_endo -78.61 171.13 17.2 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.539 2.159 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -147.73 139.45 7.79 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 639' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -93.39 132.05 38.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -1.074 . . . . 0.0 109.168 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 640' ' ' THR . . . . . 1.071 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.4 OUTLIER -98.46 143.63 28.69 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.994 0.902 . . . . 0.0 111.12 -179.252 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 641' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' C' ' 562' ' ' VAL . 1.5 m -160.54 85.81 0.72 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.533 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -159.41 155.43 26.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 643' ' ' THR . . . . . 0.561 HG21 ' N ' ' C' ' 558' ' ' GLY . 46.1 p -115.08 105.91 13.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.316 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.572 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 562' ' ' VAL . . . . . 0.706 ' HB ' HG22 ' C' ' 580' ' ' VAL . 2.7 p . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 121.311 0.577 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 563' ' ' SER . . . . . 0.509 ' N ' HG22 ' C' ' 562' ' ' VAL . 0.1 OUTLIER -144.86 141.21 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.131 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.09 121.63 42.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 565' ' ' VAL . . . . . 0.822 ' O ' HG12 ' C' ' 576' ' ' VAL . 0.6 OUTLIER -122.46 152.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 566' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' C' ' 565' ' ' VAL . 1.9 ptm85 -52.39 143.78 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 567' ' ' GLY . . . . . . . . . . . . . . . -117.58 -145.75 8.07 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.955 -1.593 . . . . 0.0 109.726 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 568' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.04 118.21 29.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 569' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' C' ' 574' ' ' PHE . 0.1 OUTLIER -110.24 177.91 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 570' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 22.0 m-90 -132.89 -92.89 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -138.83 -75.86 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 572' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' C' ' 630' ' ' LYS . 0.8 OUTLIER -80.16 -15.76 56.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 573' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -133.05 156.11 47.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 109.315 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 574' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 36.4 p90 -134.67 151.83 51.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 575' ' ' ASN . . . . . 0.449 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 4.3 t-20 -122.34 125.32 45.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.398 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 576' ' ' VAL . . . . . 0.822 HG12 ' O ' ' C' ' 565' ' ' VAL . 1.1 t -100.56 158.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 64.7 m -116.78 128.26 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.937 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 578' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' C' ' 624' ' ' PHE . 29.8 m-85 -115.24 125.19 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 579' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 56.6 m -96.38 141.78 29.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 580' ' ' VAL . . . . . 1.003 HG21 ' CH2' ' C' ' 586' ' ' TRP . 59.6 t -127.16 160.9 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.573 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 581' ' ' SER . . . . . 0.483 ' N ' HG12 ' C' ' 580' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.469 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 30.5 t . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.378 0.609 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 586' ' ' TRP . . . . . 1.003 ' CH2' HG21 ' C' ' 580' ' ' VAL . 27.9 m95 -77.08 124.44 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 110.395 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 587' ' ' VAL . . . . . 0.471 HG13 ' O ' ' C' ' 587' ' ' VAL . 10.0 p -160.14 31.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 588' ' ' VAL . . . . . 1.092 HG23 ' O ' ' C' ' 640' ' ' THR . 7.1 p -79.02 148.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.524 -0.735 . . . . 0.0 109.428 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 589' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 612' ' ' THR . 31.2 m -111.09 114.46 27.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 590' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' C' ' 590' ' ' LEU . 4.0 mm? -79.44 126.23 30.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -108.04 87.49 0.49 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 592' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.6 -167.84 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.188 -1.183 . . . . 0.0 109.444 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 593' ' ' ASN . . . . . 0.49 ' ND2' ' OE1' ' C' ' 596' ' ' GLN . 0.9 OUTLIER -111.43 41.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 594' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' C' ' 593' ' ' ASN . . . 44.17 68.8 0.8 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 174.38 -47.18 0.14 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 596' ' ' GLN . . . . . 0.49 ' OE1' ' ND2' ' C' ' 593' ' ' ASN . 0.0 OUTLIER -80.34 170.51 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -1.148 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 4.5 m -151.07 148.12 27.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.541 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 598' ' ' VAL . . . . . 0.421 HG13 HG13 ' C' ' 626' ' ' VAL . 85.1 t -69.43 113.54 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.492 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 599' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' C' ' 629' ' ' TYR . 6.7 tm0? -89.04 -27.97 20.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.06 168.41 10.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 5.9 p -164.46 163.3 22.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.373 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 602' ' ' TRP . . . . . 0.527 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 31.3 p90 -155.66 158.57 38.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 603' ' ' ASN . . . . . 0.688 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.4 OUTLIER 76.31 18.98 1.78 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 604' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 164.2 158.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 605' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 606' ' ' LEU . . . -100.99 154.45 18.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 606' ' ' LEU . . . . . 0.558 HD23 HG11 ' C' ' 613' ' ' VAL . 2.2 mp -118.91 164.3 15.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.3 m -131.09 94.17 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.38 17.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 609' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' C' ' 610' ' ' SER . 25.0 m -163.16 29.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 610' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.2 OUTLIER 163.98 106.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 115.61 -87.13 0.43 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 612' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 589' ' ' THR . 18.4 m -127.35 103.99 7.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 613' ' ' VAL . . . . . 0.558 HG11 HD23 ' C' ' 606' ' ' LEU . 2.1 t -106.38 109.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.172 -0.955 . . . . 0.0 108.763 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 614' ' ' THR . . . . . 0.755 HG23 ' O ' ' C' ' 588' ' ' VAL . 0.5 OUTLIER -93.01 145.12 24.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 110.028 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 615' ' ' ALA . . . . . 0.817 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -81.09 167.76 19.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.366 -0.834 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -145.95 153.0 49.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.09 135.12 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.619 2.213 . . . . 0.0 110.421 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -153.47 26.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 160.22 -93.22 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 2.1 m -178.8 55.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -119.43 118.9 4.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 622' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' C' ' 580' ' ' VAL . 1.8 m120 -87.98 -22.96 23.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -1.141 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 623' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 55.6 m -107.08 121.88 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 624' ' ' PHE . . . . . 0.587 ' HE2' HG21 ' C' ' 626' ' ' VAL . 11.6 p90 -130.31 142.83 50.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -99.5 147.53 18.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 626' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' C' ' 624' ' ' PHE . 23.9 t -139.55 133.08 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -1.175 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 86.9 m -87.87 150.58 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 628' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 91.0 m-85 -136.95 124.95 22.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 629' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' C' ' 599' ' ' GLN . 11.1 m-85 -73.34 139.48 46.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 630' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' C' ' 572' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 636' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 3.5 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 637' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 34.7 Cg_endo -76.95 170.07 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.364 2.043 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -141.27 152.88 23.6 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 639' ' ' ALA . . . . . 0.855 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -95.66 134.8 38.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.521 -0.988 . . . . 0.0 109.269 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 640' ' ' THR . . . . . 1.092 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -98.41 143.2 29.12 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.048 0.928 . . . . 0.0 111.046 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 641' ' ' CYS . . . . . 0.54 ' SG ' HG11 ' C' ' 562' ' ' VAL . 1.5 m . . . . . 0 C--N 1.294 -1.832 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 562' ' ' VAL . . . . . 0.595 HG11 ' SG ' ' C' ' 641' ' ' CYS . 3.7 m . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.587 0.708 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 563' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 19.7 m -154.3 137.6 15.75 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -119.73 90.54 3.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.085 . . . . 0.0 110.156 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 565' ' ' VAL . . . . . 0.64 ' O ' HG13 ' C' ' 576' ' ' VAL . 2.0 t -79.85 154.2 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 566' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.41 65.04 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.034 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 567' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' C' ' 569' ' ' GLU . . . -53.08 164.07 2.06 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 568' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' C' ' 575' ' ' ASN . 1.4 mt-10 -42.52 152.64 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 109.913 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 569' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' C' ' 567' ' ' GLY . 0.6 OUTLIER -160.08 97.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.003 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 570' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' C' ' 573' ' ' ARG . 10.6 m-90 -57.22 167.12 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 109.553 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 571' ' ' ALA . . . . . 0.436 ' C ' ' HE3' ' C' ' 630' ' ' LYS . . . -67.12 -24.73 65.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.03 -7.29 13.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.335 -0.853 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 573' ' ' ARG . . . . . 0.578 ' HB3' ' CE3' ' C' ' 570' ' ' TRP . 0.1 OUTLIER -134.5 164.48 27.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 574' ' ' PHE . . . . . 0.943 ' O ' HG23 ' C' ' 627' ' ' THR . 0.2 OUTLIER -128.84 163.54 25.0 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.323 -0.86 . . . . 0.0 110.705 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 575' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' C' ' 568' ' ' GLU . 2.0 t-20 -157.56 67.6 0.51 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 576' ' ' VAL . . . . . 0.64 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.9 t -79.67 153.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.56 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 99.5 m -112.94 91.56 3.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 578' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' C' ' 576' ' ' VAL . 63.6 m-85 -85.96 150.43 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 579' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 623' ' ' SER . 4.2 m -138.08 131.51 30.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.871 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 580' ' ' VAL . . . . . 0.725 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 2.6 t -106.6 155.26 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 12.3 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 586' ' ' TRP . . . . . 1.006 ' CE3' ' HB3' ' C' ' 615' ' ' ALA . 19.6 m95 -69.92 130.73 43.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 111.439 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 587' ' ' VAL . . . . . 0.506 HG22 ' O ' ' C' ' 586' ' ' TRP . 2.0 t -158.84 29.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 588' ' ' VAL . . . . . 0.684 HG22 ' SG ' ' C' ' 641' ' ' CYS . 2.1 t -79.24 165.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.754 0.788 . . . . 0.0 110.0 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 589' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 612' ' ' THR . 0.0 OUTLIER -110.47 157.31 19.73 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 590' ' ' LEU . . . . . 0.92 HD13 HG12 ' C' ' 613' ' ' VAL . 1.1 mp -121.74 132.65 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.002 . . . . 0.0 109.628 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -113.12 77.32 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 592' ' ' LEU . . . . . 0.536 HD23 ' N ' ' C' ' 592' ' ' LEU . 5.6 mt -58.14 145.14 37.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.201 -1.176 . . . . 0.0 109.554 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 593' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 85.5 m-20 -107.41 120.79 43.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.46 9.81 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 49.89 45.79 40.74 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 596' ' ' GLN . . . . . 0.469 ' O ' HD12 ' C' ' 592' ' ' LEU . 47.2 mt-30 -75.96 157.48 33.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 0.0 109.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 597' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.9 OUTLIER -116.37 169.29 9.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 109.436 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 598' ' ' VAL . . . . . 0.873 HG11 HD13 ' C' ' 606' ' ' LEU . 59.4 t -97.59 121.85 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 599' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 1.9 tt0 -85.11 -50.95 6.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 1.9 m -165.93 155.39 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 601' ' ' SER . . . . . 0.487 ' HB3' HD11 ' C' ' 606' ' ' LEU . 39.4 p -147.93 155.59 41.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 602' ' ' TRP . . . . . 0.501 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 30.5 p90 -137.41 154.32 49.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 603' ' ' ASN . . . . . 0.709 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.52 30.21 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 604' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.9 146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 605' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' C' ' 616' ' ' ARG . . . -86.1 166.28 15.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 606' ' ' LEU . . . . . 0.873 HD13 HG11 ' C' ' 598' ' ' VAL . 22.9 mt -120.73 154.19 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 607' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' C' ' 616' ' ' ARG . 90.6 m -133.8 74.39 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 136.26 -160.77 24.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 609' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' C' ' 610' ' ' SER . 22.8 p -177.78 35.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.417 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 610' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.5 OUTLIER 166.11 145.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 68.42 -139.62 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 612' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 589' ' ' THR . 3.3 m -79.94 107.1 12.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 613' ' ' VAL . . . . . 0.92 HG12 HD13 ' C' ' 590' ' ' LEU . 2.1 t -103.38 157.17 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.237 -0.914 . . . . 0.0 108.887 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 614' ' ' THR . . . . . 0.529 HG23 ' O ' ' C' ' 588' ' ' VAL . 1.3 m -121.47 139.03 54.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 109.645 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 615' ' ' ALA . . . . . 1.006 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -89.39 159.25 17.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 616' ' ' ARG . . . . . 0.901 ' HB2' ' HB3' ' C' ' 605' ' ' ALA . 3.0 mtt180 -132.35 153.31 81.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 617' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' C' ' 586' ' ' TRP . 35.5 Cg_endo -77.86 127.81 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -117.55 14.32 14.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 60.04 71.67 0.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 70.1 m -154.92 -41.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.19 -167.73 39.49 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 622' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 580' ' ' VAL . 28.4 m120 -107.42 -21.28 12.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 623' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 579' ' ' SER . 96.4 p -81.62 121.75 26.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 624' ' ' PHE . . . . . 0.628 ' CE1' ' CH2' ' C' ' 586' ' ' TRP . 2.8 p90 -137.84 142.75 40.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -105.66 139.91 14.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 626' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.31 133.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.14 . . . . 0.0 109.634 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 627' ' ' THR . . . . . 0.943 HG23 ' O ' ' C' ' 574' ' ' PHE . 45.8 m -95.41 145.24 25.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 628' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' C' ' 574' ' ' PHE . 91.8 m-85 -126.9 144.56 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 629' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' C' ' 573' ' ' ARG . 11.0 m-85 -97.47 136.1 38.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 630' ' ' LYS . . . . . 0.531 ' HD3' ' CE1' ' C' ' 574' ' ' PHE . 27.5 pttt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.52 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 636' ' ' THR . . . . . 0.639 HG23 ' HD2' ' C' ' 637' ' ' PRO . 28.9 m . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 637' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' C' ' 636' ' ' THR . 35.9 Cg_endo -79.78 170.82 16.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.375 2.05 . . . . 0.0 109.927 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 638' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' C' ' 578' ' ' TYR . . . -163.44 156.94 28.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.365 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -81.02 179.03 8.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.467 -1.019 . . . . 0.0 109.014 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 640' ' ' THR . . . . . 0.6 ' O ' HG13 ' C' ' 588' ' ' VAL . 0.2 OUTLIER -130.4 140.75 50.57 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.141 0.972 . . . . 0.0 111.122 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 641' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.493 1.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.448 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 562' ' ' VAL . . . . . 0.554 HG22 HG22 ' C' ' 580' ' ' VAL . 2.3 t . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 167.23 13.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 109.646 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -132.33 92.89 3.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 565' ' ' VAL . . . . . 0.567 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.77 162.02 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.933 . . . . 0.0 109.191 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 566' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.1 OUTLIER -83.13 62.01 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 567' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' C' ' 566' ' ' ARG . . . -37.3 157.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 568' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 27.5 mt-10 -39.98 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -1.039 . . . . 0.0 110.2 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 569' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 568' ' ' GLU . 2.9 mp0 -147.14 -163.92 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 570' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -141.5 -96.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -139.4 -72.89 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.035 -1.041 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.73 -37.11 36.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 108.863 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 573' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' C' ' 629' ' ' TYR . 33.0 ptt180 -110.17 149.96 29.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 0.0 109.012 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 574' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 11.5 p90 -130.05 154.17 47.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 575' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' C' ' 568' ' ' GLU . 11.7 t-20 -108.09 172.48 6.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.182 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 576' ' ' VAL . . . . . 0.567 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.3 t -150.12 157.71 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 32.7 m -128.7 94.66 3.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 578' ' ' TYR . . . . . 0.64 ' CD2' ' CE1' ' C' ' 624' ' ' PHE . 92.8 m-85 -79.82 137.55 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 3.4 m -120.07 121.31 38.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 580' ' ' VAL . . . . . 0.83 HG21 ' CH2' ' C' ' 586' ' ' TRP . 2.8 t -108.79 142.61 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 586' ' ' TRP . . . . . 0.83 ' CH2' HG21 ' C' ' 580' ' ' VAL . 24.3 m95 -69.57 120.85 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 587' ' ' VAL . . . . . 0.618 HG22 ' O ' ' C' ' 587' ' ' VAL . 14.4 p -160.88 31.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 588' ' ' VAL . . . . . 0.974 HG23 ' O ' ' C' ' 640' ' ' THR . 2.9 p -79.26 149.98 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 589' ' ' THR . . . . . 0.855 HG22 ' CG2' ' C' ' 612' ' ' THR . 0.2 OUTLIER -112.63 115.87 29.28 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 590' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.74 128.77 34.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -101.81 88.89 0.73 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 592' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 596' ' ' GLN . 9.6 mp -75.17 122.12 23.14 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 593' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 26.0 m-80 -111.5 138.69 47.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 96.63 31.04 7.28 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 58.38 19.86 42.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 596' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 1.8 mm100 -51.75 156.42 1.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -1.143 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 597' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.5 OUTLIER -141.56 153.83 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.45 140.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 599' ' ' GLN . . . . . 0.439 ' HG3' ' OH ' ' C' ' 629' ' ' TYR . 6.4 tt0 -109.54 -42.56 4.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.08 160.3 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 601' ' ' SER . . . . . 0.503 ' OG ' HG13 ' C' ' 626' ' ' VAL . 0.7 OUTLIER -159.75 164.12 34.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 602' ' ' TRP . . . . . 0.572 ' CH2' ' HA3' ' C' ' 625' ' ' GLY . 14.2 p90 -153.24 170.48 20.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 603' ' ' ASN . . . . . 0.664 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 3.9 t-20 76.4 12.78 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.486 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 604' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 165.28 173.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -121.67 139.94 52.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 606' ' ' LEU . . . . . 0.758 HD23 ' CG1' ' C' ' 613' ' ' VAL . 6.7 mp -114.23 163.0 15.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 63.2 m -120.24 106.67 12.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 130.49 147.04 6.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 609' ' ' SER . . . . . . . . . . . . . 4.7 p -116.34 -6.06 11.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 32.9 t -173.38 124.09 0.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.01 -124.37 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 612' ' ' THR . . . . . 0.855 ' CG2' HG22 ' C' ' 589' ' ' THR . 92.8 m -90.15 106.78 18.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -1.19 . . . . 0.0 109.389 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 613' ' ' VAL . . . . . 0.758 ' CG1' HD23 ' C' ' 606' ' ' LEU . 2.1 t -103.21 117.99 49.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.004 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 614' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 6.9 m -90.22 137.63 32.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 615' ' ' ALA . . . . . 0.727 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.29 145.91 33.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 109.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 616' ' ' ARG . . . . . 0.474 ' HG2' ' HD2' ' C' ' 617' ' ' PRO . 0.0 OUTLIER -131.46 143.83 50.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.441 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 617' ' ' PRO . . . . . 0.474 ' HD2' ' HG2' ' C' ' 616' ' ' ARG . 36.0 Cg_endo -78.39 155.17 28.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 110.314 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -145.51 32.78 1.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.86 . . . . 0.0 109.316 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 619' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' C' ' 620' ' ' SER . . . 110.24 57.26 0.51 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 620' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 68.53 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.235 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.6 99.01 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 622' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 16.9 m120 -97.83 -0.36 45.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.629 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 623' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 3.3 m -117.04 126.79 53.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.075 -1.015 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 624' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' C' ' 578' ' ' TYR . 23.4 p90 -142.87 141.65 31.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 625' ' ' GLY . . . . . 0.572 ' HA3' ' CH2' ' C' ' 602' ' ' TRP . . . -109.49 142.09 16.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 626' ' ' VAL . . . . . 0.503 HG13 ' OG ' ' C' ' 601' ' ' SER . 3.2 t -140.51 156.37 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 627' ' ' THR . . . . . 0.446 HG23 ' O ' ' C' ' 574' ' ' PHE . 68.6 m -121.52 140.99 51.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 628' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 18.6 m-85 -132.05 140.98 49.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 629' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' C' ' 573' ' ' ARG . 60.5 m-85 -86.37 124.13 32.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.937 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 630' ' ' LYS . . . . . 0.544 ' HG2' ' CD1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.505 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 636' ' ' THR . . . . . 0.605 HG22 ' HD2' ' C' ' 637' ' ' PRO . 2.6 m . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 637' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' C' ' 636' ' ' THR . 35.6 Cg_endo -77.36 97.33 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.421 2.08 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -71.74 152.29 48.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 639' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -101.48 133.3 46.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -1.108 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 640' ' ' THR . . . . . 0.974 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -99.66 145.91 27.07 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.9 0.857 . . . . 0.0 111.2 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 641' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.296 -1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 109.262 178.847 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 562' ' ' VAL . . . . . 0.541 ' CG2' ' SG ' ' C' ' 641' ' ' CYS . 1.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.426 0.631 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 71.7 m -127.83 138.02 52.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -95.53 130.26 42.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.755 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 565' ' ' VAL . . . . . 0.678 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -117.81 163.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.104 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 566' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' C' ' 567' ' ' GLY . 1.0 OUTLIER -83.09 62.62 6.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 567' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -41.34 165.95 0.01 OUTLIER Glycine 0 N--CA 1.485 1.919 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 568' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 6.6 mt-10 -41.43 165.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.445 -1.033 . . . . 0.0 110.184 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.29 -162.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 570' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 27.4 m-90 -151.94 -100.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.63 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -142.03 -68.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.08 . . . . 0.0 109.481 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 572' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' C' ' 630' ' ' LYS . 0.9 OUTLIER -79.88 -17.78 52.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 0.0 109.331 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 573' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 144.36 47.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 109.185 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 574' ' ' PHE . . . . . 1.038 ' CE1' HG22 ' C' ' 636' ' ' THR . 36.6 p90 -122.29 151.57 40.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.371 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 575' ' ' ASN . . . . . 0.519 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.5 t-20 -113.61 152.14 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 576' ' ' VAL . . . . . 0.678 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -128.36 156.83 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 18.8 m -127.61 104.54 7.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.299 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 578' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' C' ' 623' ' ' SER . 67.8 m-85 -91.47 146.42 23.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 1.1 m -125.5 115.07 19.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 580' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' C' ' 586' ' ' TRP . 11.6 t -85.09 161.26 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 581' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' C' ' 580' ' ' VAL . 14.8 p . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.027 179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 45.2 m . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 586' ' ' TRP . . . . . 0.679 ' HE3' HG23 ' C' ' 588' ' ' VAL . 60.3 p-90 -87.8 112.73 22.75 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.883 . . . . 0.0 109.7 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 587' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' C' ' 614' ' ' THR . 1.0 OUTLIER -107.39 96.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 588' ' ' VAL . . . . . 0.813 HG22 ' SG ' ' C' ' 641' ' ' CYS . 11.5 t -79.53 161.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.192 0.996 . . . . 0.0 110.729 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 589' ' ' THR . . . . . 0.6 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -120.48 104.1 9.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 590' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' C' ' 613' ' ' VAL . 0.2 OUTLIER -78.78 137.01 37.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.044 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -125.58 78.02 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 592' ' ' LEU . . . . . 0.674 HD23 ' N ' ' C' ' 592' ' ' LEU . 2.5 mt -61.86 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.311 -1.111 . . . . 0.0 109.537 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 593' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -100.25 29.96 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.96 55.26 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . -134.22 -65.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.38 164.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -1.17 . . . . 0.0 109.466 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 11.9 p -148.33 154.6 40.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 63.8 t -85.05 137.28 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 599' ' ' GLN . . . . . 0.564 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 16.9 tm0? -106.95 -41.19 5.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 34.9 p -165.84 151.22 8.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.406 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 601' ' ' SER . . . . . 0.636 ' OG ' HG13 ' C' ' 626' ' ' VAL . 38.2 m -145.37 150.79 37.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 602' ' ' TRP . . . . . 0.527 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 45.6 p90 -129.62 157.42 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 603' ' ' ASN . . . . . 0.684 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.22 20.04 1.66 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 604' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 156.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.443 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 605' ' ' ALA . . . . . 0.618 ' C ' HD22 ' C' ' 606' ' ' LEU . . . -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 606' ' ' LEU . . . . . 0.693 ' N ' HD22 ' C' ' 606' ' ' LEU . 3.6 mm? -102.16 170.71 7.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.9 m -123.61 121.51 35.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 608' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' C' ' 609' ' ' SER . . . 99.84 -56.0 0.87 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 609' ' ' SER . . . . . 0.809 ' H ' HG22 ' C' ' 613' ' ' VAL . 2.8 m 69.28 24.21 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 6.8 p -171.82 150.49 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 53.41 -119.35 10.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 612' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 590' ' ' LEU . 57.3 m -86.19 108.14 18.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 613' ' ' VAL . . . . . 0.809 HG22 ' H ' ' C' ' 609' ' ' SER . 2.1 t -102.28 164.56 3.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.247 -0.908 . . . . 0.0 108.89 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 614' ' ' THR . . . . . 0.523 ' CG2' HG23 ' C' ' 587' ' ' VAL . 8.9 m -130.36 146.82 51.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 615' ' ' ALA . . . . . 0.633 ' CB ' ' CZ3' ' C' ' 586' ' ' TRP . . . -79.68 157.71 27.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.115 -0.991 . . . . 0.0 109.467 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 83.34 2.22 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 142.86 20.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.694 2.263 . . . . 0.0 110.465 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -111.56 -15.99 13.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . -147.74 48.73 0.63 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.21 42.18 7.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -81.94 114.83 3.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 622' ' ' ASN . . . . . 0.496 ' CB ' ' HB ' ' C' ' 580' ' ' VAL . 57.4 m-20 -106.77 -42.49 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 623' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 15.0 m -92.17 118.27 30.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 624' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -143.14 152.41 41.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 625' ' ' GLY . . . . . 0.527 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -108.85 134.94 12.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 626' ' ' VAL . . . . . 0.636 HG13 ' OG ' ' C' ' 601' ' ' SER . 25.8 t -126.58 134.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 627' ' ' THR . . . . . 0.483 HG22 ' N ' ' C' ' 628' ' ' PHE . 53.9 m -79.9 159.77 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 628' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 78.7 m-85 -150.62 116.76 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 629' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 46.7 m-85 -69.87 138.42 52.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 630' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' C' ' 572' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 O-C-N 121.201 -0.937 . . . . 0.0 108.985 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 636' ' ' THR . . . . . 1.038 HG22 ' CE1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 637' ' ' PRO . . . . . 0.606 ' HB3' HD22 ' C' ' 592' ' ' LEU . 35.2 Cg_endo -77.94 172.19 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.636 2.224 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -148.26 133.78 4.76 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.137 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 639' ' ' ALA . . . . . 0.698 ' HB1' HG11 ' C' ' 588' ' ' VAL . . . -90.88 131.54 36.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.959 . . . . 0.0 108.858 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 640' ' ' THR . . . . . 0.622 ' O ' HG13 ' C' ' 588' ' ' VAL . 2.7 m -93.85 150.35 20.46 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.355 1.074 . . . . 0.0 111.973 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 641' ' ' CYS . . . . . 0.813 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.476 178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 562' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' C' ' 641' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.441 0 CA-C-O 121.685 0.755 . . . . 0.0 110.292 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 563' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 3.3 m -160.23 158.48 30.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -140.08 84.85 1.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 565' ' ' VAL . . . . . 0.6 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.79 166.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 109.036 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 566' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.0 OUTLIER -83.64 61.63 6.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 567' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' C' ' 568' ' ' GLU . . . -38.95 154.97 0.02 OUTLIER Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 568' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 32.5 mt-10 -44.48 170.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 109.904 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 569' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' C' ' 574' ' ' PHE . 20.1 mt-10 -141.15 -164.07 1.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 570' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 15.0 m-90 -140.7 -100.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.603 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -143.54 -71.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.525 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.96 -11.2 59.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 573' ' ' ARG . . . . . 0.577 ' HD3' ' CE1' ' C' ' 629' ' ' TYR . 0.0 OUTLIER -144.1 145.3 32.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.913 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 574' ' ' PHE . . . . . 0.602 ' CE2' HG22 ' C' ' 636' ' ' THR . 52.7 p90 -110.97 159.17 17.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 575' ' ' ASN . . . . . 0.568 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 11.0 t-20 -116.27 170.5 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 576' ' ' VAL . . . . . 0.6 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -150.51 157.16 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.828 . . . . 0.0 109.308 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 20.7 m -122.01 102.99 8.51 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 578' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' C' ' 563' ' ' SER . 96.7 m-85 -88.9 133.64 34.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 579' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 3.5 m -114.48 146.82 40.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 580' ' ' VAL . . . . . 1.066 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 41.7 t -128.9 156.2 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.591 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.055 179.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 586' ' ' TRP . . . . . 1.066 ' CZ2' HG21 ' C' ' 580' ' ' VAL . 28.0 m95 -69.75 124.14 23.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 110.572 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 587' ' ' VAL . . . . . 0.55 ' O ' HG12 ' C' ' 587' ' ' VAL . 21.2 t -159.87 31.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 588' ' ' VAL . . . . . 1.071 HG23 ' O ' ' C' ' 640' ' ' THR . 6.0 p -79.28 148.29 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 589' ' ' THR . . . . . 0.968 ' CG2' HG23 ' C' ' 612' ' ' THR . 40.3 m -111.24 115.76 29.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 590' ' ' LEU . . . . . 0.544 ' HB3' HD21 ' C' ' 592' ' ' LEU . 0.4 OUTLIER -79.75 127.4 32.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.243 -0.91 . . . . 0.0 109.469 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -107.58 79.04 0.25 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 592' ' ' LEU . . . . . 0.756 HD23 ' N ' ' C' ' 592' ' ' LEU . 1.0 OUTLIER -65.62 -173.36 0.15 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.179 -1.189 . . . . 0.0 109.384 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 593' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' C' ' 593' ' ' ASN . 2.8 m-20 -91.27 -163.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . -90.96 69.12 2.19 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 150.64 -28.82 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -61.95 134.15 56.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.47 162.49 27.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.81 126.13 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 599' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' C' ' 600' ' ' SER . 14.2 tm0? -91.0 -43.75 9.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 600' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' C' ' 599' ' ' GLN . 36.7 p -163.82 170.13 17.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 601' ' ' SER . . . . . 0.663 ' HB3' HG22 ' C' ' 626' ' ' VAL . 1.8 p -161.33 165.56 28.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.264 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 602' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 26.2 p90 -158.48 159.39 35.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 603' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.04 21.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 604' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 169.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 605' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' C' ' 616' ' ' ARG . . . -110.62 172.86 6.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 606' ' ' LEU . . . . . 0.422 ' C ' HD12 ' C' ' 606' ' ' LEU . 3.4 pp -151.71 155.06 37.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 607' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' C' ' 613' ' ' VAL . 4.4 m -120.11 109.24 15.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 608' ' ' GLY . . . . . 0.486 ' CA ' HG22 ' C' ' 613' ' ' VAL . . . 116.83 178.99 17.88 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 609' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' C' ' 610' ' ' SER . 1.1 m -154.63 20.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -1.16 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 610' ' ' SER . . . . . 0.571 ' HA ' HD12 ' C' ' 592' ' ' LEU . 3.1 p 164.11 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.501 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.98 -98.94 0.93 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 612' ' ' THR . . . . . 0.968 HG23 ' CG2' ' C' ' 589' ' ' THR . 83.8 m -122.15 101.95 7.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 109.426 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 613' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' C' ' 614' ' ' THR . 2.1 t -106.14 165.41 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.188 -0.945 . . . . 0.0 108.964 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 614' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 11.7 m -139.18 137.24 35.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.978 . . . . 0.0 109.571 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 615' ' ' ALA . . . . . 0.78 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.55 137.24 37.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 616' ' ' ARG . . . . . 0.621 ' HB3' ' HB3' ' C' ' 605' ' ' ALA . 42.3 ttp180 -113.21 140.94 24.91 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.335 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 617' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' C' ' 616' ' ' ARG . 35.9 Cg_endo -77.88 138.46 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.418 2.079 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -115.35 -11.3 11.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 619' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 130.5 -2.48 5.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 620' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 166.73 126.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -1.209 . . . . 0.0 109.469 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 148.28 113.71 0.73 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 25.1 m120 -115.65 -18.48 10.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.492 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 623' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 50.4 m -116.61 111.39 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.182 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 624' ' ' PHE . . . . . 0.547 ' HE2' HG21 ' C' ' 626' ' ' VAL . 33.1 p90 -123.07 142.74 50.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 625' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -102.47 153.91 18.44 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 626' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' C' ' 601' ' ' SER . 59.1 t -149.67 141.49 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 627' ' ' THR . . . . . 0.602 HG22 ' N ' ' C' ' 628' ' ' PHE . 21.6 m -102.19 166.15 10.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.352 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 628' ' ' PHE . . . . . 0.603 ' CE2' ' HG3' ' C' ' 637' ' ' PRO . 97.0 m-85 -143.57 125.29 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.575 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 629' ' ' TYR . . . . . 0.577 ' CE1' ' HD3' ' C' ' 573' ' ' ARG . 10.3 m-85 -81.15 127.55 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 630' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' C' ' 629' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.535 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 636' ' ' THR . . . . . 0.63 HG22 ' CD ' ' C' ' 637' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.272 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 637' ' ' PRO . . . . . 0.63 ' CD ' HG22 ' C' ' 636' ' ' THR . 35.9 Cg_endo -78.61 171.13 17.2 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.539 2.159 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -147.73 139.45 7.79 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 639' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -93.39 132.05 38.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -1.074 . . . . 0.0 109.168 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 640' ' ' THR . . . . . 1.071 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.4 OUTLIER -98.46 143.63 28.69 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.994 0.902 . . . . 0.0 111.12 -179.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 641' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' C' ' 562' ' ' VAL . 1.5 m . . . . . 0 C--N 1.294 -1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.533 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.247 0.546 . . . . 0.0 109.55 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . -164.6 53.73 0.28 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 559' ' ' SER . . . . . 0.573 ' HB3' HG23 ' C' ' 643' ' ' THR . 57.0 p -84.98 170.64 12.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.264 -1.139 . . . . 0.0 109.377 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 560' ' ' CYS . . . . . 0.453 ' O ' ' HB3' ' C' ' 641' ' ' CYS . 0.0 OUTLIER -88.24 161.19 17.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.921 . . . . 0.0 109.128 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 561' ' ' SER . . . . . . . . . . . . . 4.4 p -108.01 116.57 32.2 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.227 -0.921 . . . . 0.0 108.642 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 562' ' ' VAL . . . . . 0.706 ' HB ' HG22 ' C' ' 580' ' ' VAL . 2.7 p -160.86 161.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 121.159 -0.963 . . . . 0.0 110.005 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 563' ' ' SER . . . . . 0.509 ' N ' HG22 ' C' ' 562' ' ' VAL . 0.1 OUTLIER -144.86 141.21 28.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.323 -0.86 . . . . 0.0 109.131 179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -102.09 121.63 42.58 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.143 -0.973 . . . . 0.0 109.643 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 565' ' ' VAL . . . . . 0.822 ' O ' HG12 ' C' ' 576' ' ' VAL . 0.6 OUTLIER -122.46 152.39 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 566' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' C' ' 565' ' ' VAL . 1.9 ptm85 -52.39 143.78 14.46 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 567' ' ' GLY . . . . . . . . . . . . . . . -117.58 -145.75 8.07 Favored Glycine 0 N--CA 1.487 2.057 0 C-N-CA 118.955 -1.593 . . . . 0.0 109.726 -178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 568' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.04 118.21 29.41 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.218 -1.166 . . . . 0.0 109.482 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 569' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' C' ' 574' ' ' PHE . 0.1 OUTLIER -110.24 177.91 4.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.458 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 570' ' ' TRP . . . . . 0.449 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 22.0 m-90 -132.89 -92.89 0.36 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.558 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -138.83 -75.86 0.37 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.247 -0.908 . . . . 0.0 109.549 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 572' ' ' ASP . . . . . 0.522 ' O ' ' CD ' ' C' ' 630' ' ' LYS . 0.8 OUTLIER -80.16 -15.76 56.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 573' ' ' ARG . . . . . 0.442 ' HA ' ' HG3' ' C' ' 630' ' ' LYS . 0.0 OUTLIER -133.05 156.11 47.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.256 -0.902 . . . . 0.0 109.315 -179.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 574' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 36.4 p90 -134.67 151.83 51.32 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -0.93 . . . . 0.0 109.497 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 575' ' ' ASN . . . . . 0.449 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 4.3 t-20 -122.34 125.32 45.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.216 -0.927 . . . . 0.0 109.398 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 576' ' ' VAL . . . . . 0.822 HG12 ' O ' ' C' ' 565' ' ' VAL . 1.1 t -100.56 158.1 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.437 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 64.7 m -116.78 128.26 55.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.937 . . . . 0.0 109.472 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 578' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' C' ' 624' ' ' PHE . 29.8 m-85 -115.24 125.19 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.0 109.517 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 579' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 56.6 m -96.38 141.78 29.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 580' ' ' VAL . . . . . 1.003 HG21 ' CH2' ' C' ' 586' ' ' TRP . 59.6 t -127.16 160.9 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -0.921 . . . . 0.0 109.573 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 581' ' ' SER . . . . . 0.483 ' N ' HG12 ' C' ' 580' ' ' VAL . 0.1 OUTLIER -110.41 -26.89 9.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.469 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 582' ' ' GLY . . . . . 0.557 ' O ' ' CB ' ' C' ' 583' ' ' SER . . . -96.49 -70.39 1.04 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 583' ' ' SER . . . . . 0.557 ' CB ' ' O ' ' C' ' 582' ' ' GLY . 0.2 OUTLIER 81.33 -66.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.682 -0.893 . . . . 0.0 109.435 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 584' ' ' SER . . . . . 0.427 ' C ' ' O ' ' C' ' 583' ' ' SER . 1.5 m -43.34 -29.77 0.46 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.267 -0.895 . . . . 0.0 109.448 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 30.5 t -110.98 66.08 0.62 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.266 -0.896 . . . . 0.0 109.384 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 586' ' ' TRP . . . . . 1.003 ' CH2' HG21 ' C' ' 580' ' ' VAL . 27.9 m95 -77.08 124.44 27.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.286 -0.884 . . . . 0.0 110.395 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 587' ' ' VAL . . . . . 0.471 HG13 ' O ' ' C' ' 587' ' ' VAL . 10.0 p -160.14 31.92 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 588' ' ' VAL . . . . . 1.092 HG23 ' O ' ' C' ' 640' ' ' THR . 7.1 p -79.02 148.96 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 121.524 -0.735 . . . . 0.0 109.428 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 589' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 612' ' ' THR . 31.2 m -111.09 114.46 27.75 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 178.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 590' ' ' LEU . . . . . 0.433 ' N ' ' CD2' ' C' ' 590' ' ' LEU . 4.0 mm? -79.44 126.23 30.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -108.04 87.49 0.49 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 592' ' ' LEU . . . . . . . . . . . . . 18.4 mt -65.6 -167.84 0.04 OUTLIER 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.188 -1.183 . . . . 0.0 109.444 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 593' ' ' ASN . . . . . 0.49 ' ND2' ' OE1' ' C' ' 596' ' ' GLN . 0.9 OUTLIER -111.43 41.14 1.94 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.217 -0.927 . . . . 0.0 109.444 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 594' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' C' ' 593' ' ' ASN . . . 44.17 68.8 0.8 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 174.38 -47.18 0.14 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 596' ' ' GLN . . . . . 0.49 ' OE1' ' ND2' ' C' ' 593' ' ' ASN . 0.0 OUTLIER -80.34 170.51 16.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.249 -1.148 . . . . 0.0 109.522 -179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 4.5 m -151.07 148.12 27.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.874 . . . . 0.0 109.541 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 598' ' ' VAL . . . . . 0.421 HG13 HG13 ' C' ' 626' ' ' VAL . 85.1 t -69.43 113.54 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.925 . . . . 0.0 109.492 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 599' ' ' GLN . . . . . 0.581 ' HG3' ' CE2' ' C' ' 629' ' ' TYR . 6.7 tm0? -89.04 -27.97 20.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -169.06 168.41 10.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 601' ' ' SER . . . . . . . . . . . . . 5.9 p -164.46 163.3 22.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.356 -0.84 . . . . 0.0 109.373 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 602' ' ' TRP . . . . . 0.527 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 31.3 p90 -155.66 158.57 38.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.24 -0.912 . . . . 0.0 109.565 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 603' ' ' ASN . . . . . 0.688 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.4 OUTLIER 76.31 18.98 1.78 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.302 -0.874 . . . . 0.0 109.5 -179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 604' ' ' ALA . . . . . 0.688 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 164.2 158.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -0.872 . . . . 0.0 109.505 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 605' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 606' ' ' LEU . . . -100.99 154.45 18.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -0.897 . . . . 0.0 109.453 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 606' ' ' LEU . . . . . 0.558 HD23 HG11 ' C' ' 613' ' ' VAL . 2.2 mp -118.91 164.3 15.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.142 -0.974 . . . . 0.0 109.458 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.3 m -131.09 94.17 3.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.915 . . . . 0.0 109.404 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 126.37 -177.38 17.23 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 609' ' ' SER . . . . . 0.525 ' O ' ' CB ' ' C' ' 610' ' ' SER . 25.0 m -163.16 29.39 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -1.162 . . . . 0.0 109.548 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 610' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.2 OUTLIER 163.98 106.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 115.61 -87.13 0.43 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 612' ' ' THR . . . . . 1.022 HG23 HG23 ' C' ' 589' ' ' THR . 18.4 m -127.35 103.99 7.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.308 -1.113 . . . . 0.0 109.471 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 613' ' ' VAL . . . . . 0.558 HG11 HD23 ' C' ' 606' ' ' LEU . 2.1 t -106.38 109.88 29.56 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.172 -0.955 . . . . 0.0 108.763 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 614' ' ' THR . . . . . 0.755 HG23 ' O ' ' C' ' 588' ' ' VAL . 0.5 OUTLIER -93.01 145.12 24.61 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.1 -1.0 . . . . 0.0 110.028 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 615' ' ' ALA . . . . . 0.817 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -81.09 167.76 19.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.366 -0.834 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -145.95 153.0 49.21 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.09 135.12 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.619 2.213 . . . . 0.0 110.421 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -153.47 26.48 0.51 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.527 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 160.22 -93.22 0.12 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 2.1 m -178.8 55.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.286 -1.126 . . . . 0.0 109.519 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 621' ' ' GLY . . . . . 0.449 ' O ' ' OG ' ' C' ' 583' ' ' SER . . . -119.43 118.9 4.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 622' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' C' ' 583' ' ' SER . 1.8 m120 -87.98 -22.96 23.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -1.141 . . . . 0.0 109.408 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 623' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 55.6 m -107.08 121.88 45.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.197 -0.94 . . . . 0.0 109.386 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 624' ' ' PHE . . . . . 0.587 ' HE2' HG21 ' C' ' 626' ' ' VAL . 11.6 p90 -130.31 142.83 50.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -99.5 147.53 18.36 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 626' ' ' VAL . . . . . 0.587 HG21 ' HE2' ' C' ' 624' ' ' PHE . 23.9 t -139.55 133.08 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -1.175 . . . . 0.0 109.604 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 627' ' ' THR . . . . . . . . . . . . . 86.9 m -87.87 150.58 23.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.365 -0.834 . . . . 0.0 109.265 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 628' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 91.0 m-85 -136.95 124.95 22.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.5 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 629' ' ' TYR . . . . . 0.581 ' CE2' ' HG3' ' C' ' 599' ' ' GLN . 11.1 m-85 -73.34 139.48 46.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.496 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 630' ' ' LYS . . . . . 0.522 ' CD ' ' O ' ' C' ' 572' ' ' ASP . 0.2 OUTLIER -94.29 -67.14 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 109.423 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 631' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' C' ' 630' ' ' LYS . 6.5 m-20 43.94 32.26 0.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -0.921 . . . . 0.0 109.356 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 116.77 9.78 10.75 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 633' ' ' SER . . . . . . . . . . . . . 1.2 m -110.68 115.97 30.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.264 -1.139 . . . . 0.0 109.459 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 19.1 m -111.25 -1.91 15.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.639 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 635' ' ' ALA . . . . . 0.428 ' HB3' ' ND2' ' C' ' 593' ' ' ASN . . . -89.44 138.96 30.99 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.278 -0.889 . . . . 0.0 109.664 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 636' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' C' ' 637' ' ' PRO . 3.5 m -89.42 141.54 28.95 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.315 -0.866 . . . . 0.0 109.263 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 637' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' C' ' 636' ' ' THR . 34.7 Cg_endo -76.95 170.07 20.48 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.364 2.043 . . . . 0.0 110.24 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -141.27 152.88 23.6 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 639' ' ' ALA . . . . . 0.855 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -95.66 134.8 38.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.521 -0.988 . . . . 0.0 109.269 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 640' ' ' THR . . . . . 1.092 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -98.41 143.2 29.12 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 122.048 0.928 . . . . 0.0 111.046 -179.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 641' ' ' CYS . . . . . 0.54 ' SG ' HG11 ' C' ' 562' ' ' VAL . 1.5 m -160.05 68.68 0.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.156 -0.965 . . . . 0.0 109.528 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 642' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' C' ' 559' ' ' SER . . . -146.03 165.06 30.15 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.336 -0.852 . . . . 0.0 109.41 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 643' ' ' THR . . . . . 0.573 HG23 ' HB3' ' C' ' 559' ' ' SER . 72.0 p -109.58 104.89 14.0 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.326 -0.859 . . . . 0.0 109.358 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.514 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 51.51 71.46 0.65 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 171.6 4.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -1.135 . . . . 0.0 109.513 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 560' ' ' CYS . . . . . 0.522 ' SG ' ' CG1' ' C' ' 562' ' ' VAL . 0.0 OUTLIER -59.91 169.34 1.49 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.352 -0.843 . . . . 0.0 108.91 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 561' ' ' SER . . . . . 0.498 ' N ' ' SG ' ' C' ' 560' ' ' CYS . 68.2 m -114.84 125.7 53.97 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.318 -0.864 . . . . 0.0 109.303 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 562' ' ' VAL . . . . . 0.595 HG11 ' SG ' ' C' ' 641' ' ' CYS . 3.7 m -143.98 176.94 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.175 -0.953 . . . . 0.0 110.296 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 563' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 19.7 m -154.3 137.6 15.75 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -119.73 90.54 3.35 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.085 . . . . 0.0 110.156 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 565' ' ' VAL . . . . . 0.64 ' O ' HG13 ' C' ' 576' ' ' VAL . 2.0 t -79.85 154.2 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 566' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.41 65.04 7.36 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.387 -0.821 . . . . 0.0 109.034 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 567' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' C' ' 569' ' ' GLU . . . -53.08 164.07 2.06 Favored Glycine 0 N--CA 1.479 1.547 0 N-CA-C 108.689 -1.765 . . . . 0.0 108.689 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 568' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' C' ' 575' ' ' ASN . 1.4 mt-10 -42.52 152.64 0.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.169 . . . . 0.0 109.913 -179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 569' ' ' GLU . . . . . 0.532 ' CG ' ' O ' ' C' ' 567' ' ' GLY . 0.6 OUTLIER -160.08 97.02 1.24 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.114 -0.991 . . . . 0.0 109.003 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 570' ' ' TRP . . . . . 0.578 ' CE3' ' HB3' ' C' ' 573' ' ' ARG . 10.6 m-90 -57.22 167.12 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.467 -0.771 . . . . 0.0 109.553 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 571' ' ' ALA . . . . . 0.436 ' C ' ' HE3' ' C' ' 630' ' ' LYS . . . -67.12 -24.73 65.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -114.03 -7.29 13.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.335 -0.853 . . . . 0.0 109.361 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 573' ' ' ARG . . . . . 0.578 ' HB3' ' CE3' ' C' ' 570' ' ' TRP . 0.1 OUTLIER -134.5 164.48 27.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.513 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 574' ' ' PHE . . . . . 0.943 ' O ' HG23 ' C' ' 627' ' ' THR . 0.2 OUTLIER -128.84 163.54 25.0 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.323 -0.86 . . . . 0.0 110.705 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 575' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' C' ' 568' ' ' GLU . 2.0 t-20 -157.56 67.6 0.51 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 576' ' ' VAL . . . . . 0.64 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.9 t -79.67 153.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.56 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 99.5 m -112.94 91.56 3.7 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 578' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' C' ' 576' ' ' VAL . 63.6 m-85 -85.96 150.43 24.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.556 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 579' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 623' ' ' SER . 4.2 m -138.08 131.51 30.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -0.907 . . . . 0.0 109.871 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 580' ' ' VAL . . . . . 0.725 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 2.6 t -106.6 155.26 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.39 -0.819 . . . . 0.0 109.123 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 581' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.94 64.3 0.46 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . 159.88 -25.41 0.31 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 583' ' ' SER . . . . . 0.401 ' O ' ' C ' ' C' ' 584' ' ' SER . 1.0 OUTLIER -88.29 83.51 6.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.229 -1.16 . . . . 0.0 109.544 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 584' ' ' SER . . . . . 0.401 ' C ' ' O ' ' C' ' 583' ' ' SER . 0.1 OUTLIER -44.31 -75.04 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 109.2 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 12.3 t -79.92 130.9 35.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.252 -0.905 . . . . 0.0 108.952 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 586' ' ' TRP . . . . . 1.006 ' CE3' ' HB3' ' C' ' 615' ' ' ALA . 19.6 m95 -69.92 130.73 43.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.076 -1.015 . . . . 0.0 111.439 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 587' ' ' VAL . . . . . 0.506 HG22 ' O ' ' C' ' 586' ' ' TRP . 2.0 t -158.84 29.97 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 588' ' ' VAL . . . . . 0.684 HG22 ' SG ' ' C' ' 641' ' ' CYS . 2.1 t -79.24 165.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 CA-C-O 121.754 0.788 . . . . 0.0 110.0 -179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 589' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 612' ' ' THR . 0.0 OUTLIER -110.47 157.31 19.73 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 590' ' ' LEU . . . . . 0.92 HD13 HG12 ' C' ' 613' ' ' VAL . 1.1 mp -121.74 132.65 54.74 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.098 -1.002 . . . . 0.0 109.628 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -113.12 77.32 0.24 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 592' ' ' LEU . . . . . 0.536 HD23 ' N ' ' C' ' 592' ' ' LEU . 5.6 mt -58.14 145.14 37.92 Favored 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.201 -1.176 . . . . 0.0 109.554 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 593' ' ' ASN . . . . . 0.45 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 85.5 m-20 -107.41 120.79 43.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 88.87 33.46 9.81 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 49.89 45.79 40.74 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 596' ' ' GLN . . . . . 0.469 ' O ' HD12 ' C' ' 592' ' ' LEU . 47.2 mt-30 -75.96 157.48 33.08 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -1.178 . . . . 0.0 109.475 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 597' ' ' SER . . . . . 0.437 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.9 OUTLIER -116.37 169.29 9.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.229 -0.92 . . . . 0.0 109.436 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 598' ' ' VAL . . . . . 0.873 HG11 HD13 ' C' ' 606' ' ' LEU . 59.4 t -97.59 121.85 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.436 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 599' ' ' GLN . . . . . 0.502 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 1.9 tt0 -85.11 -50.95 6.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.299 -0.876 . . . . 0.0 109.519 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 1.9 m -165.93 155.39 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.91 . . . . 0.0 109.447 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 601' ' ' SER . . . . . 0.487 ' HB3' HD11 ' C' ' 606' ' ' LEU . 39.4 p -147.93 155.59 41.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.24 -0.912 . . . . 0.0 109.419 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 602' ' ' TRP . . . . . 0.501 ' O ' ' CB ' ' C' ' 603' ' ' ASN . 30.5 p90 -137.41 154.32 49.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 603' ' ' ASN . . . . . 0.709 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.52 30.21 0.65 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.418 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 604' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.9 146.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.298 -0.876 . . . . 0.0 109.46 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 605' ' ' ALA . . . . . 0.901 ' HB3' ' HB2' ' C' ' 616' ' ' ARG . . . -86.1 166.28 15.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.489 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 606' ' ' LEU . . . . . 0.873 HD13 HG11 ' C' ' 598' ' ' VAL . 22.9 mt -120.73 154.19 35.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.196 -0.94 . . . . 0.0 109.462 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 607' ' ' THR . . . . . 0.52 ' OG1' ' CD ' ' C' ' 616' ' ' ARG . 90.6 m -133.8 74.39 1.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -0.857 . . . . 0.0 109.458 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 136.26 -160.77 24.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 609' ' ' SER . . . . . 0.481 ' O ' ' CB ' ' C' ' 610' ' ' SER . 22.8 p -177.78 35.56 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.228 -1.16 . . . . 0.0 109.417 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 610' ' ' SER . . . . . 0.481 ' CB ' ' O ' ' C' ' 609' ' ' SER . 0.5 OUTLIER 166.11 145.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.0 109.511 179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 68.42 -139.62 34.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 612' ' ' THR . . . . . 0.694 HG22 HG22 ' C' ' 589' ' ' THR . 3.3 m -79.94 107.1 12.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -1.113 . . . . 0.0 109.376 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 613' ' ' VAL . . . . . 0.92 HG12 HD13 ' C' ' 590' ' ' LEU . 2.1 t -103.38 157.17 5.16 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.237 -0.914 . . . . 0.0 108.887 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 614' ' ' THR . . . . . 0.529 HG23 ' O ' ' C' ' 588' ' ' VAL . 1.3 m -121.47 139.03 54.01 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.134 -0.979 . . . . 0.0 109.645 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 615' ' ' ALA . . . . . 1.006 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -89.39 159.25 17.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 616' ' ' ARG . . . . . 0.901 ' HB2' ' HB3' ' C' ' 605' ' ' ALA . 3.0 mtt180 -132.35 153.31 81.19 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.442 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 617' ' ' PRO . . . . . 0.481 ' N ' ' HB2' ' C' ' 586' ' ' TRP . 35.5 Cg_endo -77.86 127.81 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.54 2.16 . . . . 0.0 110.465 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -117.55 14.32 14.51 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.283 -0.886 . . . . 0.0 109.474 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . 60.04 71.67 0.74 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 70.1 m -154.92 -41.6 0.09 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -1.116 . . . . 0.0 109.459 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.19 -167.73 39.49 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 622' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' C' ' 580' ' ' VAL . 28.4 m120 -107.42 -21.28 12.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -1.134 . . . . 0.0 109.504 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 623' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' C' ' 579' ' ' SER . 96.4 p -81.62 121.75 26.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.442 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 624' ' ' PHE . . . . . 0.628 ' CE1' ' CH2' ' C' ' 586' ' ' TRP . 2.8 p90 -137.84 142.75 40.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -0.898 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 625' ' ' GLY . . . . . . . . . . . . . . . -105.66 139.91 14.91 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 626' ' ' VAL . . . . . . . . . . . . . 53.8 t -134.31 133.25 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.263 -1.14 . . . . 0.0 109.634 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 627' ' ' THR . . . . . 0.943 HG23 ' O ' ' C' ' 574' ' ' PHE . 45.8 m -95.41 145.24 25.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.287 -0.883 . . . . 0.0 109.227 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 628' ' ' PHE . . . . . 0.5 ' HB2' ' HB2' ' C' ' 574' ' ' PHE . 91.8 m-85 -126.9 144.56 50.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.0 109.622 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 629' ' ' TYR . . . . . 0.547 ' CE1' ' HG2' ' C' ' 573' ' ' ARG . 11.0 m-85 -97.47 136.1 38.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 630' ' ' LYS . . . . . 0.531 ' HD3' ' CE1' ' C' ' 574' ' ' PHE . 27.5 pttt -139.76 -40.99 0.44 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.52 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 631' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' C' ' 630' ' ' LYS . 7.9 m-20 73.68 1.79 4.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.649 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 149.7 77.98 0.02 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 633' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' C' ' 630' ' ' LYS . 74.5 m -138.41 147.71 43.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -1.141 . . . . 0.0 109.487 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.26 -7.36 14.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.583 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -88.62 134.31 33.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 109.464 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 636' ' ' THR . . . . . 0.639 HG23 ' HD2' ' C' ' 637' ' ' PRO . 28.9 m -90.14 140.49 27.36 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.238 -0.914 . . . . 0.0 109.42 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 637' ' ' PRO . . . . . 0.639 ' HD2' HG23 ' C' ' 636' ' ' THR . 35.9 Cg_endo -79.78 170.82 16.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.375 2.05 . . . . 0.0 109.927 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 638' ' ' GLY . . . . . 0.416 ' HA2' ' CE1' ' C' ' 578' ' ' TYR . . . -163.44 156.94 28.97 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.422 -1.371 . . . . 0.0 110.365 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 639' ' ' ALA . . . . . . . . . . . . . . . -81.02 179.03 8.05 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.467 -1.019 . . . . 0.0 109.014 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 640' ' ' THR . . . . . 0.6 ' O ' HG13 ' C' ' 588' ' ' VAL . 0.2 OUTLIER -130.4 140.75 50.57 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.141 0.972 . . . . 0.0 111.122 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 641' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m -160.57 70.19 0.4 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.448 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -137.65 168.73 19.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.616 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 43.7 p -116.28 105.42 12.52 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.361 -0.837 . . . . 0.0 109.392 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 CA-C-O 118.043 -1.421 . . . . 0.0 109.585 -179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . 133.87 115.1 1.55 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 70.6 m -148.52 160.71 42.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -1.12 . . . . 0.0 109.415 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 560' ' ' CYS . . . . . 0.42 ' HB2' HG23 ' C' ' 562' ' ' VAL . 19.7 p -115.41 161.47 18.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 561' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' C' ' 580' ' ' VAL . 1.7 m -99.01 31.96 2.83 Favored 'General case' 0 N--CA 1.487 1.425 0 CA-C-O 122.601 1.191 . . . . 0.0 108.624 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 562' ' ' VAL . . . . . 0.554 HG22 HG22 ' C' ' 580' ' ' VAL . 2.3 t -96.25 118.91 43.54 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.133 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.86 167.23 13.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.146 -0.971 . . . . 0.0 109.646 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -132.33 92.89 3.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 565' ' ' VAL . . . . . 0.567 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.77 162.02 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.933 . . . . 0.0 109.191 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 566' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.1 OUTLIER -83.13 62.01 6.37 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 567' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' C' ' 566' ' ' ARG . . . -37.3 157.19 0.01 OUTLIER Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 568' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 27.5 mt-10 -39.98 160.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.434 -1.039 . . . . 0.0 110.2 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 569' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' C' ' 568' ' ' GLU . 2.9 mp0 -147.14 -163.92 1.88 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.405 -0.809 . . . . 0.0 109.346 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 570' ' ' TRP . . . . . . . . . . . . . 21.2 m-90 -141.5 -96.76 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.307 -0.871 . . . . 0.0 109.57 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -139.4 -72.89 0.38 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.035 -1.041 . . . . 0.0 109.375 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 572' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -79.73 -37.11 36.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 108.863 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 573' ' ' ARG . . . . . 0.584 ' HB3' ' CE1' ' C' ' 629' ' ' TYR . 33.0 ptt180 -110.17 149.96 29.33 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.373 -0.829 . . . . 0.0 109.012 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 574' ' ' PHE . . . . . 0.571 ' CE1' ' HB2' ' C' ' 628' ' ' PHE . 11.5 p90 -130.05 154.17 47.7 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.526 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 575' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' C' ' 568' ' ' GLU . 11.7 t-20 -108.09 172.48 6.81 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.305 -0.872 . . . . 0.0 109.182 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 576' ' ' VAL . . . . . 0.567 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.3 t -150.12 157.71 5.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.262 -0.899 . . . . 0.0 109.518 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 32.7 m -128.7 94.66 3.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.488 -0.758 . . . . 0.0 109.318 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 578' ' ' TYR . . . . . 0.64 ' CD2' ' CE1' ' C' ' 624' ' ' PHE . 92.8 m-85 -79.82 137.55 36.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.553 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 3.4 m -120.07 121.31 38.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.265 -0.897 . . . . 0.0 109.69 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 580' ' ' VAL . . . . . 0.83 HG21 ' CH2' ' C' ' 586' ' ' TRP . 2.8 t -108.79 142.61 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.361 -0.837 . . . . 0.0 109.154 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 581' ' ' SER . . . . . 0.44 ' C ' ' CB ' ' C' ' 561' ' ' SER . 0.7 OUTLIER -157.34 55.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 582' ' ' GLY . . . . . . . . . . . . . . . 163.84 -28.96 0.23 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.329 -1.508 . . . . 0.0 109.329 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 583' ' ' SER . . . . . 0.527 ' OG ' HG22 ' C' ' 562' ' ' VAL . 5.5 m -56.53 -47.09 80.13 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.288 -1.125 . . . . 0.0 109.486 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 584' ' ' SER . . . . . 0.481 ' HB2' ' O ' ' C' ' 583' ' ' SER . 0.3 OUTLIER 74.57 -81.23 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.39 -0.819 . . . . 0.0 109.298 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.98 116.69 20.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.902 . . . . 0.0 109.267 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 586' ' ' TRP . . . . . 0.83 ' CH2' HG21 ' C' ' 580' ' ' VAL . 24.3 m95 -69.57 120.85 15.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.181 -0.95 . . . . 0.0 110.238 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 587' ' ' VAL . . . . . 0.618 HG22 ' O ' ' C' ' 587' ' ' VAL . 14.4 p -160.88 31.51 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 588' ' ' VAL . . . . . 0.974 HG23 ' O ' ' C' ' 640' ' ' THR . 2.9 p -79.26 149.98 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.324 -0.86 . . . . 0.0 109.576 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 589' ' ' THR . . . . . 0.855 HG22 ' CG2' ' C' ' 612' ' ' THR . 0.2 OUTLIER -112.63 115.87 29.28 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 177.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 590' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.74 128.77 34.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.276 -0.89 . . . . 0.0 109.523 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -101.81 88.89 0.73 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 592' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' C' ' 596' ' ' GLN . 9.6 mp -75.17 122.12 23.14 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.252 -1.146 . . . . 0.0 109.547 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 593' ' ' ASN . . . . . 0.475 ' O ' ' HG3' ' C' ' 596' ' ' GLN . 26.0 m-80 -111.5 138.69 47.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.2 -0.938 . . . . 0.0 109.538 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 96.63 31.04 7.28 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 58.38 19.86 42.22 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 596' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' C' ' 593' ' ' ASN . 1.8 mm100 -51.75 156.42 1.42 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.256 -1.143 . . . . 0.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 597' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' C' ' 628' ' ' PHE . 0.5 OUTLIER -141.56 153.83 45.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.245 -0.909 . . . . 0.0 109.465 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 58.5 t -81.45 140.62 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 599' ' ' GLN . . . . . 0.439 ' HG3' ' OH ' ' C' ' 629' ' ' TYR . 6.4 tt0 -109.54 -42.56 4.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.08 160.3 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.43 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 601' ' ' SER . . . . . 0.503 ' OG ' HG13 ' C' ' 626' ' ' VAL . 0.7 OUTLIER -159.75 164.12 34.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.177 -0.952 . . . . 0.0 109.436 -179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 602' ' ' TRP . . . . . 0.572 ' CH2' ' HA3' ' C' ' 625' ' ' GLY . 14.2 p90 -153.24 170.48 20.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 603' ' ' ASN . . . . . 0.664 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 3.9 t-20 76.4 12.78 2.57 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.896 . . . . 0.0 109.486 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 604' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 165.28 173.36 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 605' ' ' ALA . . . . . . . . . . . . . . . -121.67 139.94 52.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 606' ' ' LEU . . . . . 0.758 HD23 ' CG1' ' C' ' 613' ' ' VAL . 6.7 mp -114.23 163.0 15.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.91 . . . . 0.0 109.668 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 63.2 m -120.24 106.67 12.14 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.33 -0.856 . . . . 0.0 109.458 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 608' ' ' GLY . . . . . . . . . . . . . . . 130.49 147.04 6.05 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 609' ' ' SER . . . . . . . . . . . . . 4.7 p -116.34 -6.06 11.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.136 . . . . 0.0 109.56 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 32.9 t -173.38 124.09 0.39 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.255 -0.903 . . . . 0.0 109.525 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.01 -124.37 6.58 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 612' ' ' THR . . . . . 0.855 ' CG2' HG22 ' C' ' 589' ' ' THR . 92.8 m -90.15 106.78 18.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.177 -1.19 . . . . 0.0 109.389 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 613' ' ' VAL . . . . . 0.758 ' CG1' HD23 ' C' ' 606' ' ' LEU . 2.1 t -103.21 117.99 49.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.004 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 614' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 6.9 m -90.22 137.63 32.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 0.0 109.632 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 615' ' ' ALA . . . . . 0.727 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.29 145.91 33.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 109.162 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 616' ' ' ARG . . . . . 0.474 ' HG2' ' HD2' ' C' ' 617' ' ' PRO . 0.0 OUTLIER -131.46 143.83 50.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.288 -0.882 . . . . 0.0 109.441 -179.698 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 617' ' ' PRO . . . . . 0.474 ' HD2' ' HG2' ' C' ' 616' ' ' ARG . 36.0 Cg_endo -78.39 155.17 28.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 110.314 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -145.51 32.78 1.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.86 . . . . 0.0 109.316 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 619' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' C' ' 620' ' ' SER . . . 110.24 57.26 0.51 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 620' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 68.53 120.77 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.101 -1.235 . . . . 0.0 109.443 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 166.6 99.01 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 622' ' ' ASN . . . . . 0.494 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 16.9 m120 -97.83 -0.36 45.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.252 -1.146 . . . . 0.0 109.629 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 623' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 3.3 m -117.04 126.79 53.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.075 -1.015 . . . . 0.0 109.445 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 624' ' ' PHE . . . . . 0.64 ' CE1' ' CD2' ' C' ' 578' ' ' TYR . 23.4 p90 -142.87 141.65 31.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.255 -0.903 . . . . 0.0 109.52 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 625' ' ' GLY . . . . . 0.572 ' HA3' ' CH2' ' C' ' 602' ' ' TRP . . . -109.49 142.09 16.23 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 626' ' ' VAL . . . . . 0.503 HG13 ' OG ' ' C' ' 601' ' ' SER . 3.2 t -140.51 156.37 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 627' ' ' THR . . . . . 0.446 HG23 ' O ' ' C' ' 574' ' ' PHE . 68.6 m -121.52 140.99 51.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 628' ' ' PHE . . . . . 0.571 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 18.6 m-85 -132.05 140.98 49.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.511 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 629' ' ' TYR . . . . . 0.584 ' CE1' ' HB3' ' C' ' 573' ' ' ARG . 60.5 m-85 -86.37 124.13 32.37 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.202 -0.937 . . . . 0.0 109.429 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 630' ' ' LYS . . . . . 0.544 ' HG2' ' CD1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER -125.86 -34.46 2.6 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.297 -0.877 . . . . 0.0 109.505 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 631' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' C' ' 630' ' ' LYS . 15.4 m-20 66.01 23.39 11.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 109.327 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 68.68 33.94 77.17 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 633' ' ' SER . . . . . . . . . . . . . 1.8 m -148.2 39.5 0.92 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.176 -1.191 . . . . 0.0 109.58 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 59.9 m -156.88 161.1 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.918 . . . . 0.0 109.509 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -90.16 166.3 13.46 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.289 -0.882 . . . . 0.0 109.605 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 636' ' ' THR . . . . . 0.605 HG22 ' HD2' ' C' ' 637' ' ' PRO . 2.6 m -75.97 141.7 71.72 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.347 -0.846 . . . . 0.0 109.191 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 637' ' ' PRO . . . . . 0.605 ' HD2' HG22 ' C' ' 636' ' ' THR . 35.6 Cg_endo -77.36 97.33 1.14 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.421 2.08 . . . . 0.0 110.374 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -71.74 152.29 48.88 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 639' ' ' ALA . . . . . 0.768 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -101.48 133.3 46.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -1.108 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 640' ' ' THR . . . . . 0.974 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.3 OUTLIER -99.66 145.91 27.07 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.9 0.857 . . . . 0.0 111.2 -179.163 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 641' ' ' CYS . . . . . . . . . . . . . 1.6 m -118.87 92.49 3.82 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 109.262 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -107.76 157.88 17.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.895 . . . . 0.0 109.606 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 47.5 p -114.7 105.9 13.59 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.327 -0.858 . . . . 0.0 109.337 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 557' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.3 0.571 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 558' ' ' GLY . . . . . . . . . . . . . . . -166.39 -151.03 6.59 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 52.5 p -112.78 161.13 17.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.17 -1.194 . . . . 0.0 109.442 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 560' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' C' ' 561' ' ' SER . 0.0 OUTLIER -108.51 166.1 11.03 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.092 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 561' ' ' SER . . . . . 0.529 ' N ' ' SG ' ' C' ' 560' ' ' CYS . 0.3 OUTLIER -132.06 130.63 41.54 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 562' ' ' VAL . . . . . 0.541 ' CG2' ' SG ' ' C' ' 641' ' ' CYS . 1.7 t -154.27 158.37 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.029 -1.044 . . . . 0.0 110.233 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 563' ' ' SER . . . . . . . . . . . . . 71.7 m -127.83 138.02 52.56 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -95.53 130.26 42.44 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.111 -0.993 . . . . 0.0 109.755 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 565' ' ' VAL . . . . . 0.678 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -117.81 163.22 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.364 -0.835 . . . . 0.0 109.104 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 566' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' C' ' 567' ' ' GLY . 1.0 OUTLIER -83.09 62.62 6.69 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.069 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 567' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' C' ' 566' ' ' ARG . . . -41.34 165.95 0.01 OUTLIER Glycine 0 N--CA 1.485 1.919 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 568' ' ' GLU . . . . . 0.484 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 6.6 mt-10 -41.43 165.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.445 -1.033 . . . . 0.0 110.184 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 569' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.29 -162.53 1.29 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.34 -0.85 . . . . 0.0 109.247 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 570' ' ' TRP . . . . . 0.519 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 27.4 m-90 -151.94 -100.11 0.06 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.098 -1.001 . . . . 0.0 109.63 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -142.03 -68.89 0.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.973 -1.08 . . . . 0.0 109.481 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 572' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' C' ' 630' ' ' LYS . 0.9 OUTLIER -79.88 -17.78 52.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 0.0 109.331 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 573' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.62 144.36 47.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.325 -0.859 . . . . 0.0 109.185 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 574' ' ' PHE . . . . . 1.038 ' CE1' HG22 ' C' ' 636' ' ' THR . 36.6 p90 -122.29 151.57 40.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.895 . . . . 0.0 109.371 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 575' ' ' ASN . . . . . 0.519 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 2.5 t-20 -113.61 152.14 30.76 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.211 -0.93 . . . . 0.0 109.482 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 576' ' ' VAL . . . . . 0.678 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -128.36 156.83 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.291 -0.88 . . . . 0.0 109.292 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 18.8 m -127.61 104.54 7.93 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.425 -0.797 . . . . 0.0 109.299 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 578' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' C' ' 623' ' ' SER . 67.8 m-85 -91.47 146.42 23.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 579' ' ' SER . . . . . . . . . . . . . 1.1 m -125.5 115.07 19.65 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.914 . . . . 0.0 109.699 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 580' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' C' ' 586' ' ' TRP . 11.6 t -85.09 161.26 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 581' ' ' SER . . . . . 0.471 ' N ' ' CG1' ' C' ' 580' ' ' VAL . 14.8 p -129.05 62.95 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.446 -0.784 . . . . 0.0 109.027 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 582' ' ' GLY . . . . . 0.426 ' O ' ' OG ' ' C' ' 583' ' ' SER . . . 173.89 -30.69 0.1 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.171 -1.572 . . . . 0.0 109.171 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 583' ' ' SER . . . . . 0.527 ' O ' ' N ' ' C' ' 585' ' ' SER . 2.7 p 50.57 -105.49 0.19 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.357 -1.084 . . . . 0.0 109.448 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 584' ' ' SER . . . . . 0.448 ' C ' ' O ' ' C' ' 583' ' ' SER . 31.2 m 40.24 -94.53 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.235 -0.916 . . . . 0.0 109.736 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 585' ' ' SER . . . . . 0.527 ' N ' ' O ' ' C' ' 583' ' ' SER . 45.2 m -142.15 65.8 1.35 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.04 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 586' ' ' TRP . . . . . 0.679 ' HE3' HG23 ' C' ' 588' ' ' VAL . 60.3 p-90 -87.8 112.73 22.75 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.883 . . . . 0.0 109.7 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 587' ' ' VAL . . . . . 0.523 HG23 ' CG2' ' C' ' 614' ' ' THR . 1.0 OUTLIER -107.39 96.17 4.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.752 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 588' ' ' VAL . . . . . 0.813 HG22 ' SG ' ' C' ' 641' ' ' CYS . 11.5 t -79.53 161.77 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 122.192 0.996 . . . . 0.0 110.729 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 589' ' ' THR . . . . . 0.6 ' N ' ' CG1' ' C' ' 588' ' ' VAL . 0.0 OUTLIER -120.48 104.1 9.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 177.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 590' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' C' ' 613' ' ' VAL . 0.2 OUTLIER -78.78 137.01 37.53 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.044 -178.604 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -125.58 78.02 0.38 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 592' ' ' LEU . . . . . 0.674 HD23 ' N ' ' C' ' 592' ' ' LEU . 2.5 mt -61.86 -168.01 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.311 -1.111 . . . . 0.0 109.537 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 593' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -100.25 29.96 4.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . 60.06 20.96 55.26 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . -134.22 -65.36 0.07 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 596' ' ' GLN . . . . . 0.503 ' HG3' ' HB2' ' C' ' 633' ' ' SER . 0.8 OUTLIER -54.38 164.37 0.71 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -1.17 . . . . 0.0 109.466 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 11.9 p -148.33 154.6 40.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.184 -0.948 . . . . 0.0 109.578 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 63.8 t -85.05 137.28 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.295 -0.878 . . . . 0.0 109.488 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 599' ' ' GLN . . . . . 0.564 ' HB2' ' CE2' ' C' ' 629' ' ' TYR . 16.9 tm0? -106.95 -41.19 5.25 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.275 -0.89 . . . . 0.0 109.496 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 600' ' ' SER . . . . . . . . . . . . . 34.9 p -165.84 151.22 8.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.23 -0.919 . . . . 0.0 109.406 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 601' ' ' SER . . . . . 0.636 ' OG ' HG13 ' C' ' 626' ' ' VAL . 38.2 m -145.37 150.79 37.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.231 -0.918 . . . . 0.0 109.482 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 602' ' ' TRP . . . . . 0.527 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 45.6 p90 -129.62 157.42 42.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 603' ' ' ASN . . . . . 0.684 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.22 20.04 1.66 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.324 -0.86 . . . . 0.0 109.5 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 604' ' ' ALA . . . . . 0.684 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 156.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.443 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 605' ' ' ALA . . . . . 0.618 ' C ' HD22 ' C' ' 606' ' ' LEU . . . -116.13 135.5 53.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.535 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 606' ' ' LEU . . . . . 0.693 ' N ' HD22 ' C' ' 606' ' ' LEU . 3.6 mm? -102.16 170.71 7.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 607' ' ' THR . . . . . . . . . . . . . 3.9 m -123.61 121.51 35.76 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 608' ' ' GLY . . . . . 0.409 ' O ' ' CB ' ' C' ' 609' ' ' SER . . . 99.84 -56.0 0.87 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 609' ' ' SER . . . . . 0.809 ' H ' HG22 ' C' ' 613' ' ' VAL . 2.8 m 69.28 24.21 6.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -1.16 . . . . 0.0 109.508 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 610' ' ' SER . . . . . . . . . . . . . 6.8 p -171.82 150.49 2.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.25 -0.906 . . . . 0.0 109.537 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 53.41 -119.35 10.35 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 612' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' C' ' 590' ' ' LEU . 57.3 m -86.19 108.14 18.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.246 -1.149 . . . . 0.0 109.521 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 613' ' ' VAL . . . . . 0.809 HG22 ' H ' ' C' ' 609' ' ' SER . 2.1 t -102.28 164.56 3.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.247 -0.908 . . . . 0.0 108.89 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 614' ' ' THR . . . . . 0.523 ' CG2' HG23 ' C' ' 587' ' ' VAL . 8.9 m -130.36 146.82 51.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 615' ' ' ALA . . . . . 0.633 ' CB ' ' CZ3' ' C' ' 586' ' ' TRP . . . -79.68 157.71 27.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.115 -0.991 . . . . 0.0 109.467 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 616' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.96 83.34 2.22 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 109.405 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 617' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 142.86 20.35 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.694 2.263 . . . . 0.0 110.465 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -111.56 -15.99 13.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.293 -0.879 . . . . 0.0 109.511 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 619' ' ' GLY . . . . . . . . . . . . . . . -147.74 48.73 0.63 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 620' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.21 42.18 7.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -1.149 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . -81.94 114.83 3.9 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 622' ' ' ASN . . . . . 0.496 ' CB ' ' HB ' ' C' ' 580' ' ' VAL . 57.4 m-20 -106.77 -42.49 4.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -1.137 . . . . 0.0 109.455 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 623' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' C' ' 578' ' ' TYR . 15.0 m -92.17 118.27 30.69 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 624' ' ' PHE . . . . . . . . . . . . . 28.9 p90 -143.14 152.41 41.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.551 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 625' ' ' GLY . . . . . 0.527 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -108.85 134.94 12.54 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 626' ' ' VAL . . . . . 0.636 HG13 ' OG ' ' C' ' 601' ' ' SER . 25.8 t -126.58 134.12 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.42 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 627' ' ' THR . . . . . 0.483 HG22 ' N ' ' C' ' 628' ' ' PHE . 53.9 m -79.9 159.77 26.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.399 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 628' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' C' ' 574' ' ' PHE . 78.7 m-85 -150.62 116.76 5.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.212 -0.93 . . . . 0.0 109.503 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 629' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' C' ' 599' ' ' GLN . 46.7 m-85 -69.87 138.42 52.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.176 -0.953 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 630' ' ' LYS . . . . . 0.504 ' CG ' ' N ' ' C' ' 631' ' ' ASN . 0.0 OUTLIER -97.57 -63.86 1.09 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.201 -0.937 . . . . 0.0 108.985 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 631' ' ' ASN . . . . . 0.504 ' N ' ' CG ' ' C' ' 630' ' ' LYS . 2.5 m-80 41.86 53.37 4.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.0 109.55 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 632' ' ' GLY . . . . . . . . . . . . . . . 68.27 41.01 87.21 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 633' ' ' SER . . . . . 0.503 ' HB2' ' HG3' ' C' ' 596' ' ' GLN . 90.2 p -80.06 -150.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.294 -1.121 . . . . 0.0 109.593 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 634' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.3 -149.05 0.33 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.88 . . . . 0.0 109.489 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 635' ' ' ALA . . . . . 0.462 ' O ' ' O ' ' C' ' 636' ' ' THR . . . -49.6 138.17 14.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 109.721 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 636' ' ' THR . . . . . 1.038 HG22 ' CE1' ' C' ' 574' ' ' PHE . 0.0 OUTLIER -47.15 174.98 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.324 -0.86 . . . . 0.0 109.638 -179.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 637' ' ' PRO . . . . . 0.606 ' HB3' HD22 ' C' ' 592' ' ' LEU . 35.2 Cg_endo -77.94 172.19 16.0 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.636 2.224 . . . . 0.0 110.074 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -148.26 133.78 4.76 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.683 -1.246 . . . . 0.0 110.137 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 639' ' ' ALA . . . . . 0.698 ' HB1' HG11 ' C' ' 588' ' ' VAL . . . -90.88 131.54 36.45 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.569 -0.959 . . . . 0.0 108.858 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 640' ' ' THR . . . . . 0.622 ' O ' HG13 ' C' ' 588' ' ' VAL . 2.7 m -93.85 150.35 20.46 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 122.355 1.074 . . . . 0.0 111.973 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 641' ' ' CYS . . . . . 0.813 ' SG ' HG22 ' C' ' 588' ' ' VAL . 1.3 m -160.98 69.96 0.37 Allowed 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.476 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -156.29 164.32 38.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.0 109.503 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 643' ' ' THR . . . . . . . . . . . . . 47.9 p -114.49 105.38 13.03 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.196 -0.94 . . . . 0.0 109.417 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.362 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.515 179.995 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 557' ' ' THR . . . . . 0.42 ' C ' HG21 ' C' ' 643' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 558' ' ' GLY . . . . . 0.561 ' N ' HG21 ' C' ' 643' ' ' THR . . . -111.37 108.22 2.3 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 559' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.92 169.16 11.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -1.115 . . . . 0.0 109.436 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 560' ' ' CYS . . . . . 0.483 ' O ' ' HB3' ' C' ' 641' ' ' CYS . 0.5 OUTLIER -120.18 137.14 54.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.221 -0.924 . . . . 0.0 109.522 -179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 561' ' ' SER . . . . . 0.517 ' O ' HG13 ' C' ' 580' ' ' VAL . 46.3 m -76.06 120.37 21.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.069 -1.02 . . . . 0.0 108.399 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 562' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' C' ' 641' ' ' CYS . 0.0 OUTLIER -139.78 175.84 6.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.111 -0.993 . . . . 0.0 110.292 -179.169 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 563' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' C' ' 578' ' ' TYR . 3.3 m -160.23 158.48 30.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 564' ' ' ALA . . . . . . . . . . . . . . . -140.08 84.85 1.99 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 0.0 109.728 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 565' ' ' VAL . . . . . 0.6 ' O ' HG13 ' C' ' 576' ' ' VAL . 1.9 t -79.79 166.24 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.349 -0.844 . . . . 0.0 109.036 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 566' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' C' ' 567' ' ' GLY . 0.0 OUTLIER -83.64 61.63 6.39 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.142 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 567' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' C' ' 568' ' ' GLU . . . -38.95 154.97 0.02 OUTLIER Glycine 0 N--CA 1.485 1.957 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 568' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' C' ' 575' ' ' ASN . 32.5 mt-10 -44.48 170.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.231 -1.158 . . . . 0.0 109.904 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 569' ' ' GLU . . . . . 0.422 ' HB3' ' HA ' ' C' ' 574' ' ' PHE . 20.1 mt-10 -141.15 -164.07 1.68 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.355 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 570' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' C' ' 575' ' ' ASN . 15.0 m-90 -140.7 -100.55 0.15 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.12 -0.988 . . . . 0.0 109.603 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 571' ' ' ALA . . . . . . . . . . . . . . . -143.54 -71.01 0.31 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.977 -1.077 . . . . 0.0 109.525 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 572' ' ' ASP . . . . . 0.465 ' CA ' ' OD1' ' C' ' 631' ' ' ASN . 3.0 m-20 -79.96 -11.2 59.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 573' ' ' ARG . . . . . 0.577 ' HD3' ' CE1' ' C' ' 629' ' ' TYR . 0.0 OUTLIER -144.1 145.3 32.06 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.24 -0.913 . . . . 0.0 109.2 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 574' ' ' PHE . . . . . 0.602 ' CE2' HG22 ' C' ' 636' ' ' THR . 52.7 p90 -110.97 159.17 17.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.216 -0.928 . . . . 0.0 109.44 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 575' ' ' ASN . . . . . 0.568 ' HB2' ' CZ3' ' C' ' 570' ' ' TRP . 11.0 t-20 -116.27 170.5 8.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.182 -0.949 . . . . 0.0 109.566 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 576' ' ' VAL . . . . . 0.6 HG13 ' O ' ' C' ' 565' ' ' VAL . 2.5 t -150.51 157.16 6.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.376 -0.828 . . . . 0.0 109.308 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 577' ' ' THR . . . . . . . . . . . . . 20.7 m -122.01 102.99 8.51 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.377 -0.827 . . . . 0.0 109.455 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 578' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' C' ' 563' ' ' SER . 96.7 m-85 -88.9 133.64 34.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.182 -0.948 . . . . 0.0 109.521 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 579' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' C' ' 562' ' ' VAL . 3.5 m -114.48 146.82 40.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -0.872 . . . . 0.0 109.791 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 580' ' ' VAL . . . . . 1.066 HG21 ' CZ2' ' C' ' 586' ' ' TRP . 41.7 t -128.9 156.2 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.376 -0.828 . . . . 0.0 109.591 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 581' ' ' SER . . . . . 0.513 ' HB2' ' CB ' ' C' ' 561' ' ' SER . 13.2 m -102.85 47.12 0.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.191 -0.943 . . . . 0.0 109.055 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 582' ' ' GLY . . . . . 0.443 ' HA2' ' ND2' ' C' ' 622' ' ' ASN . . . 60.01 44.97 96.71 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 583' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' C' ' 584' ' ' SER . 0.5 OUTLIER -43.72 -28.14 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -1.113 . . . . 0.0 109.6 -179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 584' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' C' ' 583' ' ' SER . 2.1 t 76.92 -2.62 2.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 0.0 109.545 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 585' ' ' SER . . . . . . . . . . . . . 24.7 m -160.26 96.65 1.2 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.161 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 586' ' ' TRP . . . . . 1.066 ' CZ2' HG21 ' C' ' 580' ' ' VAL . 28.0 m95 -69.75 124.14 23.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.239 -0.913 . . . . 0.0 110.572 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 587' ' ' VAL . . . . . 0.55 ' O ' HG12 ' C' ' 587' ' ' VAL . 21.2 t -159.87 31.55 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 588' ' ' VAL . . . . . 1.071 HG23 ' O ' ' C' ' 640' ' ' THR . 6.0 p -79.28 148.29 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 589' ' ' THR . . . . . 0.968 ' CG2' HG23 ' C' ' 612' ' ' THR . 40.3 m -111.24 115.76 29.89 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 590' ' ' LEU . . . . . 0.544 ' HB3' HD21 ' C' ' 592' ' ' LEU . 0.4 OUTLIER -79.75 127.4 32.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.243 -0.91 . . . . 0.0 109.469 -179.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 591' ' ' GLY . . . . . . . . . . . . . . . -107.58 79.04 0.25 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 592' ' ' LEU . . . . . 0.756 HD23 ' N ' ' C' ' 592' ' ' LEU . 1.0 OUTLIER -65.62 -173.36 0.15 Allowed 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.179 -1.189 . . . . 0.0 109.384 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 593' ' ' ASN . . . . . 0.419 ' OD1' ' N ' ' C' ' 593' ' ' ASN . 2.8 m-20 -91.27 -163.97 1.11 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 109.516 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 594' ' ' GLY . . . . . . . . . . . . . . . -90.96 69.12 2.19 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 595' ' ' GLY . . . . . . . . . . . . . . . 150.64 -28.82 1.05 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 596' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -61.95 134.15 56.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -1.155 . . . . 0.0 109.551 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 597' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.47 162.49 27.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -0.912 . . . . 0.0 109.385 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 598' ' ' VAL . . . . . . . . . . . . . 54.0 t -85.81 126.13 40.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.9 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 599' ' ' GLN . . . . . 0.513 ' NE2' ' HB3' ' C' ' 600' ' ' SER . 14.2 tm0? -91.0 -43.75 9.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.341 -0.849 . . . . 0.0 109.526 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 600' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' C' ' 599' ' ' GLN . 36.7 p -163.82 170.13 17.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.236 -0.915 . . . . 0.0 109.565 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 601' ' ' SER . . . . . 0.663 ' HB3' HG22 ' C' ' 626' ' ' VAL . 1.8 p -161.33 165.56 28.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.0 109.264 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 602' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' C' ' 625' ' ' GLY . 26.2 p90 -158.48 159.39 35.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.198 -0.939 . . . . 0.0 109.636 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 603' ' ' ASN . . . . . 0.685 ' O ' ' HB2' ' C' ' 604' ' ' ALA . 0.1 OUTLIER 76.04 21.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 604' ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' C' ' 603' ' ' ASN . . . 163.98 169.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.617 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 605' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' C' ' 616' ' ' ARG . . . -110.62 172.86 6.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.486 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 606' ' ' LEU . . . . . 0.422 ' C ' HD12 ' C' ' 606' ' ' LEU . 3.4 pp -151.71 155.06 37.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.464 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 607' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' C' ' 613' ' ' VAL . 4.4 m -120.11 109.24 15.22 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.316 -0.865 . . . . 0.0 109.405 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 608' ' ' GLY . . . . . 0.486 ' CA ' HG22 ' C' ' 613' ' ' VAL . . . 116.83 178.99 17.88 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 609' ' ' SER . . . . . 0.514 ' O ' ' CB ' ' C' ' 610' ' ' SER . 1.1 m -154.63 20.95 0.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -1.16 . . . . 0.0 109.409 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 610' ' ' SER . . . . . 0.571 ' HA ' HD12 ' C' ' 592' ' ' LEU . 3.1 p 164.11 117.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.261 -0.899 . . . . 0.0 109.501 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 611' ' ' GLY . . . . . . . . . . . . . . . 113.98 -98.94 0.93 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 612' ' ' THR . . . . . 0.968 HG23 ' CG2' ' C' ' 589' ' ' THR . 83.8 m -122.15 101.95 7.84 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.294 -1.121 . . . . 0.0 109.426 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 613' ' ' VAL . . . . . 0.503 ' CG1' ' N ' ' C' ' 614' ' ' THR . 2.1 t -106.14 165.41 3.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.188 -0.945 . . . . 0.0 108.964 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 614' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' C' ' 588' ' ' VAL . 11.7 m -139.18 137.24 35.87 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.134 -0.978 . . . . 0.0 109.571 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 615' ' ' ALA . . . . . 0.78 ' HB3' ' CE3' ' C' ' 586' ' ' TRP . . . -79.55 137.24 37.1 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.123 -0.986 . . . . 0.0 109.452 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 616' ' ' ARG . . . . . 0.621 ' HB3' ' HB3' ' C' ' 605' ' ' ALA . 42.3 ttp180 -113.21 140.94 24.91 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.194 -0.941 . . . . 0.0 109.335 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 617' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' C' ' 616' ' ' ARG . 35.9 Cg_endo -77.88 138.46 16.68 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.418 2.079 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 618' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -115.35 -11.3 11.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.255 -0.903 . . . . 0.0 109.519 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 619' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' C' ' 620' ' ' SER . . . 130.5 -2.48 5.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 620' ' ' SER . . . . . 0.484 ' CB ' ' O ' ' C' ' 619' ' ' GLY . 0.4 OUTLIER 166.73 126.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.145 -1.209 . . . . 0.0 109.469 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 621' ' ' GLY . . . . . . . . . . . . . . . 148.28 113.71 0.73 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 622' ' ' ASN . . . . . 0.46 ' HB3' ' HB ' ' C' ' 580' ' ' VAL . 25.1 m120 -115.65 -18.48 10.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.235 -1.156 . . . . 0.0 109.492 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 623' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' C' ' 603' ' ' ASN . 50.4 m -116.61 111.39 19.81 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.189 -0.944 . . . . 0.0 109.182 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 624' ' ' PHE . . . . . 0.547 ' HE2' HG21 ' C' ' 626' ' ' VAL . 33.1 p90 -123.07 142.74 50.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.223 -0.923 . . . . 0.0 109.586 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 625' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' C' ' 602' ' ' TRP . . . -102.47 153.91 18.44 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 626' ' ' VAL . . . . . 0.663 HG22 ' HB3' ' C' ' 601' ' ' SER . 59.1 t -149.67 141.49 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.199 -1.177 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 627' ' ' THR . . . . . 0.602 HG22 ' N ' ' C' ' 628' ' ' PHE . 21.6 m -102.19 166.15 10.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 0.0 109.352 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 628' ' ' PHE . . . . . 0.603 ' CE2' ' HG3' ' C' ' 637' ' ' PRO . 97.0 m-85 -143.57 125.29 15.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.232 -0.917 . . . . 0.0 109.575 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 629' ' ' TYR . . . . . 0.577 ' CE1' ' HD3' ' C' ' 573' ' ' ARG . 10.3 m-85 -81.15 127.55 32.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.28 -0.887 . . . . 0.0 109.513 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 630' ' ' LYS . . . . . 0.56 ' O ' ' CB ' ' C' ' 631' ' ' ASN . 0.0 OUTLIER 174.94 -29.74 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 0.0 109.535 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 631' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' C' ' 630' ' ' LYS . 11.1 m-20 83.41 39.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.545 -0.722 . . . . 0.0 110.211 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 632' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' C' ' 631' ' ' ASN . . . 41.13 96.37 0.01 OUTLIER Glycine 0 N--CA 1.494 2.532 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 633' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' C' ' 630' ' ' LYS . 21.7 m -156.64 43.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.133 -1.216 . . . . 0.0 109.486 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 634' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' C' ' 633' ' ' SER . 0.1 OUTLIER 170.82 -153.19 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.378 -179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 635' ' ' ALA . . . . . . . . . . . . . . . -90.06 131.1 36.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.285 -0.885 . . . . 0.0 109.638 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 636' ' ' THR . . . . . 0.63 HG22 ' CD ' ' C' ' 637' ' ' PRO . 0.0 OUTLIER -53.1 176.98 0.08 OUTLIER Pre-proline 0 C--N 1.304 -1.388 0 O-C-N 121.338 -0.851 . . . . 0.0 109.455 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 637' ' ' PRO . . . . . 0.63 ' CD ' HG22 ' C' ' 636' ' ' THR . 35.9 Cg_endo -78.61 171.13 17.2 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.539 2.159 . . . . 0.0 110.243 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 638' ' ' GLY . . . . . . . . . . . . . . . -147.73 139.45 7.79 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 639' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' C' ' 588' ' ' VAL . . . -93.39 132.05 38.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.375 -1.074 . . . . 0.0 109.168 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 640' ' ' THR . . . . . 1.071 ' O ' HG23 ' C' ' 588' ' ' VAL . 0.4 OUTLIER -98.46 143.63 28.69 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.994 0.902 . . . . 0.0 111.12 -179.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 641' ' ' CYS . . . . . 0.531 ' HB2' ' CG2' ' C' ' 562' ' ' VAL . 1.5 m -160.54 85.81 0.72 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.611 -0.681 . . . . 0.0 109.533 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 642' ' ' ALA . . . . . . . . . . . . . . . -159.41 155.43 26.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.306 -0.871 . . . . 0.0 109.54 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 643' ' ' THR . . . . . 0.561 HG21 ' N ' ' C' ' 558' ' ' GLY . 46.1 p -115.08 105.91 13.49 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.288 -0.882 . . . . 0.0 109.316 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 CA-C-O 118.011 -1.438 . . . . 0.0 109.572 179.966 . . . . . . . . 0 0 . 1 stop_ save_